AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|RACE|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-14|3.4|3.8|3.6|1942|Incidence|53943757|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|3.5|3.8|3.7|2013|Incidence|55173748|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|3.7|4.0|3.8|2127|Incidence|56086557|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|3.5|3.8|3.6|2016|Incidence|56123816|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|3.6|3.7|3.7|10044|Incidence|274499921|All Races|Male and Female|Acute Lymphocytic|2002-2006|||
0-14|3.4|3.7|3.5|2056|Incidence|58431001|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|3.6|3.9|3.8|2262|Incidence|59678430|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|3.5|3.8|3.6|2180|Incidence|59582794|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|3.6|3.9|3.7|2181|Incidence|58268801|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|0.6|0.8|0.7|372|Incidence|53943757|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.5|0.7|0.6|324|Incidence|55173748|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.6|0.7|0.7|376|Incidence|56086557|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.6|0.7|0.7|380|Incidence|56123816|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.6|0.7|0.7|1823|Incidence|274499921|All Races|Male and Female|Acute Myeloid|2002-2006|||
0-14|0.6|0.7|0.6|379|Incidence|58431001|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.6|0.8|0.7|416|Incidence|59678430|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.6|0.7|0.6|373|Incidence|59582794|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.6|0.7|0.7|387|Incidence|58268801|All Races|Male and Female|Acute Myeloid|2006|||
0-14|14.5|15.1|14.8|8142|Incidence|55173748|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|15.2|15.9|15.5|8703|Incidence|56086557|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|15.0|15.7|15.4|8629|Incidence|56123816|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|14.7|15.3|15.0|8801|Incidence|58431001|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|15.4|16.0|15.7|9445|Incidence|59678430|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|14.8|15.4|15.1|9069|Incidence|59582794|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|14.8|15.4|15.1|8864|Incidence|58268801|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|0.7|0.8|0.7|399|Incidence|53943757|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.6|0.7|0.7|375|Incidence|55173748|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.6|0.8|0.7|401|Incidence|56086557|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.6|0.8|0.7|402|Incidence|56123816|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.7|0.7|0.7|1951|Incidence|274499921|All Races|Male and Female|Bones and Joints|2002-2006|||
0-14|0.6|0.8|0.7|410|Incidence|58431001|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.7|0.8|0.7|440|Incidence|59678430|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.6|0.8|0.7|408|Incidence|59582794|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.6|0.8|0.7|406|Incidence|58268801|All Races|Male and Female|Bones and Joints|2006|||
0-14|3.1|3.4|3.2|1735|Incidence|53943757|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|3.2|3.5|3.4|1852|Incidence|55173748|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|3.1|3.4|3.3|1832|Incidence|56086557|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|3.3|3.6|3.4|1932|Incidence|56123816|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|3.3|3.4|3.3|9154|Incidence|274499921|All Races|Male and Female|Brain and Other Nervous System|2002-2006|||
0-14|3.1|3.4|3.3|1919|Incidence|58431001|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|3.3|3.6|3.4|2049|Incidence|59678430|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|3.1|3.4|3.2|1916|Incidence|59582794|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|3.1|3.3|3.2|1872|Incidence|58268801|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|0.5|0.6|0.5|293|Incidence|53943757|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|0.5|0.6|0.6|321|Incidence|55173748|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|0.5|0.7|0.6|334|Incidence|56086557|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|0.5|0.6|0.5|305|Incidence|56123816|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|0.5|0.6|0.6|1564|Incidence|274499921|All Races|Male and Female|Hodgkin Lymphoma|2002-2006|||
0-14|0.5|0.6|0.6|340|Incidence|58431001|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|0.5|0.6|0.5|316|Incidence|59678430|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|0.5|0.7|0.6|348|Incidence|59582794|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|0.5|0.7|0.6|350|Incidence|58268801|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|0.8|0.9|0.8|451|Incidence|53943757|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.8|0.9|0.9|476|Incidence|55173748|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.8|1.0|0.9|491|Incidence|56086557|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.8|0.9|0.9|476|Incidence|56123816|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.8|0.9|0.8|2343|Incidence|274499921|All Races|Male and Female|Kidney and Renal Pelvis|2002-2006|||
0-14|0.8|0.9|0.8|495|Incidence|58431001|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.8|0.9|0.8|501|Incidence|59678430|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.8|0.9|0.8|501|Incidence|59582794|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.8|0.9|0.8|498|Incidence|58268801|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|4.4|4.8|4.6|2486|Incidence|53943757|All Races|Male and Female|Leukemia|1999|||
0-14|4.4|4.8|4.6|2520|Incidence|55173748|All Races|Male and Female|Leukemia|2000|||
0-14|4.7|5.0|4.9|2713|Incidence|56086557|All Races|Male and Female|Leukemia|2001|||
0-14|4.5|4.9|4.7|2629|Incidence|56123816|All Races|Male and Female|Leukemia|2002|||
0-14|4.6|4.8|4.7|12899|Incidence|274499921|All Races|Male and Female|Leukemia|2002-2006|||
0-14|4.3|4.7|4.5|2628|Incidence|58431001|All Races|Male and Female|Leukemia|2003|||
0-14|4.7|5.0|4.9|2911|Incidence|59678430|All Races|Male and Female|Leukemia|2004|||
0-14|4.4|4.8|4.6|2779|Incidence|59582794|All Races|Male and Female|Leukemia|2005|||
0-14|4.5|4.9|4.7|2773|Incidence|58268801|All Races|Male and Female|Leukemia|2006|||
0-14|0.8|1.0|0.9|485|Incidence|53943757|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.8|1.0|0.9|512|Incidence|55173748|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.8|1.0|0.9|512|Incidence|56086557|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.8|1.0|0.9|509|Incidence|56123816|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.9|1.0|0.9|2528|Incidence|274499921|All Races|Male and Female|Non-Hodgkin Lymphoma|2002-2006|||
0-14|0.8|1.0|0.9|526|Incidence|58431001|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.9|1.0|1.0|568|Incidence|59678430|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.8|1.0|0.9|542|Incidence|59582794|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.8|1.0|0.9|515|Incidence|58268801|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|2.7|3.0|2.9|1550|Incidence|53943757|All Races|Male and Female|Other|1999|||
0-14|2.7|3.0|2.9|1573|Incidence|55173748|All Races|Male and Female|Other|2000|||
0-14|3.2|3.5|3.3|1867|Incidence|56086557|All Races|Male and Female|Other|2001|||
0-14|3.0|3.3|3.2|1802|Incidence|56123816|All Races|Male and Female|Other|2002|||
0-14|3.2|3.4|3.3|9138|Incidence|274499921|All Races|Male and Female|Other|2002-2006|||
0-14|3.1|3.4|3.3|1926|Incidence|58431001|All Races|Male and Female|Other|2003|||
0-14|3.3|3.6|3.4|2064|Incidence|59678430|All Races|Male and Female|Other|2004|||
0-14|3.1|3.4|3.3|1991|Incidence|59582794|All Races|Male and Female|Other|2005|||
0-14|3.0|3.3|3.2|1893|Incidence|58268801|All Races|Male and Female|Other|2006|||
0-14|0.8|0.9|0.8|453|Incidence|53943757|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.9|1.0|0.9|513|Incidence|55173748|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.9|1.1|1.0|553|Incidence|56086557|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.9|1.1|1.0|574|Incidence|56123816|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.9|1.0|1.0|2700|Incidence|274499921|All Races|Male and Female|Soft Tissue|2002-2006|||
0-14|0.9|1.0|0.9|557|Incidence|58431001|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.9|1.1|1.0|596|Incidence|59678430|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.9|1.0|1.0|584|Incidence|59582794|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.9|1.0|0.9|557|Incidence|58268801|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.3|0.4|0.3|194|Mortality|59955368|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|0.3|0.4|0.4|234|Mortality|60284171|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|0.3|0.4|0.3|208|Mortality|60476968|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|0.3|0.4|0.4|217|Mortality|60621252|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|0.3|0.4|0.3|1027|Mortality|303500790|All Races|Male and Female|Acute Lymphocytic|2002-2006|||
0-14|0.4|0.5|0.4|246|Mortality|60720015|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|0.3|0.4|0.3|202|Mortality|60776555|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|0.3|0.4|0.3|188|Mortality|60670417|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|0.2|0.3|0.3|174|Mortality|60712551|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|0.2|0.3|0.2|141|Mortality|59955368|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.2|0.3|0.2|145|Mortality|60284171|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.2|0.3|0.3|157|Mortality|60476968|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.2|0.3|0.2|131|Mortality|60621252|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.2|0.2|0.2|681|Mortality|303500790|All Races|Male and Female|Acute Myeloid|2002-2006|||
0-14|0.2|0.3|0.2|142|Mortality|60720015|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.2|0.3|0.2|147|Mortality|60776555|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.2|0.3|0.2|137|Mortality|60670417|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.2|0.2|0.2|124|Mortality|60712551|All Races|Male and Female|Acute Myeloid|2006|||
0-14|2.4|2.7|2.5|1526|Mortality|60284171|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|2.3|2.6|2.5|1494|Mortality|60476968|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|2.4|2.7|2.6|1548|Mortality|60621252|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|2.4|2.7|2.5|1543|Mortality|60720015|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|2.3|2.6|2.5|1492|Mortality|60776555|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|2.3|2.5|2.4|1452|Mortality|60670417|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|2.1|2.4|2.2|1360|Mortality|60712551|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|0.1|0.2|0.1|82|Mortality|59955368|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.1|0.2|0.1|83|Mortality|60284171|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.1|0.2|0.1|88|Mortality|60476968|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.1|0.2|0.1|85|Mortality|60621252|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.1|0.1|0.1|389|Mortality|303500790|All Races|Male and Female|Bones and Joints|2002-2006|||
0-14|0.1|0.2|0.1|82|Mortality|60720015|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.1|0.2|0.1|75|Mortality|60776555|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.1|0.2|0.1|88|Mortality|60670417|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.1|0.1|0.1|59|Mortality|60712551|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.7|0.8|0.7|431|Mortality|59955368|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|0.7|0.8|0.7|440|Mortality|60284171|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|0.6|0.8|0.7|416|Mortality|60476968|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|0.7|0.8|0.8|463|Mortality|60621252|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|0.7|0.8|0.7|2215|Mortality|303500790|All Races|Male and Female|Brain and Other Nervous System|2002-2006|||
0-14|0.7|0.8|0.8|458|Mortality|60720015|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|0.7|0.8|0.7|446|Mortality|60776555|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|0.6|0.8|0.7|426|Mortality|60670417|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|0.6|0.8|0.7|422|Mortality|60712551|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|~|~|~|~|Mortality|59955368|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|~|~|~|~|Mortality|60284171|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|~|~|~|~|Mortality|60476968|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|~|~|~|~|Mortality|60621252|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|0.0|0.0|0.0|33|Mortality|303500790|All Races|Male and Female|Hodgkin Lymphoma|2002-2006|||
0-14|~|~|~|~|Mortality|60720015|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|~|~|~|~|Mortality|60776555|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|~|~|~|~|Mortality|60670417|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|~|~|~|~|Mortality|60712551|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|0.1|0.1|0.1|54|Mortality|59955368|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.1|0.1|0.1|46|Mortality|60284171|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.1|0.1|0.1|58|Mortality|60476968|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.1|0.1|0.1|42|Mortality|60621252|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.1|0.1|0.1|244|Mortality|303500790|All Races|Male and Female|Kidney and Renal Pelvis|2002-2006|||
0-14|0.1|0.1|0.1|54|Mortality|60720015|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.1|0.1|0.1|51|Mortality|60776555|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.1|0.1|0.1|54|Mortality|60670417|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.1|0.1|0.1|43|Mortality|60712551|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.7|0.8|0.8|451|Mortality|59955368|All Races|Male and Female|Leukemia|1999|||
0-14|0.7|0.9|0.8|490|Mortality|60284171|All Races|Male and Female|Leukemia|2000|||
0-14|0.8|0.9|0.8|503|Mortality|60476968|All Races|Male and Female|Leukemia|2001|||
0-14|0.7|0.8|0.7|441|Mortality|60621252|All Races|Male and Female|Leukemia|2002|||
0-14|0.7|0.8|0.7|2229|Mortality|303500790|All Races|Male and Female|Leukemia|2002-2006|||
0-14|0.8|0.9|0.8|505|Mortality|60720015|All Races|Male and Female|Leukemia|2003|||
0-14|0.7|0.8|0.7|455|Mortality|60776555|All Races|Male and Female|Leukemia|2004|||
0-14|0.6|0.8|0.7|417|Mortality|60670417|All Races|Male and Female|Leukemia|2005|||
0-14|0.6|0.7|0.7|411|Mortality|60712551|All Races|Male and Female|Leukemia|2006|||
0-14|0.1|0.1|0.1|55|Mortality|59955368|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.1|0.1|0.1|55|Mortality|60284171|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.0|0.1|0.1|40|Mortality|60476968|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.1|0.2|0.1|74|Mortality|60621252|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.1|0.1|0.1|267|Mortality|303500790|All Races|Male and Female|Non-Hodgkin Lymphoma|2002-2006|||
0-14|0.1|0.1|0.1|50|Mortality|60720015|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.1|0.1|0.1|44|Mortality|60776555|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.1|0.1|0.1|55|Mortality|60670417|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.1|0.1|0.1|44|Mortality|60712551|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.5|0.6|0.5|328|Mortality|59955368|All Races|Male and Female|Other|1999|||
0-14|0.5|0.6|0.6|333|Mortality|60284171|All Races|Male and Female|Other|2000|||
0-14|0.4|0.6|0.5|297|Mortality|60476968|All Races|Male and Female|Other|2001|||
0-14|0.5|0.6|0.6|342|Mortality|60621252|All Races|Male and Female|Other|2002|||
0-14|0.5|0.5|0.5|1584|Mortality|303500790|All Races|Male and Female|Other|2002-2006|||
0-14|0.5|0.6|0.5|311|Mortality|60720015|All Races|Male and Female|Other|2003|||
0-14|0.5|0.6|0.5|317|Mortality|60776555|All Races|Male and Female|Other|2004|||
0-14|0.5|0.6|0.5|318|Mortality|60670417|All Races|Male and Female|Other|2005|||
0-14|0.4|0.5|0.5|296|Mortality|60712551|All Races|Male and Female|Other|2006|||
0-14|0.1|0.2|0.1|87|Mortality|59955368|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.1|0.1|0.1|71|Mortality|60284171|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.1|0.2|0.1|86|Mortality|60476968|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.1|0.2|0.2|95|Mortality|60621252|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.1|0.2|0.1|434|Mortality|303500790|All Races|Male and Female|Soft Tissue|2002-2006|||
0-14|0.1|0.2|0.1|78|Mortality|60720015|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.1|0.2|0.2|98|Mortality|60776555|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.1|0.2|0.1|83|Mortality|60670417|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.1|0.2|0.1|80|Mortality|60712551|All Races|Male and Female|Soft Tissue|2006|||
0-19|2.5|2.8|2.6|926|Incidence|35052274|All Races|Female|Acute Lymphocytic|1999|2.5|2.8|2.6
0-19|2.7|3.0|2.8|1016|Incidence|35895120|All Races|Female|Acute Lymphocytic|2000|2.7|3.0|2.8
0-19|2.8|3.1|2.9|1067|Incidence|36489368|All Races|Female|Acute Lymphocytic|2001|2.8|3.1|2.9
0-19|2.5|2.9|2.7|988|Incidence|36527304|All Races|Female|Acute Lymphocytic|2002|2.5|2.9|2.7
0-19|2.6|2.8|2.7|4870|Incidence|179754611|All Races|Female|Acute Lymphocytic|2002-2006|2.6|2.8|2.7
0-19|2.5|2.8|2.7|1017|Incidence|38101882|All Races|Female|Acute Lymphocytic|2003|2.5|2.8|2.7
0-19|2.6|2.9|2.7|1074|Incidence|39026331|All Races|Female|Acute Lymphocytic|2004|2.6|2.9|2.8
0-19|2.5|2.9|2.7|1063|Incidence|39142019|All Races|Female|Acute Lymphocytic|2005|2.6|2.9|2.7
0-19|2.6|2.9|2.7|1055|Incidence|38424803|All Races|Female|Acute Lymphocytic|2006|2.6|2.9|2.7
0-19|0.6|0.8|0.7|240|Incidence|35052274|All Races|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.7|0.6|226|Incidence|35895120|All Races|Female|Acute Myeloid|2000|0.6|0.7|0.6
0-19|0.6|0.7|0.7|239|Incidence|36489368|All Races|Female|Acute Myeloid|2001|0.6|0.7|0.7
0-19|0.6|0.8|0.7|249|Incidence|36527304|All Races|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.6|0.7|0.6|1169|Incidence|179754611|All Races|Female|Acute Myeloid|2002-2006|0.6|0.7|0.7
0-19|0.6|0.7|0.6|241|Incidence|38101882|All Races|Female|Acute Myeloid|2003|0.6|0.7|0.6
0-19|0.5|0.7|0.6|239|Incidence|39026331|All Races|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|252|Incidence|39142019|All Races|Female|Acute Myeloid|2005|0.6|0.7|0.6
0-19|0.6|0.8|0.7|271|Incidence|38424803|All Races|Female|Acute Myeloid|2006|0.6|0.8|0.7
0-19|14.4|15.2|14.8|5183|Incidence|35052274|All Races|Female|All Cancer Sites Combined|1999|14.4|15.2|14.8
0-19|14.8|15.6|15.2|5448|Incidence|35895120|All Races|Female|All Cancer Sites Combined|2000|14.8|15.6|15.2
0-19|15.7|16.5|16.1|5867|Incidence|36489368|All Races|Female|All Cancer Sites Combined|2001|15.7|16.5|16.1
0-19|15.3|16.1|15.7|5729|Incidence|36527304|All Races|Female|All Cancer Sites Combined|2002|15.3|16.1|15.7
0-19|15.8|16.1|16.0|28830|Incidence|179754611|All Races|Female|All Cancer Sites Combined|2002-2006|15.9|16.2|16.0
0-19|15.5|16.3|15.9|6088|Incidence|38101882|All Races|Female|All Cancer Sites Combined|2003|15.6|16.4|16.0
0-19|15.8|16.6|16.2|6366|Incidence|39026331|All Races|Female|All Cancer Sites Combined|2004|15.9|16.7|16.3
0-19|15.7|16.4|16.0|6335|Incidence|39142019|All Races|Female|All Cancer Sites Combined|2005|15.8|16.6|16.2
0-19|15.1|15.9|15.5|6014|Incidence|38424803|All Races|Female|All Cancer Sites Combined|2006|15.3|16.1|15.7
0-19|0.7|0.9|0.8|269|Incidence|35052274|All Races|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|278|Incidence|35895120|All Races|Female|Bones and Joints|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|305|Incidence|36489368|All Races|Female|Bones and Joints|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|286|Incidence|36527304|All Races|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|0.9|0.8|1484|Incidence|179754611|All Races|Female|Bones and Joints|2002-2006|0.8|0.9|0.8
0-19|0.8|0.9|0.9|326|Incidence|38101882|All Races|Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.8|1.0|0.9|343|Incidence|39026331|All Races|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.7|0.9|0.8|312|Incidence|39142019|All Races|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|302|Incidence|38424803|All Races|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|2.6|2.9|2.7|961|Incidence|35052274|All Races|Female|Brain and Other Nervous System|1999|2.6|2.9|2.7
0-19|2.6|3.0|2.8|1003|Incidence|35895120|All Races|Female|Brain and Other Nervous System|2000|2.6|3.0|2.8
0-19|2.7|3.0|2.8|1032|Incidence|36489368|All Races|Female|Brain and Other Nervous System|2001|2.7|3.0|2.8
0-19|2.6|3.0|2.8|1012|Incidence|36527304|All Races|Female|Brain and Other Nervous System|2002|2.6|2.9|2.8
0-19|2.8|3.0|2.9|5172|Incidence|179754611|All Races|Female|Brain and Other Nervous System|2002-2006|2.8|3.0|2.9
0-19|2.7|3.1|2.9|1100|Incidence|38101882|All Races|Female|Brain and Other Nervous System|2003|2.7|3.1|2.9
0-19|2.9|3.2|3.0|1188|Incidence|39026331|All Races|Female|Brain and Other Nervous System|2004|2.9|3.2|3.0
0-19|2.7|3.0|2.9|1117|Incidence|39142019|All Races|Female|Brain and Other Nervous System|2005|2.7|3.0|2.9
0-19|2.6|2.9|2.7|1057|Incidence|38424803|All Races|Female|Brain and Other Nervous System|2006|2.6|2.9|2.8
0-19|1.0|1.2|1.1|381|Incidence|35052274|All Races|Female|Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.3|1.2|427|Incidence|35895120|All Races|Female|Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.3|1.2|431|Incidence|36489368|All Races|Female|Hodgkin Lymphoma|2001|1.1|1.3|1.2
0-19|1.1|1.3|1.2|443|Incidence|36527304|All Races|Female|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.1|1.2|1.2|2143|Incidence|179754611|All Races|Female|Hodgkin Lymphoma|2002-2006|1.1|1.2|1.2
0-19|1.0|1.3|1.1|436|Incidence|38101882|All Races|Female|Hodgkin Lymphoma|2003|1.0|1.3|1.1
0-19|1.1|1.3|1.2|460|Incidence|39026331|All Races|Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.1|1.3|1.2|472|Incidence|39142019|All Races|Female|Hodgkin Lymphoma|2005|1.1|1.3|1.2
0-19|1.0|1.3|1.1|447|Incidence|38424803|All Races|Female|Hodgkin Lymphoma|2006|1.1|1.3|1.2
0-19|0.6|0.8|0.7|246|Incidence|35052274|All Races|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|253|Incidence|35895120|All Races|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.8|273|Incidence|36489368|All Races|Female|Kidney and Renal Pelvis|2001|0.7|0.8|0.7
0-19|0.6|0.8|0.7|246|Incidence|36527304|All Races|Female|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.7|0.7|0.7|1280|Incidence|179754611|All Races|Female|Kidney and Renal Pelvis|2002-2006|0.7|0.8|0.7
0-19|0.7|0.9|0.8|290|Incidence|38101882|All Races|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.6|0.8|0.7|264|Incidence|39026331|All Races|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|286|Incidence|39142019|All Races|Female|Kidney and Renal Pelvis|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|272|Incidence|38424803|All Races|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|3.4|3.8|3.6|1272|Incidence|35052274|All Races|Female|Leukemia|1999|3.4|3.8|3.6
0-19|3.6|4.0|3.8|1354|Incidence|35895120|All Races|Female|Leukemia|2000|3.6|4.0|3.8
0-19|3.8|4.2|4.0|1438|Incidence|36489368|All Races|Female|Leukemia|2001|3.7|4.1|3.9
0-19|3.6|4.0|3.8|1385|Incidence|36527304|All Races|Female|Leukemia|2002|3.6|4.0|3.8
0-19|3.6|3.8|3.7|6685|Incidence|179754611|All Races|Female|Leukemia|2002-2006|3.6|3.8|3.7
0-19|3.4|3.8|3.6|1377|Incidence|38101882|All Races|Female|Leukemia|2003|3.4|3.8|3.6
0-19|3.5|3.9|3.7|1452|Incidence|39026331|All Races|Female|Leukemia|2004|3.5|3.9|3.7
0-19|3.5|3.9|3.7|1455|Incidence|39142019|All Races|Female|Leukemia|2005|3.5|3.9|3.7
0-19|3.6|4.0|3.8|1462|Incidence|38424803|All Races|Female|Leukemia|2006|3.6|4.0|3.8
0-19|0.6|0.8|0.7|248|Incidence|35052274|All Races|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.8|0.8|270|Incidence|35895120|All Races|Female|Non-Hodgkin Lymphoma|2000|0.7|0.8|0.8
0-19|0.7|0.9|0.8|291|Incidence|36489368|All Races|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|287|Incidence|36527304|All Races|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.8|1395|Incidence|179754611|All Races|Female|Non-Hodgkin Lymphoma|2002-2006|0.7|0.8|0.8
0-19|0.6|0.8|0.7|275|Incidence|38101882|All Races|Female|Non-Hodgkin Lymphoma|2003|0.6|0.8|0.7
0-19|0.7|0.9|0.8|306|Incidence|39026331|All Races|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.9|0.8|311|Incidence|39142019|All Races|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.6|0.8|0.7|283|Incidence|38424803|All Races|Female|Non-Hodgkin Lymphoma|2006|0.7|0.8|0.7
0-19|4.1|4.5|4.3|1497|Incidence|35052274|All Races|Female|Other|1999|4.1|4.5|4.3
0-19|4.0|4.4|4.2|1512|Incidence|35895120|All Races|Female|Other|2000|4.0|4.4|4.2
0-19|4.5|5.0|4.7|1732|Incidence|36489368|All Races|Female|Other|2001|4.5|5.0|4.7
0-19|4.5|4.9|4.7|1709|Incidence|36527304|All Races|Female|Other|2002|4.5|4.9|4.7
0-19|4.8|5.0|4.9|8863|Incidence|179754611|All Races|Female|Other|2002-2006|4.8|5.0|4.9
0-19|4.7|5.2|4.9|1897|Incidence|38101882|All Races|Female|Other|2003|4.8|5.2|5.0
0-19|4.7|5.1|4.9|1935|Incidence|39026331|All Races|Female|Other|2004|4.7|5.2|5.0
0-19|4.8|5.3|5.0|2003|Incidence|39142019|All Races|Female|Other|2005|4.9|5.3|5.1
0-19|4.4|4.9|4.6|1816|Incidence|38424803|All Races|Female|Other|2006|4.5|4.9|4.7
0-19|0.8|1.0|0.9|309|Incidence|35052274|All Races|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|351|Incidence|35895120|All Races|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|365|Incidence|36489368|All Races|Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|361|Incidence|36527304|All Races|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|1.0|1.0|1.0|1808|Incidence|179754611|All Races|Female|Soft Tissue|2002-2006|1.0|1.1|1.0
0-19|0.9|1.1|1.0|387|Incidence|38101882|All Races|Female|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.2|1.1|418|Incidence|39026331|All Races|Female|Soft Tissue|2004|1.0|1.2|1.1
0-19|0.9|1.1|1.0|379|Incidence|39142019|All Races|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|0.9|1.1|1.0|375|Incidence|38424803|All Races|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|3.3|3.6|3.4|1268|Incidence|36868306|All Races|Male|Acute Lymphocytic|1999|3.3|3.6|3.4
0-19|3.3|3.6|3.5|1299|Incidence|37753973|All Races|Male|Acute Lymphocytic|2000|3.3|3.6|3.4
0-19|3.4|3.7|3.6|1355|Incidence|38388725|All Races|Male|Acute Lymphocytic|2001|3.3|3.7|3.5
0-19|3.3|3.7|3.5|1328|Incidence|38412005|All Races|Male|Acute Lymphocytic|2002|3.3|3.6|3.5
0-19|3.4|3.6|3.5|6647|Incidence|188738186|All Races|Male|Acute Lymphocytic|2002-2006|3.4|3.6|3.5
0-19|3.1|3.5|3.3|1320|Incidence|40010152|All Races|Male|Acute Lymphocytic|2003|3.1|3.5|3.3
0-19|3.5|3.9|3.7|1517|Incidence|40953126|All Races|Male|Acute Lymphocytic|2004|3.5|3.9|3.7
0-19|3.3|3.7|3.5|1438|Incidence|41058994|All Races|Male|Acute Lymphocytic|2005|3.3|3.7|3.5
0-19|3.4|3.8|3.6|1451|Incidence|40293824|All Races|Male|Acute Lymphocytic|2006|3.4|3.8|3.6
0-19|0.7|0.9|0.8|291|Incidence|36868306|All Races|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|250|Incidence|37753973|All Races|Male|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.7|0.8|0.8|290|Incidence|38388725|All Races|Male|Acute Myeloid|2001|0.7|0.8|0.8
0-19|0.7|0.9|0.8|293|Incidence|38412005|All Races|Male|Acute Myeloid|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1416|Incidence|188738186|All Races|Male|Acute Myeloid|2002-2006|0.7|0.8|0.8
0-19|0.7|0.8|0.7|294|Incidence|40010152|All Races|Male|Acute Myeloid|2003|0.7|0.8|0.7
0-19|0.8|0.9|0.8|350|Incidence|40953126|All Races|Male|Acute Myeloid|2004|0.8|0.9|0.9
0-19|0.6|0.7|0.7|270|Incidence|41058994|All Races|Male|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|283|Incidence|40293824|All Races|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|16.5|17.3|16.9|6218|Incidence|36868306|All Races|Male|All Cancer Sites Combined|1999|16.4|17.3|16.9
0-19|16.7|17.6|17.1|6457|Incidence|37753973|All Races|Male|All Cancer Sites Combined|2000|16.7|17.5|17.1
0-19|17.3|18.1|17.7|6791|Incidence|38388725|All Races|Male|All Cancer Sites Combined|2001|17.3|18.1|17.7
0-19|17.6|18.5|18.1|6938|Incidence|38412005|All Races|Male|All Cancer Sites Combined|2002|17.6|18.5|18.1
0-19|17.6|18.0|17.8|33798|Incidence|188738186|All Races|Male|All Cancer Sites Combined|2002-2006|17.7|18.1|17.9
0-19|16.7|17.5|17.1|6872|Incidence|40010152|All Races|Male|All Cancer Sites Combined|2003|16.8|17.6|17.2
0-19|17.7|18.5|18.1|7457|Incidence|40953126|All Races|Male|All Cancer Sites Combined|2004|17.8|18.6|18.2
0-19|17.2|18.0|17.6|7263|Incidence|41058994|All Races|Male|All Cancer Sites Combined|2005|17.3|18.1|17.7
0-19|17.2|18.1|17.6|7172|Incidence|40293824|All Races|Male|All Cancer Sites Combined|2006|17.4|18.2|17.8
0-19|0.9|1.1|1.0|378|Incidence|36868306|All Races|Male|Bones and Joints|1999|0.9|1.1|1.0
0-19|0.8|1.0|0.9|354|Incidence|37753973|All Races|Male|Bones and Joints|2000|0.8|1.0|0.9
0-19|1.0|1.2|1.1|414|Incidence|38388725|All Races|Male|Bones and Joints|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|413|Incidence|38412005|All Races|Male|Bones and Joints|2002|1.0|1.2|1.1
0-19|1.0|1.1|1.0|1914|Incidence|188738186|All Races|Male|Bones and Joints|2002-2006|1.0|1.1|1.0
0-19|0.8|1.0|0.9|377|Incidence|40010152|All Races|Male|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.9|1.1|1.0|399|Incidence|40953126|All Races|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|0.9|1.1|1.0|405|Incidence|41058994|All Races|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.2|1.1|431|Incidence|40293824|All Races|Male|Bones and Joints|2006|1.0|1.2|1.1
0-19|2.9|3.3|3.1|1143|Incidence|36868306|All Races|Male|Brain and Other Nervous System|1999|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1253|Incidence|37753973|All Races|Male|Brain and Other Nervous System|2000|3.1|3.5|3.3
0-19|3.0|3.3|3.1|1199|Incidence|38388725|All Races|Male|Brain and Other Nervous System|2001|2.9|3.3|3.1
0-19|3.3|3.6|3.5|1323|Incidence|38412005|All Races|Male|Brain and Other Nervous System|2002|3.3|3.6|3.4
0-19|3.1|3.3|3.2|6064|Incidence|188738186|All Races|Male|Brain and Other Nervous System|2002-2006|3.1|3.3|3.2
0-19|2.9|3.3|3.1|1237|Incidence|40010152|All Races|Male|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.1|3.4|3.2|1325|Incidence|40953126|All Races|Male|Brain and Other Nervous System|2004|3.1|3.4|3.2
0-19|2.9|3.2|3.1|1251|Incidence|41058994|All Races|Male|Brain and Other Nervous System|2005|2.9|3.2|3.0
0-19|3.0|3.3|3.2|1276|Incidence|40293824|All Races|Male|Brain and Other Nervous System|2006|3.0|3.3|3.2
0-19|1.2|1.4|1.3|468|Incidence|36868306|All Races|Male|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.1|1.4|1.2|469|Incidence|37753973|All Races|Male|Hodgkin Lymphoma|2000|1.1|1.4|1.2
0-19|1.2|1.4|1.3|499|Incidence|38388725|All Races|Male|Hodgkin Lymphoma|2001|1.2|1.4|1.3
0-19|1.1|1.3|1.2|467|Incidence|38412005|All Races|Male|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.2|1.3|1.3|2454|Incidence|188738186|All Races|Male|Hodgkin Lymphoma|2002-2006|1.2|1.4|1.3
0-19|1.2|1.4|1.3|534|Incidence|40010152|All Races|Male|Hodgkin Lymphoma|2003|1.2|1.5|1.3
0-19|1.1|1.3|1.2|494|Incidence|40953126|All Races|Male|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.2|1.5|1.3|555|Incidence|41058994|All Races|Male|Hodgkin Lymphoma|2005|1.2|1.5|1.4
0-19|1.2|1.5|1.3|544|Incidence|40293824|All Races|Male|Hodgkin Lymphoma|2006|1.2|1.5|1.4
0-19|0.6|0.7|0.6|232|Incidence|36868306|All Races|Male|Kidney and Renal Pelvis|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.7|246|Incidence|37753973|All Races|Male|Kidney and Renal Pelvis|2000|0.6|0.7|0.7
0-19|0.6|0.7|0.7|248|Incidence|38388725|All Races|Male|Kidney and Renal Pelvis|2001|0.6|0.7|0.6
0-19|0.6|0.8|0.7|254|Incidence|38412005|All Races|Male|Kidney and Renal Pelvis|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.6|1230|Incidence|188738186|All Races|Male|Kidney and Renal Pelvis|2002-2006|0.6|0.7|0.7
0-19|0.5|0.7|0.6|234|Incidence|40010152|All Races|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.6|0.8|0.7|276|Incidence|40953126|All Races|Male|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.5|0.7|0.6|259|Incidence|41058994|All Races|Male|Kidney and Renal Pelvis|2005|0.6|0.7|0.6
0-19|0.6|0.8|0.7|273|Incidence|40293824|All Races|Male|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|4.4|4.8|4.6|1702|Incidence|36868306|All Races|Male|Leukemia|1999|4.4|4.8|4.6
0-19|4.2|4.7|4.5|1675|Incidence|37753973|All Races|Male|Leukemia|2000|4.2|4.7|4.4
0-19|4.5|5.0|4.7|1809|Incidence|38388725|All Races|Male|Leukemia|2001|4.5|4.9|4.7
0-19|4.4|4.9|4.6|1779|Incidence|38412005|All Races|Male|Leukemia|2002|4.4|4.9|4.6
0-19|4.6|4.8|4.7|8880|Incidence|188738186|All Races|Male|Leukemia|2002-2006|4.6|4.8|4.7
0-19|4.2|4.7|4.4|1777|Incidence|40010152|All Races|Male|Leukemia|2003|4.2|4.7|4.4
0-19|4.8|5.2|5.0|2042|Incidence|40953126|All Races|Male|Leukemia|2004|4.8|5.2|5.0
0-19|4.4|4.8|4.6|1892|Incidence|41058994|All Races|Male|Leukemia|2005|4.4|4.8|4.6
0-19|4.5|4.9|4.7|1911|Incidence|40293824|All Races|Male|Leukemia|2006|4.5|5.0|4.7
0-19|1.3|1.5|1.4|516|Incidence|36868306|All Races|Male|Non-Hodgkin Lymphoma|1999|1.3|1.5|1.4
0-19|1.4|1.6|1.5|571|Incidence|37753973|All Races|Male|Non-Hodgkin Lymphoma|2000|1.4|1.6|1.5
0-19|1.3|1.5|1.4|548|Incidence|38388725|All Races|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.4
0-19|1.3|1.6|1.4|554|Incidence|38412005|All Races|Male|Non-Hodgkin Lymphoma|2002|1.3|1.6|1.4
0-19|1.4|1.5|1.5|2784|Incidence|188738186|All Races|Male|Non-Hodgkin Lymphoma|2002-2006|1.4|1.5|1.5
0-19|1.3|1.5|1.4|569|Incidence|40010152|All Races|Male|Non-Hodgkin Lymphoma|2003|1.3|1.5|1.4
0-19|1.3|1.6|1.4|592|Incidence|40953126|All Races|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.4|1.7|1.5|629|Incidence|41058994|All Races|Male|Non-Hodgkin Lymphoma|2005|1.4|1.7|1.5
0-19|1.3|1.6|1.5|591|Incidence|40293824|All Races|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|3.8|4.2|4.0|1464|Incidence|36868306|All Races|Male|Other|1999|3.8|4.2|4.0
0-19|3.8|4.2|4.0|1501|Incidence|37753973|All Races|Male|Other|2000|3.8|4.2|4.0
0-19|4.2|4.6|4.4|1682|Incidence|38388725|All Races|Male|Other|2001|4.2|4.6|4.4
0-19|4.3|4.7|4.5|1735|Incidence|38412005|All Races|Male|Other|2002|4.3|4.7|4.5
0-19|4.4|4.5|4.4|8499|Incidence|188738186|All Races|Male|Other|2002-2006|4.4|4.6|4.5
0-19|4.1|4.5|4.3|1732|Incidence|40010152|All Races|Male|Other|2003|4.1|4.5|4.3
0-19|4.4|4.8|4.6|1910|Incidence|40953126|All Races|Male|Other|2004|4.5|4.9|4.7
0-19|4.2|4.6|4.4|1830|Incidence|41058994|All Races|Male|Other|2005|4.3|4.7|4.5
0-19|4.0|4.4|4.2|1747|Incidence|40293824|All Races|Male|Other|2006|4.1|4.5|4.3
0-19|0.8|1.0|0.9|315|Incidence|36868306|All Races|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|388|Incidence|37753973|All Races|Male|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|392|Incidence|38388725|All Races|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|413|Incidence|38412005|All Races|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|1.0|1.1|1.0|1973|Incidence|188738186|All Races|Male|Soft Tissue|2002-2006|1.0|1.1|1.0
0-19|0.9|1.1|1.0|412|Incidence|40010152|All Races|Male|Soft Tissue|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|419|Incidence|40953126|All Races|Male|Soft Tissue|2004|0.9|1.1|1.0
0-19|1.0|1.2|1.1|442|Incidence|41058994|All Races|Male|Soft Tissue|2005|1.0|1.2|1.1
0-19|0.9|1.1|1.0|399|Incidence|40293824|All Races|Male|Soft Tissue|2006|0.9|1.1|1.0
0-19|2.9|3.2|3.0|2194|Incidence|71920580|All Races|Male and Female|Acute Lymphocytic|1999|2.9|3.2|3.1
0-19|3.0|3.3|3.2|2315|Incidence|73649093|All Races|Male and Female|Acute Lymphocytic|2000|3.0|3.3|3.1
0-19|3.1|3.4|3.3|2422|Incidence|74878093|All Races|Male and Female|Acute Lymphocytic|2001|3.1|3.4|3.2
0-19|3.0|3.2|3.1|2316|Incidence|74939309|All Races|Male and Female|Acute Lymphocytic|2002|3.0|3.2|3.1
0-19|3.1|3.2|3.1|11517|Incidence|368492797|All Races|Male and Female|Acute Lymphocytic|2002-2006|3.1|3.2|3.1
0-19|2.9|3.1|3.0|2337|Incidence|78112034|All Races|Male and Female|Acute Lymphocytic|2003|2.9|3.1|3.0
0-19|3.1|3.4|3.2|2591|Incidence|79979457|All Races|Male and Female|Acute Lymphocytic|2004|3.1|3.4|3.2
0-19|3.0|3.2|3.1|2501|Incidence|80201013|All Races|Male and Female|Acute Lymphocytic|2005|3.0|3.2|3.1
0-19|3.1|3.3|3.2|2506|Incidence|78718627|All Races|Male and Female|Acute Lymphocytic|2006|3.1|3.3|3.2
0-19|0.7|0.8|0.7|531|Incidence|71920580|All Races|Male and Female|Acute Myeloid|1999|0.7|0.8|0.7
0-19|0.6|0.7|0.6|476|Incidence|73649093|All Races|Male and Female|Acute Myeloid|2000|0.6|0.7|0.6
0-19|0.6|0.8|0.7|529|Incidence|74878093|All Races|Male and Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.7|0.8|0.7|542|Incidence|74939309|All Races|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.7|0.7|0.7|2585|Incidence|368492797|All Races|Male and Female|Acute Myeloid|2002-2006|0.7|0.7|0.7
0-19|0.6|0.7|0.7|535|Incidence|78112034|All Races|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.8|0.7|589|Incidence|79979457|All Races|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.6|0.7|0.6|522|Incidence|80201013|All Races|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.8|0.7|554|Incidence|78718627|All Races|Male and Female|Acute Myeloid|2006|0.6|0.8|0.7
0-19|15.6|16.2|15.9|11401|Incidence|71920580|All Races|Male and Female|All Cancer Sites Combined|1999|15.6|16.1|15.9
0-19|15.9|16.5|16.2|11905|Incidence|73649093|All Races|Male and Female|All Cancer Sites Combined|2000|15.9|16.5|16.2
0-19|16.6|17.2|16.9|12658|Incidence|74878093|All Races|Male and Female|All Cancer Sites Combined|2001|16.6|17.2|16.9
0-19|16.6|17.2|16.9|12667|Incidence|74939309|All Races|Male and Female|All Cancer Sites Combined|2002|16.6|17.2|16.9
0-19|16.8|17.0|16.9|62628|Incidence|368492797|All Races|Male and Female|All Cancer Sites Combined|2002-2006|16.9|17.1|17.0
0-19|16.3|16.8|16.5|12960|Incidence|78112034|All Races|Male and Female|All Cancer Sites Combined|2003|16.3|16.9|16.6
0-19|16.9|17.5|17.2|13823|Incidence|79979457|All Races|Male and Female|All Cancer Sites Combined|2004|17.0|17.6|17.3
0-19|16.5|17.1|16.8|13598|Incidence|80201013|All Races|Male and Female|All Cancer Sites Combined|2005|16.7|17.2|17.0
0-19|16.3|16.9|16.6|13186|Incidence|78718627|All Races|Male and Female|All Cancer Sites Combined|2006|16.5|17.0|16.8
0-19|0.8|1.0|0.9|647|Incidence|71920580|All Races|Male and Female|Bones and Joints|1999|0.8|1.0|0.9
0-19|0.8|0.9|0.9|632|Incidence|73649093|All Races|Male and Female|Bones and Joints|2000|0.8|0.9|0.9
0-19|0.9|1.0|1.0|719|Incidence|74878093|All Races|Male and Female|Bones and Joints|2001|0.9|1.0|1.0
0-19|0.9|1.0|0.9|699|Incidence|74939309|All Races|Male and Female|Bones and Joints|2002|0.9|1.0|0.9
0-19|0.9|0.9|0.9|3398|Incidence|368492797|All Races|Male and Female|Bones and Joints|2002-2006|0.9|1.0|0.9
0-19|0.8|1.0|0.9|703|Incidence|78112034|All Races|Male and Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.9|1.0|0.9|742|Incidence|79979457|All Races|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.8|1.0|0.9|717|Incidence|80201013|All Races|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.0|0.9|733|Incidence|78718627|All Races|Male and Female|Bones and Joints|2006|0.9|1.0|0.9
0-19|2.8|3.0|2.9|2104|Incidence|71920580|All Races|Male and Female|Brain and Other Nervous System|1999|2.8|3.1|2.9
0-19|2.9|3.2|3.1|2256|Incidence|73649093|All Races|Male and Female|Brain and Other Nervous System|2000|2.9|3.2|3.1
0-19|2.9|3.1|3.0|2231|Incidence|74878093|All Races|Male and Female|Brain and Other Nervous System|2001|2.9|3.1|3.0
0-19|3.0|3.3|3.1|2335|Incidence|74939309|All Races|Male and Female|Brain and Other Nervous System|2002|3.0|3.2|3.1
0-19|3.0|3.1|3.1|11236|Incidence|368492797|All Races|Male and Female|Brain and Other Nervous System|2002-2006|3.0|3.1|3.0
0-19|2.9|3.1|3.0|2337|Incidence|78112034|All Races|Male and Female|Brain and Other Nervous System|2003|2.9|3.1|3.0
0-19|3.0|3.3|3.1|2513|Incidence|79979457|All Races|Male and Female|Brain and Other Nervous System|2004|3.0|3.3|3.1
0-19|2.8|3.1|3.0|2368|Incidence|80201013|All Races|Male and Female|Brain and Other Nervous System|2005|2.8|3.1|3.0
0-19|2.8|3.1|3.0|2333|Incidence|78718627|All Races|Male and Female|Brain and Other Nervous System|2006|2.8|3.1|3.0
0-19|1.1|1.3|1.2|849|Incidence|71920580|All Races|Male and Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.1|1.3|1.2|896|Incidence|73649093|All Races|Male and Female|Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.2|1.3|1.2|930|Incidence|74878093|All Races|Male and Female|Hodgkin Lymphoma|2001|1.2|1.3|1.2
0-19|1.1|1.3|1.2|910|Incidence|74939309|All Races|Male and Female|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.2|1.3|1.2|4597|Incidence|368492797|All Races|Male and Female|Hodgkin Lymphoma|2002-2006|1.2|1.3|1.2
0-19|1.2|1.3|1.2|970|Incidence|78112034|All Races|Male and Female|Hodgkin Lymphoma|2003|1.2|1.3|1.2
0-19|1.1|1.3|1.2|954|Incidence|79979457|All Races|Male and Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.2|1.3|1.3|1027|Incidence|80201013|All Races|Male and Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.2|1.3|1.2|991|Incidence|78718627|All Races|Male and Female|Hodgkin Lymphoma|2006|1.2|1.3|1.3
0-19|0.6|0.7|0.7|478|Incidence|71920580|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.7
0-19|0.6|0.7|0.7|499|Incidence|73649093|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|521|Incidence|74878093|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.7|500|Incidence|74939309|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2510|Incidence|368492797|All Races|Male and Female|Kidney and Renal Pelvis|2002-2006|0.7|0.7|0.7
0-19|0.6|0.7|0.7|524|Incidence|78112034|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.7|540|Incidence|79979457|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Incidence|80201013|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Incidence|78718627|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|4.0|4.3|4.1|2974|Incidence|71920580|All Races|Male and Female|Leukemia|1999|4.0|4.3|4.1
0-19|4.0|4.3|4.1|3029|Incidence|73649093|All Races|Male and Female|Leukemia|2000|4.0|4.3|4.1
0-19|4.2|4.5|4.4|3247|Incidence|74878093|All Races|Male and Female|Leukemia|2001|4.2|4.5|4.3
0-19|4.1|4.4|4.2|3164|Incidence|74939309|All Races|Male and Female|Leukemia|2002|4.1|4.4|4.2
0-19|4.2|4.3|4.2|15565|Incidence|368492797|All Races|Male and Female|Leukemia|2002-2006|4.2|4.3|4.2
0-19|3.9|4.2|4.0|3154|Incidence|78112034|All Races|Male and Female|Leukemia|2003|3.9|4.2|4.0
0-19|4.2|4.5|4.4|3494|Incidence|79979457|All Races|Male and Female|Leukemia|2004|4.2|4.5|4.4
0-19|4.0|4.3|4.2|3347|Incidence|80201013|All Races|Male and Female|Leukemia|2005|4.0|4.3|4.2
0-19|4.1|4.4|4.3|3373|Incidence|78718627|All Races|Male and Female|Leukemia|2006|4.1|4.4|4.3
0-19|1.0|1.1|1.1|764|Incidence|71920580|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.1|1.1
0-19|1.1|1.2|1.1|841|Incidence|73649093|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.2|1.1
0-19|1.0|1.2|1.1|839|Incidence|74878093|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|841|Incidence|74939309|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.2|1.1
0-19|1.1|1.2|1.1|4179|Incidence|368492797|All Races|Male and Female|Non-Hodgkin Lymphoma|2002-2006|1.1|1.2|1.1
0-19|1.0|1.2|1.1|844|Incidence|78112034|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.0|1.2|1.1|898|Incidence|79979457|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|1.1|1.2|1.1
0-19|1.1|1.2|1.2|940|Incidence|80201013|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|1.1|1.2|1.2
0-19|1.0|1.2|1.1|874|Incidence|78718627|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.2|1.1
0-19|4.0|4.3|4.1|2961|Incidence|71920580|All Races|Male and Female|Other|1999|4.0|4.3|4.1
0-19|4.0|4.3|4.1|3013|Incidence|73649093|All Races|Male and Female|Other|2000|3.9|4.2|4.1
0-19|4.4|4.7|4.6|3414|Incidence|74878093|All Races|Male and Female|Other|2001|4.4|4.7|4.6
0-19|4.4|4.7|4.6|3444|Incidence|74939309|All Races|Male and Female|Other|2002|4.4|4.8|4.6
0-19|4.6|4.7|4.7|17362|Incidence|368492797|All Races|Male and Female|Other|2002-2006|4.6|4.8|4.7
0-19|4.5|4.8|4.6|3629|Incidence|78112034|All Races|Male and Female|Other|2003|4.5|4.8|4.6
0-19|4.6|4.9|4.8|3845|Incidence|79979457|All Races|Male and Female|Other|2004|4.7|5.0|4.8
0-19|4.6|4.9|4.7|3833|Incidence|80201013|All Races|Male and Female|Other|2005|4.6|4.9|4.8
0-19|4.3|4.6|4.4|3563|Incidence|78718627|All Races|Male and Female|Other|2006|4.4|4.7|4.5
0-19|0.8|0.9|0.9|624|Incidence|71920580|All Races|Male and Female|Soft Tissue|1999|0.8|0.9|0.9
0-19|0.9|1.1|1.0|739|Incidence|73649093|All Races|Male and Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|757|Incidence|74878093|All Races|Male and Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.1|1.0|774|Incidence|74939309|All Races|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|1.0|1.0|1.0|3781|Incidence|368492797|All Races|Male and Female|Soft Tissue|2002-2006|1.0|1.1|1.0
0-19|0.9|1.1|1.0|799|Incidence|78112034|All Races|Male and Female|Soft Tissue|2003|1.0|1.1|1.0
0-19|1.0|1.1|1.0|837|Incidence|79979457|All Races|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|0.9|1.1|1.0|821|Incidence|80201013|All Races|Male and Female|Soft Tissue|2005|1.0|1.1|1.0
0-19|0.9|1.0|1.0|774|Incidence|78718627|All Races|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|1.3|2.5|1.8|39|Incidence|2278758|American Indian/Alaska Native|Female|Acute Lymphocytic|2002-2006|1.2|2.3|1.7
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|0.5|1.3|0.9|19|Incidence|2278758|American Indian/Alaska Native|Female|Acute Myeloid|2002-2006|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|7.0|12.7|9.5|47|Incidence|500145|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|6.9|12.5|9.4
0-19|5.7|10.8|8.0|41|Incidence|518776|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|5.7|10.7|7.9
0-19|8.8|14.9|11.5|60|Incidence|532293|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|8.6|14.5|11.3
0-19|8.8|14.9|11.5|59|Incidence|526610|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|8.5|14.5|11.2
0-19|9.7|12.5|11.0|245|Incidence|2278758|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002-2006|9.4|12.2|10.8
0-19|6.5|11.9|8.9|46|Incidence|526495|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|6.4|11.7|8.7
0-19|7.8|13.6|10.4|53|Incidence|522749|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|7.6|13.3|10.1
0-19|9.3|15.6|12.1|62|Incidence|516919|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|9.2|15.4|12.0
0-19|8.7|15.4|11.7|51|Incidence|452815|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|8.4|14.8|11.3
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|2278758|American Indian/Alaska Native|Female|Bones and Joints|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|1.3|2.5|1.8|40|Incidence|2278758|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002-2006|1.3|2.4|1.8
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|2278758|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|2278758|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|1.8|5.2|3.2|16|Incidence|500145|American Indian/Alaska Native|Female|Leukemia|1999|1.8|5.2|3.2
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|2.1|5.5|3.5|19|Incidence|532293|American Indian/Alaska Native|Female|Leukemia|2001|2.1|5.6|3.6
0-19|1.8|5.1|3.1|16|Incidence|526610|American Indian/Alaska Native|Female|Leukemia|2002|1.7|4.9|3.0
0-19|2.3|3.8|2.9|64|Incidence|2278758|American Indian/Alaska Native|Female|Leukemia|2002-2006|2.2|3.6|2.8
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|2278758|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|2.2|5.8|3.7|18|Incidence|500145|American Indian/Alaska Native|Female|Other|1999|2.1|5.7|3.6
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|2.4|6.2|4.0|20|Incidence|532293|American Indian/Alaska Native|Female|Other|2001|2.3|5.8|3.8
0-19|2.2|5.8|3.7|19|Incidence|526610|American Indian/Alaska Native|Female|Other|2002|2.2|5.6|3.6
0-19|2.7|4.3|3.5|79|Incidence|2278758|American Indian/Alaska Native|Female|Other|2002-2006|2.7|4.3|3.5
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|2.7|6.6|4.3|23|Incidence|516919|American Indian/Alaska Native|Female|Other|2005|2.8|6.7|4.4
0-19|2.2|6.2|3.8|17|Incidence|452815|American Indian/Alaska Native|Female|Other|2006|2.2|6.0|3.8
0-19|~|~|~|~|Incidence|500145|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|518776|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|532293|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|526610|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|0.6|1.5|1.0|20|Incidence|2278758|American Indian/Alaska Native|Female|Soft Tissue|2002-2006|0.5|1.4|0.9
0-19|~|~|~|~|Incidence|526495|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|522749|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|516919|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|452815|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|2.0|5.4|3.3|17|Incidence|518709|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|1.9|5.2|3.3
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|1.9|5.2|3.2|17|Incidence|550686|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|1.8|4.9|3.1
0-19|2.0|5.4|3.4|18|Incidence|543641|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|2.0|5.2|3.3
0-19|1.9|3.2|2.5|55|Incidence|2353631|American Indian/Alaska Native|Male|Acute Lymphocytic|2002-2006|1.8|3.0|2.3
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|2.1|5.7|3.6|18|Incidence|538790|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|2.0|5.3|3.3
0-19|1.8|5.2|3.2|16|Incidence|532401|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|1.7|4.9|3.0
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|2353631|American Indian/Alaska Native|Male|Acute Myeloid|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|6.2|11.5|8.6|44|Incidence|518709|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|6.2|11.4|8.5
0-19|6.6|11.9|8.9|48|Incidence|537305|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|6.6|11.8|8.9
0-19|7.9|13.6|10.4|56|Incidence|550686|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|7.7|13.2|10.2
0-19|9.5|15.7|12.3|66|Incidence|543641|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|9.4|15.4|12.1
0-19|9.4|12.2|10.7|247|Incidence|2353631|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002-2006|9.2|11.9|10.5
0-19|7.4|13.0|10.0|53|Incidence|542449|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|7.3|12.8|9.8
0-19|8.8|14.9|11.5|59|Incidence|538790|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|8.3|14.1|11.0
0-19|10.1|16.6|13.1|68|Incidence|532401|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|9.9|16.2|12.8
0-19|7.6|13.7|10.3|48|Incidence|467111|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|7.6|13.6|10.3
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|0.4|1.1|0.7|17|Incidence|2353631|American Indian/Alaska Native|Male|Bones and Joints|2002-2006|0.4|1.2|0.7
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|1.1|2.2|1.6|37|Incidence|2353631|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002-2006|1.1|2.2|1.6
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|2353631|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|2353631|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|2.1|5.6|3.5|18|Incidence|518709|American Indian/Alaska Native|Male|Leukemia|1999|2.1|5.5|3.5
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Leukemia|2000|~|~|~
0-19|2.6|6.3|4.2|22|Incidence|550686|American Indian/Alaska Native|Male|Leukemia|2001|2.5|6.0|4.0
0-19|3.0|7.0|4.7|25|Incidence|543641|American Indian/Alaska Native|Male|Leukemia|2002|3.0|6.8|4.6
0-19|2.9|4.6|3.7|82|Incidence|2353631|American Indian/Alaska Native|Male|Leukemia|2002-2006|2.8|4.3|3.5
0-19|1.9|5.3|3.3|17|Incidence|542449|American Indian/Alaska Native|Male|Leukemia|2003|1.8|5.0|3.1
0-19|2.8|6.8|4.5|22|Incidence|538790|American Indian/Alaska Native|Male|Leukemia|2004|2.6|6.2|4.1
0-19|2.9|6.9|4.6|23|Incidence|532401|American Indian/Alaska Native|Male|Leukemia|2005|2.7|6.5|4.3
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Leukemia|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.4|1.1|0.7|17|Incidence|2353631|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002-2006|0.4|1.2|0.7
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|2.1|5.5|3.5|19|Incidence|543641|American Indian/Alaska Native|Male|Other|2002|2.1|5.5|3.5
0-19|2.1|3.5|2.7|63|Incidence|2353631|American Indian/Alaska Native|Male|Other|2002-2006|2.1|3.4|2.7
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Other|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Other|2006|~|~|~
0-19|~|~|~|~|Incidence|518709|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|537305|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|550686|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|543641|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|2353631|American Indian/Alaska Native|Male|Soft Tissue|2002-2006|~|~|~
0-19|~|~|~|~|Incidence|542449|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|538790|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|532401|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|467111|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|2.0|4.3|3.0|30|Incidence|1018854|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|2.0|4.2|2.9
0-19|1.3|3.2|2.1|22|Incidence|1056081|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|1.3|3.2|2.1
0-19|2.0|4.2|3.0|32|Incidence|1082979|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|2.0|4.2|3.0
0-19|1.8|3.9|2.7|28|Incidence|1070251|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|1.7|3.8|2.6
0-19|1.7|2.6|2.2|94|Incidence|4632389|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002-2006|1.6|2.5|2.0
0-19|1.1|2.8|1.8|18|Incidence|1068944|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|1.0|2.7|1.7
0-19|2.0|4.2|2.9|29|Incidence|1061539|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|1.8|3.9|2.7
0-19|1.8|3.9|2.7|26|Incidence|1049320|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|1.6|3.6|2.5
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Incidence|1018854|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1082979|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1070251|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|0.5|1.0|0.7|31|Incidence|4632389|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002-2006|0.5|0.9|0.7
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|1061539|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|1049320|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|7.3|11.1|9.0|91|Incidence|1018854|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|7.2|11.0|8.9
0-19|6.8|10.4|8.5|89|Incidence|1056081|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|6.8|10.4|8.4
0-19|9.1|13.2|11.0|116|Incidence|1082979|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|8.9|12.8|10.7
0-19|9.9|14.2|11.9|125|Incidence|1070251|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|9.7|13.9|11.7
0-19|9.9|11.9|10.9|492|Incidence|4632389|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002-2006|9.7|11.6|10.6
0-19|7.6|11.5|9.4|99|Incidence|1068944|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|7.5|11.3|9.3
0-19|9.0|13.2|11.0|112|Incidence|1061539|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|8.7|12.7|10.6
0-19|10.5|15.0|12.6|130|Incidence|1049320|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|10.4|14.7|12.4
0-19|8.9|13.4|11.0|99|Incidence|919926|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|8.7|13.1|10.8
0-19|~|~|~|~|Incidence|1018854|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1082979|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1070251|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|0.4|0.9|0.6|30|Incidence|4632389|American Indian/Alaska Native|Male and Female|Bones and Joints|2002-2006|0.4|0.9|0.6
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|1061539|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|1049320|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|0.9|2.5|1.6|16|Incidence|1018854|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|0.9|2.6|1.6
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|1.0|2.7|1.7|18|Incidence|1082979|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|1.0|2.6|1.7
0-19|1.1|2.8|1.8|19|Incidence|1070251|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|1.1|2.8|1.8
0-19|1.4|2.1|1.7|77|Incidence|4632389|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002-2006|1.3|2.1|1.7
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|1.3|3.2|2.1|21|Incidence|1061539|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|1.2|3.0|2.0
0-19|1.6|3.7|2.5|26|Incidence|1049320|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|1.6|3.6|2.5
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|1018854|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1082979|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1070251|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|0.3|0.7|0.5|23|Incidence|4632389|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002-2006|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1061539|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1049320|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1018854|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1082979|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1070251|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.3|0.7|0.5|19|Incidence|4632389|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002-2006|0.2|0.6|0.4
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1061539|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1049320|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|2.3|4.7|3.4|34|Incidence|1018854|American Indian/Alaska Native|Male and Female|Leukemia|1999|2.3|4.7|3.3
0-19|1.9|4.0|2.8|29|Incidence|1056081|American Indian/Alaska Native|Male and Female|Leukemia|2000|1.8|3.9|2.7
0-19|2.8|5.2|3.8|41|Incidence|1082979|American Indian/Alaska Native|Male and Female|Leukemia|2001|2.7|5.1|3.8
0-19|2.8|5.3|3.9|41|Incidence|1070251|American Indian/Alaska Native|Male and Female|Leukemia|2002|2.7|5.2|3.8
0-19|2.8|3.9|3.3|146|Incidence|4632389|American Indian/Alaska Native|Male and Female|Leukemia|2002-2006|2.7|3.7|3.2
0-19|2.0|4.2|3.0|30|Incidence|1068944|American Indian/Alaska Native|Male and Female|Leukemia|2003|1.9|4.0|2.8
0-19|2.7|5.2|3.8|37|Incidence|1061539|American Indian/Alaska Native|Male and Female|Leukemia|2004|2.5|4.8|3.5
0-19|2.7|5.4|3.9|38|Incidence|1049320|American Indian/Alaska Native|Male and Female|Leukemia|2005|2.6|5.0|3.6
0-19|2.0|4.5|3.1|27|Incidence|919926|American Indian/Alaska Native|Male and Female|Leukemia|2006|1.9|4.3|2.9
0-19|~|~|~|~|Incidence|1018854|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1082979|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1070251|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.3|0.7|0.5|23|Incidence|4632389|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1061539|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1049320|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|1.7|3.8|2.6|26|Incidence|1018854|American Indian/Alaska Native|Male and Female|Other|1999|1.7|3.7|2.6
0-19|1.1|2.9|1.8|19|Incidence|1056081|American Indian/Alaska Native|Male and Female|Other|2000|1.1|2.8|1.8
0-19|2.2|4.5|3.2|33|Incidence|1082979|American Indian/Alaska Native|Male and Female|Other|2001|2.1|4.3|3.0
0-19|2.6|5.0|3.6|38|Incidence|1070251|American Indian/Alaska Native|Male and Female|Other|2002|2.5|4.9|3.6
0-19|2.6|3.6|3.1|142|Incidence|4632389|American Indian/Alaska Native|Male and Female|Other|2002-2006|2.6|3.6|3.1
0-19|1.8|3.9|2.7|29|Incidence|1068944|American Indian/Alaska Native|Male and Female|Other|2003|1.8|3.9|2.7
0-19|1.4|3.2|2.1|23|Incidence|1061539|American Indian/Alaska Native|Male and Female|Other|2004|1.4|3.3|2.2
0-19|2.4|4.7|3.4|36|Incidence|1049320|American Indian/Alaska Native|Male and Female|Other|2005|2.4|4.7|3.4
0-19|2.4|4.9|3.5|32|Incidence|919926|American Indian/Alaska Native|Male and Female|Other|2006|2.4|4.9|3.5
0-19|~|~|~|~|Incidence|1018854|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1056081|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1082979|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1070251|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|0.5|1.1|0.7|32|Incidence|4632389|American Indian/Alaska Native|Male and Female|Soft Tissue|2002-2006|0.5|1.0|0.7
0-19|~|~|~|~|Incidence|1068944|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|1061539|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|1049320|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|919926|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|1.8|3.4|2.5|39|Incidence|1563562|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|1.8|3.4|2.5
0-19|1.3|2.8|1.9|32|Incidence|1615393|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|1.4|2.8|2.0
0-19|2.0|3.7|2.8|46|Incidence|1644074|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|2.0|3.7|2.8
0-19|2.2|3.9|2.9|50|Incidence|1669560|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|2.2|3.9|3.0
0-19|2.2|2.9|2.6|225|Incidence|8567662|Asian/Pacific Islander|Female|Acute Lymphocytic|2002-2006|2.3|3.0|2.6
0-19|1.8|3.4|2.5|45|Incidence|1750397|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|1.9|3.4|2.6
0-19|2.0|3.5|2.7|49|Incidence|1796106|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|2.0|3.6|2.7
0-19|1.8|3.3|2.5|48|Incidence|1833453|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|1.9|3.5|2.6
0-19|1.7|3.1|2.3|44|Incidence|1848456|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|1.7|3.2|2.4
0-19|~|~|~|~|Incidence|1563562|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1615393|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1644074|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1669560|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|0.6|0.9|0.7|63|Incidence|8567662|Asian/Pacific Islander|Female|Acute Myeloid|2002-2006|0.6|0.9|0.7
0-19|~|~|~|~|Incidence|1750397|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|1796106|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|1833453|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|0.6|1.6|1.0|19|Incidence|1848456|Asian/Pacific Islander|Female|Acute Myeloid|2006|0.6|1.6|1.0
0-19|10.5|14.1|12.2|192|Incidence|1563562|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|10.6|14.1|12.3
0-19|8.7|11.9|10.2|166|Incidence|1615393|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|8.8|12.0|10.3
0-19|11.3|14.8|12.9|214|Incidence|1644074|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|11.3|14.9|13.0
0-19|11.0|14.5|12.7|212|Incidence|1669560|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|11.0|14.5|12.7
0-19|11.7|13.2|12.4|1072|Incidence|8567662|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002-2006|11.8|13.3|12.5
0-19|9.8|13.0|11.3|199|Incidence|1750397|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|9.8|13.1|11.4
0-19|10.4|13.7|12.0|218|Incidence|1796106|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|10.6|13.9|12.1
0-19|11.7|15.1|13.3|246|Incidence|1833453|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|11.8|15.2|13.4
0-19|11.0|14.2|12.5|233|Incidence|1848456|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|11.0|14.3|12.6
0-19|~|~|~|~|Incidence|1563562|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1615393|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1644074|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1669560|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|0.3|0.6|0.5|40|Incidence|8567662|Asian/Pacific Islander|Female|Bones and Joints|2002-2006|0.3|0.6|0.5
0-19|~|~|~|~|Incidence|1750397|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|1796106|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|1833453|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|1848456|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|1.3|2.7|1.9|29|Incidence|1563562|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|1.2|2.7|1.9
0-19|1.3|2.7|1.9|30|Incidence|1615393|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|1.3|2.7|1.9
0-19|1.9|3.6|2.7|44|Incidence|1644074|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|1.9|3.6|2.7
0-19|1.1|2.4|1.7|28|Incidence|1669560|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|1.1|2.4|1.7
0-19|1.7|2.3|2.0|174|Incidence|8567662|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002-2006|1.7|2.4|2.0
0-19|1.2|2.6|1.8|32|Incidence|1750397|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|1.3|2.6|1.8
0-19|1.7|3.1|2.3|42|Incidence|1796106|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|1.7|3.2|2.3
0-19|1.7|3.2|2.4|44|Incidence|1833453|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|1.7|3.2|2.4
0-19|1.4|2.7|2.0|37|Incidence|1848456|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|1.4|2.8|2.0
0-19|~|~|~|~|Incidence|1563562|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1615393|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1644074|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1669560|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|0.5|0.9|0.7|58|Incidence|8567662|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002-2006|0.5|0.9|0.7
0-19|~|~|~|~|Incidence|1750397|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1796106|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1833453|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.6|1.6|1.1|19|Incidence|1848456|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|0.6|1.6|1.0
0-19|~|~|~|~|Incidence|1563562|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1615393|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1644074|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1669560|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.3|0.5|0.4|33|Incidence|8567662|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002-2006|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|1750397|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1796106|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1833453|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1848456|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|2.6|4.5|3.5|55|Incidence|1563562|Asian/Pacific Islander|Female|Leukemia|1999|2.6|4.6|3.5
0-19|1.6|3.2|2.3|38|Incidence|1615393|Asian/Pacific Islander|Female|Leukemia|2000|1.7|3.2|2.4
0-19|2.9|4.9|3.8|63|Incidence|1644074|Asian/Pacific Islander|Female|Leukemia|2001|2.9|4.9|3.8
0-19|3.1|5.0|4.0|67|Incidence|1669560|Asian/Pacific Islander|Female|Leukemia|2002|3.1|5.1|4.0
0-19|3.2|4.0|3.6|316|Incidence|8567662|Asian/Pacific Islander|Female|Leukemia|2002-2006|3.3|4.1|3.7
0-19|2.6|4.4|3.4|61|Incidence|1750397|Asian/Pacific Islander|Female|Leukemia|2003|2.7|4.5|3.5
0-19|3.0|4.8|3.8|70|Incidence|1796106|Asian/Pacific Islander|Female|Leukemia|2004|3.0|4.9|3.9
0-19|2.8|4.5|3.6|67|Incidence|1833453|Asian/Pacific Islander|Female|Leukemia|2005|2.8|4.6|3.7
0-19|2.7|4.4|3.5|65|Incidence|1848456|Asian/Pacific Islander|Female|Leukemia|2006|2.7|4.5|3.5
0-19|~|~|~|~|Incidence|1563562|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1615393|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1644074|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1669560|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|0.6|1.6|1.0
0-19|0.7|1.1|0.9|73|Incidence|8567662|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002-2006|0.7|1.1|0.9
0-19|~|~|~|~|Incidence|1750397|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1796106|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.7|1.8|1.2|21|Incidence|1833453|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|0.7|1.8|1.1
0-19|~|~|~|~|Incidence|1848456|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|2.9|4.9|3.8|61|Incidence|1563562|Asian/Pacific Islander|Female|Other|1999|3.0|5.0|3.9
0-19|2.6|4.5|3.4|56|Incidence|1615393|Asian/Pacific Islander|Female|Other|2000|2.6|4.5|3.5
0-19|2.7|4.6|3.6|60|Incidence|1644074|Asian/Pacific Islander|Female|Other|2001|2.8|4.7|3.6
0-19|2.5|4.3|3.3|55|Incidence|1669560|Asian/Pacific Islander|Female|Other|2002|2.5|4.3|3.3
0-19|3.3|4.1|3.7|317|Incidence|8567662|Asian/Pacific Islander|Female|Other|2002-2006|3.3|4.1|3.7
0-19|2.7|4.5|3.5|62|Incidence|1750397|Asian/Pacific Islander|Female|Other|2003|2.7|4.5|3.5
0-19|2.5|4.3|3.3|60|Incidence|1796106|Asian/Pacific Islander|Female|Other|2004|2.5|4.3|3.3
0-19|3.0|4.9|3.9|71|Incidence|1833453|Asian/Pacific Islander|Female|Other|2005|3.0|4.9|3.9
0-19|3.2|5.1|4.1|76|Incidence|1848456|Asian/Pacific Islander|Female|Other|2006|3.2|5.1|4.1
0-19|~|~|~|~|Incidence|1563562|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1615393|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1644074|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1669560|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|0.5|0.9|0.7|61|Incidence|8567662|Asian/Pacific Islander|Female|Soft Tissue|2002-2006|0.5|0.9|0.7
0-19|~|~|~|~|Incidence|1750397|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|1796106|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|1833453|Asian/Pacific Islander|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Incidence|1848456|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|2.0|3.7|2.8|45|Incidence|1632817|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|2.0|3.7|2.8
0-19|1.8|3.4|2.5|42|Incidence|1683177|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|1.8|3.4|2.5
0-19|2.4|4.2|3.2|55|Incidence|1715990|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|2.4|4.2|3.2
0-19|2.4|4.2|3.2|56|Incidence|1743785|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|2.4|4.2|3.2
0-19|2.9|3.6|3.3|296|Incidence|8957619|Asian/Pacific Islander|Male|Acute Lymphocytic|2002-2006|2.9|3.7|3.3
0-19|2.5|4.2|3.3|60|Incidence|1829258|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|2.5|4.2|3.3
0-19|2.2|3.8|3.0|56|Incidence|1876380|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|2.3|3.9|3.0
0-19|2.8|4.6|3.6|72|Incidence|1915896|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|2.9|4.7|3.8
0-19|2.3|3.9|3.0|60|Incidence|1932441|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|2.4|4.0|3.1
0-19|~|~|~|~|Incidence|1632817|Asian/Pacific Islander|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1683177|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1715990|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1743785|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|0.6|1.0|0.8|72|Incidence|8957619|Asian/Pacific Islander|Male|Acute Myeloid|2002-2006|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|1829258|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|0.7|1.7|1.1|21|Incidence|1876380|Asian/Pacific Islander|Male|Acute Myeloid|2004|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|1915896|Asian/Pacific Islander|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|1932441|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|10.9|14.4|12.6|206|Incidence|1632817|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|11.0|14.5|12.6
0-19|11.5|15.0|13.2|223|Incidence|1683177|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|11.6|15.1|13.2
0-19|13.1|16.8|14.9|256|Incidence|1715990|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|13.1|16.9|14.9
0-19|12.2|15.7|13.9|243|Incidence|1743785|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|12.2|15.8|13.9
0-19|13.2|14.7|13.9|1262|Incidence|8957619|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002-2006|13.3|14.9|14.1
0-19|12.2|15.6|13.8|254|Incidence|1829258|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|12.2|15.7|13.9
0-19|12.2|15.6|13.8|262|Incidence|1876380|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|12.3|15.8|14.0
0-19|13.4|16.9|15.1|293|Incidence|1915896|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|13.6|17.1|15.3
0-19|11.1|14.3|12.6|248|Incidence|1932441|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|11.3|14.5|12.8
0-19|~|~|~|~|Incidence|1632817|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1683177|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1715990|Asian/Pacific Islander|Male|Bones and Joints|2001|0.6|1.6|1.0
0-19|0.5|1.5|0.9|16|Incidence|1743785|Asian/Pacific Islander|Male|Bones and Joints|2002|0.5|1.5|0.9
0-19|0.7|1.1|0.9|78|Incidence|8957619|Asian/Pacific Islander|Male|Bones and Joints|2002-2006|0.7|1.1|0.9
0-19|0.5|1.4|0.9|16|Incidence|1829258|Asian/Pacific Islander|Male|Bones and Joints|2003|0.5|1.4|0.9
0-19|~|~|~|~|Incidence|1876380|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|0.6|1.5|1.0|18|Incidence|1915896|Asian/Pacific Islander|Male|Bones and Joints|2005|0.6|1.5|0.9
0-19|0.5|1.4|0.8|16|Incidence|1932441|Asian/Pacific Islander|Male|Bones and Joints|2006|0.5|1.3|0.8
0-19|1.3|2.7|1.9|31|Incidence|1632817|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|1.3|2.7|1.9
0-19|1.5|2.9|2.1|35|Incidence|1683177|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|1.4|2.9|2.1
0-19|1.6|3.1|2.3|39|Incidence|1715990|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|1.6|3.1|2.3
0-19|1.4|2.8|2.0|35|Incidence|1743785|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|1.4|2.8|2.0
0-19|1.8|2.4|2.1|186|Incidence|8957619|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002-2006|1.8|2.4|2.1
0-19|1.7|3.2|2.4|43|Incidence|1829258|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|1.7|3.2|2.4
0-19|1.3|2.6|1.9|35|Incidence|1876380|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|1.3|2.6|1.9
0-19|1.5|2.9|2.1|40|Incidence|1915896|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|1.5|2.8|2.1
0-19|1.4|2.8|2.0|40|Incidence|1932441|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|1.5|2.8|2.1
0-19|~|~|~|~|Incidence|1632817|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1683177|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1715990|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1743785|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|0.8|1.2|1.0|86|Incidence|8957619|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002-2006|0.8|1.2|1.0
0-19|0.7|1.7|1.1|20|Incidence|1829258|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|0.7|1.7|1.1
0-19|0.5|1.5|0.9|17|Incidence|1876380|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|0.5|1.5|0.9
0-19|0.8|1.8|1.2|23|Incidence|1915896|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|0.8|1.8|1.2
0-19|~|~|~|~|Incidence|1932441|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1632817|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1683177|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1715990|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1743785|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.2|0.4|0.3|29|Incidence|8957619|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002-2006|0.2|0.5|0.3
0-19|~|~|~|~|Incidence|1829258|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1876380|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1915896|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|1932441|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|3.3|5.3|4.2|69|Incidence|1632817|Asian/Pacific Islander|Male|Leukemia|1999|3.3|5.3|4.2
0-19|2.8|4.7|3.7|62|Incidence|1683177|Asian/Pacific Islander|Male|Leukemia|2000|2.8|4.7|3.7
0-19|3.7|5.8|4.7|80|Incidence|1715990|Asian/Pacific Islander|Male|Leukemia|2001|3.7|5.8|4.7
0-19|3.5|5.6|4.5|78|Incidence|1743785|Asian/Pacific Islander|Male|Leukemia|2002|3.5|5.6|4.5
0-19|4.1|5.0|4.5|412|Incidence|8957619|Asian/Pacific Islander|Male|Leukemia|2002-2006|4.2|5.1|4.6
0-19|3.6|5.6|4.5|83|Incidence|1829258|Asian/Pacific Islander|Male|Leukemia|2003|3.6|5.6|4.5
0-19|3.7|5.7|4.6|88|Incidence|1876380|Asian/Pacific Islander|Male|Leukemia|2004|3.8|5.8|4.7
0-19|3.8|5.8|4.7|94|Incidence|1915896|Asian/Pacific Islander|Male|Leukemia|2005|4.0|6.0|4.9
0-19|3.3|5.1|4.1|82|Incidence|1932441|Asian/Pacific Islander|Male|Leukemia|2006|3.4|5.3|4.2
0-19|0.7|1.7|1.1|18|Incidence|1632817|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|0.7|1.7|1.1
0-19|1.0|2.3|1.6|27|Incidence|1683177|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|1.1|2.3|1.6
0-19|0.8|2.0|1.3|22|Incidence|1715990|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|0.8|1.9|1.3
0-19|0.6|1.6|1.0|18|Incidence|1743785|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|0.6|1.6|1.0
0-19|1.0|1.4|1.2|106|Incidence|8957619|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002-2006|1.0|1.4|1.2
0-19|0.9|2.1|1.4|26|Incidence|1829258|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|0.9|2.1|1.4
0-19|0.5|1.5|0.9|17|Incidence|1876380|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|0.5|1.5|0.9
0-19|1.1|2.3|1.6|31|Incidence|1915896|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|1.1|2.3|1.6
0-19|0.5|1.4|0.9|17|Incidence|1932441|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|0.5|1.4|0.9
0-19|2.3|4.1|3.1|51|Incidence|1632817|Asian/Pacific Islander|Male|Other|1999|2.3|4.1|3.1
0-19|2.5|4.3|3.4|57|Incidence|1683177|Asian/Pacific Islander|Male|Other|2000|2.6|4.4|3.4
0-19|2.8|4.6|3.6|63|Incidence|1715990|Asian/Pacific Islander|Male|Other|2001|2.8|4.7|3.7
0-19|2.4|4.2|3.2|57|Incidence|1743785|Asian/Pacific Islander|Male|Other|2002|2.5|4.2|3.3
0-19|2.8|3.5|3.1|284|Incidence|8957619|Asian/Pacific Islander|Male|Other|2002-2006|2.8|3.6|3.2
0-19|1.9|3.4|2.6|48|Incidence|1829258|Asian/Pacific Islander|Male|Other|2003|1.9|3.5|2.6
0-19|2.7|4.5|3.5|67|Incidence|1876380|Asian/Pacific Islander|Male|Other|2004|2.8|4.5|3.6
0-19|2.4|4.1|3.2|62|Incidence|1915896|Asian/Pacific Islander|Male|Other|2005|2.5|4.1|3.2
0-19|2.3|3.8|3.0|59|Incidence|1932441|Asian/Pacific Islander|Male|Other|2006|2.3|3.9|3.1
0-19|~|~|~|~|Incidence|1632817|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1683177|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1715990|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|0.8|1.9|1.2|22|Incidence|1743785|Asian/Pacific Islander|Male|Soft Tissue|2002|0.8|1.9|1.3
0-19|0.7|1.1|0.9|81|Incidence|8957619|Asian/Pacific Islander|Male|Soft Tissue|2002-2006|0.7|1.1|0.9
0-19|~|~|~|~|Incidence|1829258|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|0.6|1.5|0.9|18|Incidence|1876380|Asian/Pacific Islander|Male|Soft Tissue|2004|0.6|1.5|1.0
0-19|0.7|1.6|1.1|21|Incidence|1915896|Asian/Pacific Islander|Male|Soft Tissue|2005|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|1932441|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|2.1|3.2|2.6|84|Incidence|3196379|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|2.1|3.3|2.6
0-19|1.7|2.8|2.2|74|Incidence|3298570|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|1.8|2.8|2.2
0-19|2.4|3.6|3.0|101|Incidence|3360064|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|2.4|3.7|3.0
0-19|2.5|3.7|3.1|106|Incidence|3413345|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|2.5|3.8|3.1
0-19|2.7|3.2|2.9|521|Incidence|17525281|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002-2006|2.7|3.2|3.0
0-19|2.4|3.5|2.9|105|Incidence|3579655|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|2.4|3.6|2.9
0-19|2.3|3.4|2.8|105|Incidence|3672486|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|2.3|3.5|2.9
0-19|2.5|3.7|3.1|120|Incidence|3749349|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|2.7|3.8|3.2
0-19|2.2|3.3|2.7|104|Incidence|3780897|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|2.2|3.3|2.8
0-19|0.5|1.2|0.8|26|Incidence|3196379|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|0.5|1.2|0.8
0-19|0.3|0.8|0.5|16|Incidence|3298570|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|0.3|0.8|0.5
0-19|0.5|1.1|0.7|25|Incidence|3360064|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|0.5|1.1|0.7
0-19|0.4|0.9|0.6|21|Incidence|3413345|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.6|0.9|0.8|135|Incidence|17525281|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002-2006|0.6|0.9|0.8
0-19|0.4|1.0|0.7|24|Incidence|3579655|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|0.4|1.0|0.7
0-19|0.7|1.3|1.0|35|Incidence|3672486|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|0.7|1.3|1.0
0-19|0.5|1.1|0.7|27|Incidence|3749349|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|0.5|1.0|0.7
0-19|0.6|1.2|0.9|33|Incidence|3780897|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|0.6|1.2|0.9
0-19|11.2|13.7|12.4|398|Incidence|3196379|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|11.3|13.7|12.5
0-19|10.6|12.9|11.7|389|Incidence|3298570|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|10.7|13.0|11.8
0-19|12.7|15.3|13.9|470|Incidence|3360064|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|12.8|15.3|14.0
0-19|12.1|14.6|13.3|455|Incidence|3413345|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|12.1|14.6|13.3
0-19|12.7|13.7|13.2|2334|Incidence|17525281|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002-2006|12.8|13.9|13.3
0-19|11.4|13.8|12.6|453|Incidence|3579655|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|11.5|13.9|12.7
0-19|11.8|14.1|12.9|480|Incidence|3672486|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|11.9|14.3|13.1
0-19|13.1|15.5|14.2|539|Incidence|3749349|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|13.2|15.6|14.4
0-19|11.5|13.7|12.6|481|Incidence|3780897|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|11.6|13.9|12.7
0-19|0.3|0.9|0.5|17|Incidence|3196379|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|0.3|0.9|0.5
0-19|0.4|1.0|0.7|23|Incidence|3298570|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|0.4|1.0|0.7
0-19|0.6|1.2|0.9|29|Incidence|3360064|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|0.6|1.2|0.9
0-19|0.5|1.1|0.7|25|Incidence|3413345|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|0.5|1.1|0.7
0-19|0.6|0.8|0.7|118|Incidence|17525281|Asian/Pacific Islander|Male and Female|Bones and Joints|2002-2006|0.6|0.8|0.7
0-19|0.4|1.0|0.7|24|Incidence|3579655|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|0.4|1.0|0.7
0-19|0.4|1.0|0.6|23|Incidence|3672486|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|0.4|0.9|0.6
0-19|0.5|1.0|0.7|26|Incidence|3749349|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|0.5|1.0|0.7
0-19|0.4|0.9|0.6|22|Incidence|3780897|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|0.4|0.9|0.6
0-19|1.4|2.4|1.9|60|Incidence|3196379|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|1.4|2.4|1.9
0-19|1.5|2.5|2.0|65|Incidence|3298570|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|1.5|2.5|2.0
0-19|2.0|3.1|2.5|83|Incidence|3360064|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|2.0|3.1|2.5
0-19|1.4|2.4|1.8|63|Incidence|3413345|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|1.4|2.4|1.8
0-19|1.8|2.3|2.0|360|Incidence|17525281|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002-2006|1.8|2.3|2.1
0-19|1.6|2.6|2.1|75|Incidence|3579655|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|1.6|2.6|2.1
0-19|1.6|2.6|2.1|77|Incidence|3672486|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|1.7|2.6|2.1
0-19|1.8|2.8|2.2|84|Incidence|3749349|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|1.8|2.8|2.2
0-19|1.6|2.5|2.0|77|Incidence|3780897|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|1.6|2.5|2.0
0-19|0.3|0.8|0.5|16|Incidence|3196379|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|0.3|0.8|0.5
0-19|0.3|0.9|0.6|19|Incidence|3298570|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|0.3|0.9|0.6
0-19|0.5|1.1|0.8|25|Incidence|3360064|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|0.5|1.1|0.7
0-19|0.6|1.2|0.9|29|Incidence|3413345|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|0.6|1.2|0.8
0-19|0.7|1.0|0.8|144|Incidence|17525281|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002-2006|0.7|1.0|0.8
0-19|0.5|1.1|0.7|26|Incidence|3579655|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|0.5|1.1|0.7
0-19|0.4|0.9|0.6|22|Incidence|3672486|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|0.4|0.9|0.6
0-19|0.7|1.4|1.0|38|Incidence|3749349|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|0.7|1.4|1.0
0-19|0.6|1.3|0.9|34|Incidence|3780897|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|0.6|1.3|0.9
0-19|~|~|~|~|Incidence|3196379|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|3298570|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|3360064|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|3413345|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.3|0.4|0.3|62|Incidence|17525281|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002-2006|0.3|0.5|0.4
0-19|0.3|0.8|0.5|19|Incidence|3579655|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|0.3|0.8|0.5
0-19|~|~|~|~|Incidence|3672486|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|3749349|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Incidence|3780897|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|3.2|4.6|3.9|124|Incidence|3196379|Asian/Pacific Islander|Male and Female|Leukemia|1999|3.2|4.6|3.9
0-19|2.4|3.7|3.0|100|Incidence|3298570|Asian/Pacific Islander|Male and Female|Leukemia|2000|2.5|3.7|3.0
0-19|3.6|5.0|4.2|143|Incidence|3360064|Asian/Pacific Islander|Male and Female|Leukemia|2001|3.6|5.0|4.3
0-19|3.6|5.0|4.2|145|Incidence|3413345|Asian/Pacific Islander|Male and Female|Leukemia|2002|3.6|5.0|4.2
0-19|3.8|4.4|4.1|728|Incidence|17525281|Asian/Pacific Islander|Male and Female|Leukemia|2002-2006|3.9|4.5|4.2
0-19|3.3|4.7|4.0|144|Incidence|3579655|Asian/Pacific Islander|Male and Female|Leukemia|2003|3.4|4.7|4.0
0-19|3.6|4.9|4.2|158|Incidence|3672486|Asian/Pacific Islander|Male and Female|Leukemia|2004|3.7|5.0|4.3
0-19|3.5|4.9|4.2|161|Incidence|3749349|Asian/Pacific Islander|Male and Female|Leukemia|2005|3.7|5.0|4.3
0-19|3.2|4.5|3.8|147|Incidence|3780897|Asian/Pacific Islander|Male and Female|Leukemia|2006|3.3|4.6|3.9
0-19|0.7|1.4|1.0|31|Incidence|3196379|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|0.7|1.4|1.0
0-19|0.9|1.7|1.3|42|Incidence|3298570|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|0.9|1.7|1.3
0-19|0.7|1.5|1.1|35|Incidence|3360064|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|0.7|1.4|1.0
0-19|0.7|1.4|1.0|35|Incidence|3413345|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|0.7|1.4|1.0
0-19|0.9|1.2|1.0|179|Incidence|17525281|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.9|1.2|1.0
0-19|0.7|1.4|1.0|37|Incidence|3579655|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.4|1.0
0-19|0.6|1.2|0.8|30|Incidence|3672486|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|0.6|1.2|0.8
0-19|1.0|1.8|1.4|52|Incidence|3749349|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.8|1.4
0-19|0.5|1.1|0.8|29|Incidence|3780897|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|0.5|1.1|0.8
0-19|2.8|4.2|3.5|112|Incidence|3196379|Asian/Pacific Islander|Male and Female|Other|1999|2.9|4.2|3.5
0-19|2.8|4.1|3.4|113|Incidence|3298570|Asian/Pacific Islander|Male and Female|Other|2000|2.8|4.1|3.4
0-19|3.0|4.3|3.6|123|Incidence|3360064|Asian/Pacific Islander|Male and Female|Other|2001|3.0|4.4|3.7
0-19|2.7|3.9|3.3|112|Incidence|3413345|Asian/Pacific Islander|Male and Female|Other|2002|2.7|3.9|3.3
0-19|3.1|3.7|3.4|601|Incidence|17525281|Asian/Pacific Islander|Male and Female|Other|2002-2006|3.2|3.7|3.4
0-19|2.5|3.7|3.0|110|Incidence|3579655|Asian/Pacific Islander|Male and Female|Other|2003|2.5|3.7|3.1
0-19|2.8|4.1|3.4|127|Incidence|3672486|Asian/Pacific Islander|Male and Female|Other|2004|2.9|4.1|3.5
0-19|2.9|4.2|3.5|133|Incidence|3749349|Asian/Pacific Islander|Male and Female|Other|2005|3.0|4.2|3.5
0-19|2.9|4.2|3.5|135|Incidence|3780897|Asian/Pacific Islander|Male and Female|Other|2006|3.0|4.2|3.6
0-19|0.5|1.1|0.7|24|Incidence|3196379|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|0.5|1.1|0.8
0-19|0.3|0.8|0.5|16|Incidence|3298570|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|0.3|0.8|0.5
0-19|0.4|0.9|0.6|20|Incidence|3360064|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|0.4|0.9|0.6
0-19|0.7|1.4|1.0|36|Incidence|3413345|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|0.7|1.5|1.1
0-19|0.7|0.9|0.8|142|Incidence|17525281|Asian/Pacific Islander|Male and Female|Soft Tissue|2002-2006|0.7|1.0|0.8
0-19|0.3|0.8|0.5|18|Incidence|3579655|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|0.3|0.8|0.5
0-19|0.5|1.1|0.8|30|Incidence|3672486|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|0.6|1.2|0.8
0-19|0.7|1.3|1.0|36|Incidence|3749349|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|0.7|1.3|1.0
0-19|0.4|0.9|0.6|25|Incidence|3780897|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|0.4|1.0|0.7
0-19|1.1|1.7|1.4|75|Incidence|5423803|Black|Female|Acute Lymphocytic|1999|1.1|1.7|1.4
0-19|1.1|1.7|1.4|79|Incidence|5675852|Black|Female|Acute Lymphocytic|2000|1.1|1.7|1.4
0-19|1.3|2.0|1.6|95|Incidence|5784700|Black|Female|Acute Lymphocytic|2001|1.3|2.0|1.6
0-19|1.0|1.6|1.3|74|Incidence|5758829|Black|Female|Acute Lymphocytic|2002|1.0|1.6|1.3
0-19|1.2|1.4|1.3|372|Incidence|28826479|Black|Female|Acute Lymphocytic|2002-2006|1.2|1.4|1.3
0-19|1.1|1.7|1.4|85|Incidence|6259473|Black|Female|Acute Lymphocytic|2003|1.1|1.7|1.4
0-19|1.1|1.7|1.4|89|Incidence|6460006|Black|Female|Acute Lymphocytic|2004|1.1|1.7|1.4
0-19|1.1|1.7|1.4|88|Incidence|6489830|Black|Female|Acute Lymphocytic|2005|1.1|1.7|1.4
0-19|1.1|1.6|1.3|86|Incidence|6479923|Black|Female|Acute Lymphocytic|2006|1.1|1.6|1.3
0-19|0.4|0.9|0.6|34|Incidence|5423803|Black|Female|Acute Myeloid|1999|0.4|0.9|0.6
0-19|0.4|0.8|0.5|30|Incidence|5675852|Black|Female|Acute Myeloid|2000|0.4|0.8|0.5
0-19|0.4|0.7|0.5|30|Incidence|5784700|Black|Female|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.5|0.9|0.7|40|Incidence|5758829|Black|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.7|0.6|182|Incidence|28826479|Black|Female|Acute Myeloid|2002-2006|0.5|0.7|0.6
0-19|0.5|0.9|0.7|42|Incidence|6259473|Black|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Incidence|6460006|Black|Female|Acute Myeloid|2004|0.4|0.8|0.6
0-19|0.4|0.7|0.5|35|Incidence|6489830|Black|Female|Acute Myeloid|2005|0.4|0.8|0.5
0-19|0.6|1.0|0.8|51|Incidence|6479923|Black|Female|Acute Myeloid|2006|0.6|1.0|0.8
0-19|10.5|12.3|11.4|610|Incidence|5423803|Black|Female|All Cancer Sites Combined|1999|10.4|12.2|11.2
0-19|9.8|11.5|10.6|597|Incidence|5675852|Black|Female|All Cancer Sites Combined|2000|9.7|11.4|10.5
0-19|10.5|12.3|11.4|656|Incidence|5784700|Black|Female|All Cancer Sites Combined|2001|10.5|12.2|11.3
0-19|10.4|12.1|11.2|646|Incidence|5758829|Black|Female|All Cancer Sites Combined|2002|10.4|12.1|11.2
0-19|11.6|12.4|12.0|3479|Incidence|28826479|Black|Female|All Cancer Sites Combined|2002-2006|11.7|12.5|12.1
0-19|11.6|13.4|12.5|780|Incidence|6259473|Black|Female|All Cancer Sites Combined|2003|11.6|13.4|12.5
0-19|11.5|13.3|12.4|802|Incidence|6460006|Black|Female|All Cancer Sites Combined|2004|11.6|13.3|12.4
0-19|11.4|13.2|12.3|803|Incidence|6489830|Black|Female|All Cancer Sites Combined|2005|11.5|13.3|12.4
0-19|10.7|12.3|11.5|751|Incidence|6479923|Black|Female|All Cancer Sites Combined|2006|10.8|12.4|11.6
0-19|0.5|0.9|0.6|35|Incidence|5423803|Black|Female|Bones and Joints|1999|0.4|0.9|0.6
0-19|0.3|0.7|0.5|28|Incidence|5675852|Black|Female|Bones and Joints|2000|0.3|0.7|0.5
0-19|0.5|0.9|0.7|39|Incidence|5784700|Black|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.4|0.8|0.6|35|Incidence|5758829|Black|Female|Bones and Joints|2002|0.4|0.8|0.6
0-19|0.6|0.8|0.7|208|Incidence|28826479|Black|Female|Bones and Joints|2002-2006|0.6|0.8|0.7
0-19|0.5|0.9|0.6|40|Incidence|6259473|Black|Female|Bones and Joints|2003|0.5|0.9|0.6
0-19|0.7|1.2|0.9|59|Incidence|6460006|Black|Female|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.5|0.9|0.6|41|Incidence|6489830|Black|Female|Bones and Joints|2005|0.5|0.9|0.6
0-19|0.5|0.9|0.7|44|Incidence|6479923|Black|Female|Bones and Joints|2006|0.5|0.9|0.7
0-19|1.5|2.2|1.8|98|Incidence|5423803|Black|Female|Brain and Other Nervous System|1999|1.5|2.2|1.8
0-19|1.7|2.4|2.0|114|Incidence|5675852|Black|Female|Brain and Other Nervous System|2000|1.7|2.4|2.0
0-19|1.7|2.4|2.0|117|Incidence|5784700|Black|Female|Brain and Other Nervous System|2001|1.7|2.4|2.0
0-19|1.6|2.4|2.0|115|Incidence|5758829|Black|Female|Brain and Other Nervous System|2002|1.6|2.4|2.0
0-19|2.0|2.4|2.2|633|Incidence|28826479|Black|Female|Brain and Other Nervous System|2002-2006|2.0|2.4|2.2
0-19|1.8|2.6|2.2|136|Incidence|6259473|Black|Female|Brain and Other Nervous System|2003|1.8|2.6|2.2
0-19|1.9|2.7|2.3|147|Incidence|6460006|Black|Female|Brain and Other Nervous System|2004|1.9|2.7|2.3
0-19|1.9|2.7|2.3|149|Incidence|6489830|Black|Female|Brain and Other Nervous System|2005|1.9|2.7|2.3
0-19|1.8|2.5|2.1|137|Incidence|6479923|Black|Female|Brain and Other Nervous System|2006|1.8|2.5|2.1
0-19|0.5|1.0|0.7|38|Incidence|5423803|Black|Female|Hodgkin Lymphoma|1999|0.5|1.0|0.7
0-19|0.6|1.1|0.8|44|Incidence|5675852|Black|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.5|1.0|0.7|41|Incidence|5784700|Black|Female|Hodgkin Lymphoma|2001|0.5|1.0|0.7
0-19|0.7|1.2|0.9|51|Incidence|5758829|Black|Female|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.8|1.0|0.9|254|Incidence|28826479|Black|Female|Hodgkin Lymphoma|2002-2006|0.8|1.0|0.9
0-19|0.7|1.2|0.9|58|Incidence|6259473|Black|Female|Hodgkin Lymphoma|2003|0.7|1.2|0.9
0-19|0.7|1.1|0.9|56|Incidence|6460006|Black|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.8|1.3|1.0|69|Incidence|6489830|Black|Female|Hodgkin Lymphoma|2005|0.8|1.3|1.1
0-19|0.6|1.0|0.8|50|Incidence|6479923|Black|Female|Hodgkin Lymphoma|2006|0.6|1.0|0.8
0-19|0.6|1.1|0.8|45|Incidence|5423803|Black|Female|Kidney and Renal Pelvis|1999|0.6|1.1|0.8
0-19|0.8|1.3|1.0|59|Incidence|5675852|Black|Female|Kidney and Renal Pelvis|2000|0.8|1.3|1.0
0-19|0.5|1.0|0.7|42|Incidence|5784700|Black|Female|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.6|1.1|0.8|49|Incidence|5758829|Black|Female|Kidney and Renal Pelvis|2002|0.6|1.1|0.9
0-19|0.7|0.9|0.8|225|Incidence|28826479|Black|Female|Kidney and Renal Pelvis|2002-2006|0.7|0.9|0.8
0-19|0.5|0.9|0.7|44|Incidence|6259473|Black|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.5|0.9|0.7|43|Incidence|6460006|Black|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.7|1.2|0.9|61|Incidence|6489830|Black|Female|Kidney and Renal Pelvis|2005|0.7|1.2|0.9
0-19|0.6|1.0|0.8|50|Incidence|6479923|Black|Female|Kidney and Renal Pelvis|2006|0.6|1.0|0.8
0-19|2.0|2.9|2.4|130|Incidence|5423803|Black|Female|Leukemia|1999|2.0|2.8|2.4
0-19|1.7|2.5|2.1|118|Incidence|5675852|Black|Female|Leukemia|2000|1.7|2.5|2.1
0-19|2.0|2.9|2.4|140|Incidence|5784700|Black|Female|Leukemia|2001|2.0|2.9|2.4
0-19|2.0|2.8|2.4|136|Incidence|5758829|Black|Female|Leukemia|2002|2.0|2.8|2.4
0-19|2.1|2.4|2.2|647|Incidence|28826479|Black|Female|Leukemia|2002-2006|2.1|2.4|2.2
0-19|1.9|2.6|2.2|139|Incidence|6259473|Black|Female|Leukemia|2003|1.9|2.6|2.2
0-19|2.0|2.7|2.3|151|Incidence|6460006|Black|Female|Leukemia|2004|2.0|2.7|2.3
0-19|1.8|2.5|2.1|140|Incidence|6489830|Black|Female|Leukemia|2005|1.8|2.5|2.2
0-19|2.0|2.8|2.4|156|Incidence|6479923|Black|Female|Leukemia|2006|2.0|2.8|2.4
0-19|0.4|0.9|0.6|33|Incidence|5423803|Black|Female|Non-Hodgkin Lymphoma|1999|0.4|0.9|0.6
0-19|0.5|0.9|0.6|36|Incidence|5675852|Black|Female|Non-Hodgkin Lymphoma|2000|0.4|0.9|0.6
0-19|0.6|1.1|0.8|46|Incidence|5784700|Black|Female|Non-Hodgkin Lymphoma|2001|0.6|1.1|0.8
0-19|0.6|1.1|0.8|46|Incidence|5758829|Black|Female|Non-Hodgkin Lymphoma|2002|0.6|1.1|0.8
0-19|0.7|0.9|0.8|234|Incidence|28826479|Black|Female|Non-Hodgkin Lymphoma|2002-2006|0.7|0.9|0.8
0-19|0.5|0.9|0.7|42|Incidence|6259473|Black|Female|Non-Hodgkin Lymphoma|2003|0.5|0.9|0.7
0-19|0.6|1.1|0.8|54|Incidence|6460006|Black|Female|Non-Hodgkin Lymphoma|2004|0.6|1.1|0.8
0-19|0.6|1.1|0.8|55|Incidence|6489830|Black|Female|Non-Hodgkin Lymphoma|2005|0.6|1.1|0.8
0-19|0.6|1.1|0.8|53|Incidence|6479923|Black|Female|Non-Hodgkin Lymphoma|2006|0.6|1.1|0.8
0-19|3.1|4.2|3.6|191|Incidence|5423803|Black|Female|Other|1999|3.0|4.1|3.5
0-19|2.2|3.0|2.6|143|Incidence|5675852|Black|Female|Other|2000|2.1|3.0|2.5
0-19|2.8|3.8|3.3|188|Incidence|5784700|Black|Female|Other|2001|2.8|3.7|3.2
0-19|2.4|3.3|2.8|161|Incidence|5758829|Black|Female|Other|2002|2.4|3.3|2.8
0-19|3.3|3.7|3.5|1018|Incidence|28826479|Black|Female|Other|2002-2006|3.3|3.8|3.5
0-19|3.8|4.8|4.3|269|Incidence|6259473|Black|Female|Other|2003|3.8|4.8|4.3
0-19|2.9|3.8|3.3|215|Incidence|6460006|Black|Female|Other|2004|2.9|3.8|3.3
0-19|3.2|4.1|3.6|238|Incidence|6489830|Black|Female|Other|2005|3.2|4.2|3.7
0-19|2.8|3.7|3.2|213|Incidence|6479923|Black|Female|Other|2006|2.9|3.8|3.3
0-19|0.5|1.0|0.7|40|Incidence|5423803|Black|Female|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.3|1.0|55|Incidence|5675852|Black|Female|Soft Tissue|2000|0.7|1.3|1.0
0-19|0.5|1.0|0.7|43|Incidence|5784700|Black|Female|Soft Tissue|2001|0.5|1.0|0.7
0-19|0.7|1.2|0.9|53|Incidence|5758829|Black|Female|Soft Tissue|2002|0.7|1.2|0.9
0-19|0.8|1.0|0.9|260|Incidence|28826479|Black|Female|Soft Tissue|2002-2006|0.8|1.0|0.9
0-19|0.6|1.1|0.8|52|Incidence|6259473|Black|Female|Soft Tissue|2003|0.6|1.1|0.8
0-19|0.9|1.5|1.2|77|Incidence|6460006|Black|Female|Soft Tissue|2004|0.9|1.5|1.2
0-19|0.6|1.0|0.8|50|Incidence|6489830|Black|Female|Soft Tissue|2005|0.6|1.0|0.8
0-19|0.5|1.0|0.7|48|Incidence|6479923|Black|Female|Soft Tissue|2006|0.5|1.0|0.7
0-19|1.5|2.2|1.8|103|Incidence|5590427|Black|Male|Acute Lymphocytic|1999|1.5|2.2|1.8
0-19|1.2|1.8|1.5|88|Incidence|5854815|Black|Male|Acute Lymphocytic|2000|1.2|1.9|1.5
0-19|1.3|1.9|1.6|94|Incidence|5977693|Black|Male|Acute Lymphocytic|2001|1.3|1.9|1.6
0-19|1.3|2.0|1.6|98|Incidence|5955495|Black|Male|Acute Lymphocytic|2002|1.3|2.0|1.6
0-19|1.7|2.0|1.9|554|Incidence|29775692|Black|Male|Acute Lymphocytic|2002-2006|1.7|2.0|1.9
0-19|1.4|2.0|1.7|107|Incidence|6459821|Black|Male|Acute Lymphocytic|2003|1.4|2.0|1.7
0-19|1.7|2.3|2.0|132|Incidence|6663647|Black|Male|Acute Lymphocytic|2004|1.7|2.3|2.0
0-19|1.8|2.5|2.1|141|Incidence|6694035|Black|Male|Acute Lymphocytic|2005|1.8|2.5|2.1
0-19|1.7|2.4|2.0|137|Incidence|6681026|Black|Male|Acute Lymphocytic|2006|1.7|2.4|2.1
0-19|0.6|1.1|0.8|43|Incidence|5590427|Black|Male|Acute Myeloid|1999|0.6|1.0|0.8
0-19|0.5|0.9|0.7|40|Incidence|5854815|Black|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.4|0.7|0.5|31|Incidence|5977693|Black|Male|Acute Myeloid|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.6|38|Incidence|5955495|Black|Male|Acute Myeloid|2002|0.5|0.9|0.6
0-19|0.6|0.8|0.7|211|Incidence|29775692|Black|Male|Acute Myeloid|2002-2006|0.6|0.8|0.7
0-19|0.6|1.1|0.8|52|Incidence|6459821|Black|Male|Acute Myeloid|2003|0.6|1.1|0.8
0-19|0.6|1.0|0.7|50|Incidence|6663647|Black|Male|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.5|0.8|0.6|42|Incidence|6694035|Black|Male|Acute Myeloid|2005|0.5|0.8|0.6
0-19|0.5|0.9|0.7|45|Incidence|6681026|Black|Male|Acute Myeloid|2006|0.5|0.9|0.7
0-19|11.2|13.1|12.1|672|Incidence|5590427|Black|Male|All Cancer Sites Combined|1999|11.1|13.0|12.0
0-19|11.3|13.1|12.2|708|Incidence|5854815|Black|Male|All Cancer Sites Combined|2000|11.2|13.0|12.1
0-19|10.9|12.7|11.8|702|Incidence|5977693|Black|Male|All Cancer Sites Combined|2001|10.9|12.6|11.7
0-19|11.1|12.9|12.0|710|Incidence|5955495|Black|Male|All Cancer Sites Combined|2002|11.1|12.8|11.9
0-19|12.5|13.3|12.9|3850|Incidence|29775692|Black|Male|All Cancer Sites Combined|2002-2006|12.5|13.3|12.9
0-19|11.9|13.7|12.8|825|Incidence|6459821|Black|Male|All Cancer Sites Combined|2003|11.9|13.7|12.8
0-19|12.4|14.1|13.2|885|Incidence|6663647|Black|Male|All Cancer Sites Combined|2004|12.4|14.2|13.3
0-19|12.4|14.2|13.3|893|Incidence|6694035|Black|Male|All Cancer Sites Combined|2005|12.5|14.2|13.3
0-19|12.0|13.7|12.9|866|Incidence|6681026|Black|Male|All Cancer Sites Combined|2006|12.1|13.9|13.0
0-19|0.6|1.2|0.9|48|Incidence|5590427|Black|Male|Bones and Joints|1999|0.6|1.1|0.9
0-19|0.5|1.0|0.8|43|Incidence|5854815|Black|Male|Bones and Joints|2000|0.5|1.0|0.7
0-19|0.4|0.9|0.6|37|Incidence|5977693|Black|Male|Bones and Joints|2001|0.4|0.9|0.6
0-19|0.6|1.1|0.8|49|Incidence|5955495|Black|Male|Bones and Joints|2002|0.6|1.1|0.8
0-19|0.8|1.0|0.9|263|Incidence|29775692|Black|Male|Bones and Joints|2002-2006|0.8|1.0|0.9
0-19|0.6|1.0|0.8|49|Incidence|6459821|Black|Male|Bones and Joints|2003|0.6|1.0|0.8
0-19|0.7|1.2|1.0|64|Incidence|6663647|Black|Male|Bones and Joints|2004|0.7|1.2|1.0
0-19|0.7|1.2|0.9|62|Incidence|6694035|Black|Male|Bones and Joints|2005|0.7|1.2|0.9
0-19|0.6|1.1|0.8|56|Incidence|6681026|Black|Male|Bones and Joints|2006|0.6|1.1|0.8
0-19|1.9|2.8|2.3|131|Incidence|5590427|Black|Male|Brain and Other Nervous System|1999|2.0|2.8|2.3
0-19|2.1|2.9|2.5|147|Incidence|5854815|Black|Male|Brain and Other Nervous System|2000|2.1|3.0|2.5
0-19|1.7|2.4|2.0|121|Incidence|5977693|Black|Male|Brain and Other Nervous System|2001|1.7|2.4|2.0
0-19|2.0|2.8|2.4|142|Incidence|5955495|Black|Male|Brain and Other Nervous System|2002|2.0|2.8|2.4
0-19|2.1|2.4|2.3|671|Incidence|29775692|Black|Male|Brain and Other Nervous System|2002-2006|2.1|2.4|2.3
0-19|1.9|2.6|2.2|143|Incidence|6459821|Black|Male|Brain and Other Nervous System|2003|1.9|2.6|2.2
0-19|2.0|2.8|2.4|160|Incidence|6663647|Black|Male|Brain and Other Nervous System|2004|2.0|2.8|2.4
0-19|1.8|2.5|2.1|142|Incidence|6694035|Black|Male|Brain and Other Nervous System|2005|1.8|2.5|2.1
0-19|1.7|2.4|2.0|136|Incidence|6681026|Black|Male|Brain and Other Nervous System|2006|1.7|2.4|2.0
0-19|0.8|1.3|1.0|55|Incidence|5590427|Black|Male|Hodgkin Lymphoma|1999|0.7|1.3|1.0
0-19|0.9|1.4|1.1|63|Incidence|5854815|Black|Male|Hodgkin Lymphoma|2000|0.8|1.4|1.1
0-19|0.7|1.3|1.0|57|Incidence|5977693|Black|Male|Hodgkin Lymphoma|2001|0.7|1.2|1.0
0-19|0.7|1.2|0.9|53|Incidence|5955495|Black|Male|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.9|1.1|1.0|304|Incidence|29775692|Black|Male|Hodgkin Lymphoma|2002-2006|0.9|1.1|1.0
0-19|0.7|1.2|0.9|58|Incidence|6459821|Black|Male|Hodgkin Lymphoma|2003|0.7|1.2|0.9
0-19|0.8|1.3|1.0|67|Incidence|6663647|Black|Male|Hodgkin Lymphoma|2004|0.8|1.3|1.0
0-19|1.0|1.5|1.2|83|Incidence|6694035|Black|Male|Hodgkin Lymphoma|2005|1.0|1.5|1.2
0-19|0.8|1.3|1.0|70|Incidence|6681026|Black|Male|Hodgkin Lymphoma|2006|0.8|1.3|1.0
0-19|0.5|0.9|0.7|38|Incidence|5590427|Black|Male|Kidney and Renal Pelvis|1999|0.5|0.9|0.7
0-19|0.7|1.2|0.9|53|Incidence|5854815|Black|Male|Kidney and Renal Pelvis|2000|0.7|1.2|0.9
0-19|0.5|1.0|0.7|44|Incidence|5977693|Black|Male|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.5|0.9|0.7|41|Incidence|5955495|Black|Male|Kidney and Renal Pelvis|2002|0.5|0.9|0.7
0-19|0.7|0.9|0.8|233|Incidence|29775692|Black|Male|Kidney and Renal Pelvis|2002-2006|0.7|0.9|0.8
0-19|0.5|0.9|0.7|43|Incidence|6459821|Black|Male|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.7|1.1|0.9|59|Incidence|6663647|Black|Male|Kidney and Renal Pelvis|2004|0.7|1.1|0.9
0-19|0.5|1.0|0.7|50|Incidence|6694035|Black|Male|Kidney and Renal Pelvis|2005|0.6|1.0|0.7
0-19|0.7|1.1|0.9|59|Incidence|6681026|Black|Male|Kidney and Renal Pelvis|2006|0.7|1.1|0.9
0-19|2.4|3.3|2.9|160|Incidence|5590427|Black|Male|Leukemia|1999|2.4|3.3|2.9
0-19|2.0|2.8|2.4|141|Incidence|5854815|Black|Male|Leukemia|2000|2.0|2.8|2.4
0-19|2.0|2.8|2.4|141|Incidence|5977693|Black|Male|Leukemia|2001|2.0|2.8|2.4
0-19|2.2|3.0|2.6|154|Incidence|5955495|Black|Male|Leukemia|2002|2.2|3.0|2.6
0-19|2.7|3.1|2.9|868|Incidence|29775692|Black|Male|Leukemia|2002-2006|2.7|3.1|2.9
0-19|2.6|3.4|3.0|191|Incidence|6459821|Black|Male|Leukemia|2003|2.6|3.4|3.0
0-19|2.7|3.5|3.1|207|Incidence|6663647|Black|Male|Leukemia|2004|2.7|3.6|3.1
0-19|2.6|3.5|3.0|202|Incidence|6694035|Black|Male|Leukemia|2005|2.6|3.5|3.0
0-19|2.6|3.4|3.0|199|Incidence|6681026|Black|Male|Leukemia|2006|2.6|3.4|3.0
0-19|1.0|1.6|1.2|68|Incidence|5590427|Black|Male|Non-Hodgkin Lymphoma|1999|0.9|1.5|1.2
0-19|0.8|1.4|1.1|63|Incidence|5854815|Black|Male|Non-Hodgkin Lymphoma|2000|0.8|1.4|1.1
0-19|0.9|1.5|1.2|69|Incidence|5977693|Black|Male|Non-Hodgkin Lymphoma|2001|0.9|1.5|1.2
0-19|0.8|1.4|1.1|65|Incidence|5955495|Black|Male|Non-Hodgkin Lymphoma|2002|0.8|1.4|1.1
0-19|1.2|1.5|1.4|407|Incidence|29775692|Black|Male|Non-Hodgkin Lymphoma|2002-2006|1.2|1.5|1.4
0-19|1.0|1.6|1.3|81|Incidence|6459821|Black|Male|Non-Hodgkin Lymphoma|2003|1.0|1.6|1.3
0-19|1.2|1.9|1.5|102|Incidence|6663647|Black|Male|Non-Hodgkin Lymphoma|2004|1.2|1.9|1.5
0-19|1.3|1.9|1.5|103|Incidence|6694035|Black|Male|Non-Hodgkin Lymphoma|2005|1.3|1.9|1.5
0-19|1.2|1.7|1.4|96|Incidence|6681026|Black|Male|Non-Hodgkin Lymphoma|2006|1.2|1.8|1.4
0-19|2.0|2.9|2.4|132|Incidence|5590427|Black|Male|Other|1999|2.0|2.8|2.4
0-19|2.1|3.0|2.5|146|Incidence|5854815|Black|Male|Other|2000|2.1|2.9|2.5
0-19|2.4|3.3|2.8|170|Incidence|5977693|Black|Male|Other|2001|2.4|3.3|2.8
0-19|2.4|3.2|2.8|165|Incidence|5955495|Black|Male|Other|2002|2.4|3.2|2.8
0-19|2.7|3.1|2.9|855|Incidence|29775692|Black|Male|Other|2002-2006|2.7|3.1|2.9
0-19|2.7|3.6|3.1|201|Incidence|6459821|Black|Male|Other|2003|2.7|3.6|3.1
0-19|2.2|3.0|2.6|172|Incidence|6663647|Black|Male|Other|2004|2.2|3.0|2.6
0-19|2.4|3.3|2.8|191|Incidence|6694035|Black|Male|Other|2005|2.5|3.3|2.9
0-19|2.4|3.2|2.8|191|Incidence|6681026|Black|Male|Other|2006|2.5|3.3|2.9
0-19|0.5|1.0|0.7|40|Incidence|5590427|Black|Male|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|52|Incidence|5854815|Black|Male|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.8|1.4|1.1|63|Incidence|5977693|Black|Male|Soft Tissue|2001|0.8|1.3|1.1
0-19|0.5|0.9|0.7|41|Incidence|5955495|Black|Male|Soft Tissue|2002|0.5|0.9|0.7
0-19|0.7|0.9|0.8|249|Incidence|29775692|Black|Male|Soft Tissue|2002-2006|0.7|0.9|0.8
0-19|0.7|1.2|0.9|59|Incidence|6459821|Black|Male|Soft Tissue|2003|0.7|1.2|0.9
0-19|0.6|1.0|0.8|54|Incidence|6663647|Black|Male|Soft Tissue|2004|0.6|1.1|0.8
0-19|0.7|1.1|0.9|60|Incidence|6694035|Black|Male|Soft Tissue|2005|0.7|1.2|0.9
0-19|0.7|1.1|0.9|59|Incidence|6681026|Black|Male|Soft Tissue|2006|0.7|1.1|0.9
0-19|1.4|1.9|1.6|178|Incidence|11014230|Black|Male and Female|Acute Lymphocytic|1999|1.4|1.9|1.6
0-19|1.2|1.7|1.4|167|Incidence|11530667|Black|Male and Female|Acute Lymphocytic|2000|1.2|1.7|1.4
0-19|1.4|1.9|1.6|189|Incidence|11762393|Black|Male and Female|Acute Lymphocytic|2001|1.4|1.9|1.6
0-19|1.3|1.7|1.5|172|Incidence|11714324|Black|Male and Female|Acute Lymphocytic|2002|1.3|1.7|1.5
0-19|1.5|1.7|1.6|926|Incidence|58602171|Black|Male and Female|Acute Lymphocytic|2002-2006|1.5|1.7|1.6
0-19|1.3|1.7|1.5|192|Incidence|12719294|Black|Male and Female|Acute Lymphocytic|2003|1.3|1.7|1.5
0-19|1.5|1.9|1.7|221|Incidence|13123653|Black|Male and Female|Acute Lymphocytic|2004|1.5|1.9|1.7
0-19|1.5|2.0|1.7|229|Incidence|13183865|Black|Male and Female|Acute Lymphocytic|2005|1.5|2.0|1.7
0-19|1.5|1.9|1.7|223|Incidence|13160949|Black|Male and Female|Acute Lymphocytic|2006|1.5|1.9|1.7
0-19|0.6|0.9|0.7|77|Incidence|11014230|Black|Male and Female|Acute Myeloid|1999|0.6|0.9|0.7
0-19|0.5|0.8|0.6|70|Incidence|11530667|Black|Male and Female|Acute Myeloid|2000|0.5|0.8|0.6
0-19|0.4|0.7|0.5|61|Incidence|11762393|Black|Male and Female|Acute Myeloid|2001|0.4|0.7|0.5
0-19|0.5|0.8|0.7|78|Incidence|11714324|Black|Male and Female|Acute Myeloid|2002|0.5|0.8|0.7
0-19|0.6|0.7|0.7|393|Incidence|58602171|Black|Male and Female|Acute Myeloid|2002-2006|0.6|0.7|0.7
0-19|0.6|0.9|0.7|94|Incidence|12719294|Black|Male and Female|Acute Myeloid|2003|0.6|0.9|0.7
0-19|0.5|0.8|0.7|86|Incidence|13123653|Black|Male and Female|Acute Myeloid|2004|0.5|0.8|0.7
0-19|0.5|0.7|0.6|77|Incidence|13183865|Black|Male and Female|Acute Myeloid|2005|0.5|0.7|0.6
0-19|0.6|0.9|0.7|96|Incidence|13160949|Black|Male and Female|Acute Myeloid|2006|0.6|0.9|0.7
0-19|11.1|12.4|11.8|1282|Incidence|11014230|Black|Male and Female|All Cancer Sites Combined|1999|11.0|12.3|11.6
0-19|10.8|12.0|11.4|1305|Incidence|11530667|Black|Male and Female|All Cancer Sites Combined|2000|10.7|11.9|11.3
0-19|11.0|12.2|11.6|1358|Incidence|11762393|Black|Male and Female|All Cancer Sites Combined|2001|10.9|12.2|11.5
0-19|11.0|12.2|11.6|1356|Incidence|11714324|Black|Male and Female|All Cancer Sites Combined|2002|11.0|12.2|11.6
0-19|12.2|12.8|12.5|7329|Incidence|58602171|Black|Male and Female|All Cancer Sites Combined|2002-2006|12.2|12.8|12.5
0-19|12.0|13.2|12.6|1605|Incidence|12719294|Black|Male and Female|All Cancer Sites Combined|2003|12.0|13.3|12.6
0-19|12.2|13.4|12.8|1687|Incidence|13123653|Black|Male and Female|All Cancer Sites Combined|2004|12.2|13.5|12.9
0-19|12.2|13.4|12.8|1696|Incidence|13183865|Black|Male and Female|All Cancer Sites Combined|2005|12.3|13.5|12.9
0-19|11.6|12.8|12.2|1617|Incidence|13160949|Black|Male and Female|All Cancer Sites Combined|2006|11.7|12.9|12.3
0-19|0.6|0.9|0.8|83|Incidence|11014230|Black|Male and Female|Bones and Joints|1999|0.6|0.9|0.8
0-19|0.5|0.8|0.6|71|Incidence|11530667|Black|Male and Female|Bones and Joints|2000|0.5|0.8|0.6
0-19|0.5|0.8|0.7|76|Incidence|11762393|Black|Male and Female|Bones and Joints|2001|0.5|0.8|0.6
0-19|0.6|0.9|0.7|84|Incidence|11714324|Black|Male and Female|Bones and Joints|2002|0.6|0.9|0.7
0-19|0.7|0.9|0.8|471|Incidence|58602171|Black|Male and Female|Bones and Joints|2002-2006|0.7|0.9|0.8
0-19|0.6|0.9|0.7|89|Incidence|12719294|Black|Male and Female|Bones and Joints|2003|0.6|0.9|0.7
0-19|0.8|1.1|0.9|123|Incidence|13123653|Black|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.6|0.9|0.8|103|Incidence|13183865|Black|Male and Female|Bones and Joints|2005|0.6|0.9|0.8
0-19|0.6|0.9|0.8|100|Incidence|13160949|Black|Male and Female|Bones and Joints|2006|0.6|0.9|0.8
0-19|1.8|2.3|2.1|229|Incidence|11014230|Black|Male and Female|Brain and Other Nervous System|1999|1.8|2.4|2.1
0-19|2.0|2.5|2.3|261|Incidence|11530667|Black|Male and Female|Brain and Other Nervous System|2000|2.0|2.6|2.3
0-19|1.8|2.3|2.0|238|Incidence|11762393|Black|Male and Female|Brain and Other Nervous System|2001|1.8|2.3|2.0
0-19|1.9|2.5|2.2|257|Incidence|11714324|Black|Male and Female|Brain and Other Nervous System|2002|1.9|2.5|2.2
0-19|2.1|2.4|2.2|1304|Incidence|58602171|Black|Male and Female|Brain and Other Nervous System|2002-2006|2.1|2.3|2.2
0-19|1.9|2.5|2.2|279|Incidence|12719294|Black|Male and Female|Brain and Other Nervous System|2003|1.9|2.5|2.2
0-19|2.1|2.6|2.3|307|Incidence|13123653|Black|Male and Female|Brain and Other Nervous System|2004|2.1|2.6|2.3
0-19|2.0|2.5|2.2|291|Incidence|13183865|Black|Male and Female|Brain and Other Nervous System|2005|2.0|2.5|2.2
0-19|1.8|2.3|2.1|273|Incidence|13160949|Black|Male and Female|Brain and Other Nervous System|2006|1.8|2.3|2.1
0-19|0.7|1.1|0.9|93|Incidence|11014230|Black|Male and Female|Hodgkin Lymphoma|1999|0.7|1.0|0.8
0-19|0.8|1.2|1.0|107|Incidence|11530667|Black|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|0.7|1.0|0.8|98|Incidence|11762393|Black|Male and Female|Hodgkin Lymphoma|2001|0.7|1.0|0.8
0-19|0.7|1.1|0.9|104|Incidence|11714324|Black|Male and Female|Hodgkin Lymphoma|2002|0.7|1.1|0.9
0-19|0.9|1.0|1.0|558|Incidence|58602171|Black|Male and Female|Hodgkin Lymphoma|2002-2006|0.9|1.0|1.0
0-19|0.8|1.1|0.9|116|Incidence|12719294|Black|Male and Female|Hodgkin Lymphoma|2003|0.8|1.1|0.9
0-19|0.8|1.1|0.9|123|Incidence|13123653|Black|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|1.0|1.3|1.1|152|Incidence|13183865|Black|Male and Female|Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|0.7|1.1|0.9|120|Incidence|13160949|Black|Male and Female|Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.6|0.9|0.7|83|Incidence|11014230|Black|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.9|0.8
0-19|0.8|1.2|1.0|112|Incidence|11530667|Black|Male and Female|Kidney and Renal Pelvis|2000|0.8|1.2|1.0
0-19|0.6|0.9|0.7|86|Incidence|11762393|Black|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.9|0.7
0-19|0.6|0.9|0.8|90|Incidence|11714324|Black|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.9|0.8
0-19|0.7|0.9|0.8|458|Incidence|58602171|Black|Male and Female|Kidney and Renal Pelvis|2002-2006|0.7|0.9|0.8
0-19|0.5|0.8|0.7|87|Incidence|12719294|Black|Male and Female|Kidney and Renal Pelvis|2003|0.5|0.8|0.7
0-19|0.6|0.9|0.8|102|Incidence|13123653|Black|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.9|0.8
0-19|0.7|1.0|0.8|111|Incidence|13183865|Black|Male and Female|Kidney and Renal Pelvis|2005|0.7|1.0|0.8
0-19|0.7|1.0|0.8|109|Incidence|13160949|Black|Male and Female|Kidney and Renal Pelvis|2006|0.7|1.0|0.8
0-19|2.3|3.0|2.6|290|Incidence|11014230|Black|Male and Female|Leukemia|1999|2.3|3.0|2.6
0-19|2.0|2.5|2.2|259|Incidence|11530667|Black|Male and Female|Leukemia|2000|2.0|2.5|2.2
0-19|2.1|2.7|2.4|281|Incidence|11762393|Black|Male and Female|Leukemia|2001|2.1|2.7|2.4
0-19|2.2|2.8|2.5|290|Incidence|11714324|Black|Male and Female|Leukemia|2002|2.2|2.8|2.5
0-19|2.4|2.7|2.6|1515|Incidence|58602171|Black|Male and Female|Leukemia|2002-2006|2.5|2.7|2.6
0-19|2.3|2.9|2.6|330|Incidence|12719294|Black|Male and Female|Leukemia|2003|2.3|2.9|2.6
0-19|2.4|3.0|2.7|358|Incidence|13123653|Black|Male and Female|Leukemia|2004|2.5|3.0|2.7
0-19|2.3|2.9|2.6|342|Incidence|13183865|Black|Male and Female|Leukemia|2005|2.3|2.9|2.6
0-19|2.4|3.0|2.7|355|Incidence|13160949|Black|Male and Female|Leukemia|2006|2.4|3.0|2.7
0-19|0.8|1.1|0.9|101|Incidence|11014230|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.7|1.1|0.9
0-19|0.7|1.1|0.9|99|Incidence|11530667|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.7|1.0|0.9
0-19|0.8|1.2|1.0|115|Incidence|11762393|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.2|1.0
0-19|0.8|1.1|1.0|111|Incidence|11714324|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.8|1.1|0.9
0-19|1.0|1.2|1.1|641|Incidence|58602171|Black|Male and Female|Non-Hodgkin Lymphoma|2002-2006|1.0|1.2|1.1
0-19|0.8|1.2|1.0|123|Incidence|12719294|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.8|1.2|1.0
0-19|1.0|1.4|1.2|156|Incidence|13123653|Black|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.4|1.2
0-19|1.0|1.4|1.2|158|Incidence|13183865|Black|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|0.9|1.3|1.1|149|Incidence|13160949|Black|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.3|1.1
0-19|2.7|3.4|3.0|323|Incidence|11014230|Black|Male and Female|Other|1999|2.6|3.3|2.9
0-19|2.3|2.9|2.5|289|Incidence|11530667|Black|Male and Female|Other|2000|2.2|2.8|2.5
0-19|2.8|3.4|3.1|358|Incidence|11762393|Black|Male and Female|Other|2001|2.7|3.4|3.0
0-19|2.5|3.1|2.8|326|Incidence|11714324|Black|Male and Female|Other|2002|2.5|3.1|2.8
0-19|3.0|3.3|3.2|1873|Incidence|58602171|Black|Male and Female|Other|2002-2006|3.1|3.3|3.2
0-19|3.4|4.0|3.7|470|Incidence|12719294|Black|Male and Female|Other|2003|3.4|4.0|3.7
0-19|2.6|3.2|2.9|387|Incidence|13123653|Black|Male and Female|Other|2004|2.7|3.3|2.9
0-19|2.9|3.5|3.2|429|Incidence|13183865|Black|Male and Female|Other|2005|3.0|3.6|3.3
0-19|2.7|3.3|3.0|404|Incidence|13160949|Black|Male and Female|Other|2006|2.8|3.4|3.1
0-19|0.6|0.9|0.7|80|Incidence|11014230|Black|Male and Female|Soft Tissue|1999|0.6|0.9|0.7
0-19|0.8|1.1|0.9|107|Incidence|11530667|Black|Male and Female|Soft Tissue|2000|0.8|1.1|0.9
0-19|0.7|1.1|0.9|106|Incidence|11762393|Black|Male and Female|Soft Tissue|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|94|Incidence|11714324|Black|Male and Female|Soft Tissue|2002|0.6|1.0|0.8
0-19|0.8|0.9|0.9|509|Incidence|58602171|Black|Male and Female|Soft Tissue|2002-2006|0.8|0.9|0.9
0-19|0.7|1.0|0.9|111|Incidence|12719294|Black|Male and Female|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.8|1.2|1.0|131|Incidence|13123653|Black|Male and Female|Soft Tissue|2004|0.8|1.2|1.0
0-19|0.7|1.0|0.8|110|Incidence|13183865|Black|Male and Female|Soft Tissue|2005|0.7|1.0|0.8
0-19|0.7|1.0|0.8|107|Incidence|13160949|Black|Male and Female|Soft Tissue|2006|0.7|1.0|0.8
0-19|2.8|3.7|3.2|212|Incidence|6242965|Hispanic|Female|Acute Lymphocytic|1999|3.0|3.9|3.4
0-19|3.5|4.4|3.9|267|Incidence|6519278|Hispanic|Female|Acute Lymphocytic|2000|3.6|4.6|4.1
0-19|3.2|4.1|3.6|256|Incidence|6725905|Hispanic|Female|Acute Lymphocytic|2001|3.4|4.3|3.8
0-19|3.3|4.2|3.7|268|Incidence|6911708|Hispanic|Female|Acute Lymphocytic|2002|3.4|4.4|3.9
0-19|3.4|3.7|3.5|1310|Incidence|35076963|Hispanic|Female|Acute Lymphocytic|2002-2006|3.5|3.9|3.7
0-19|3.1|4.0|3.5|268|Incidence|7193432|Hispanic|Female|Acute Lymphocytic|2003|3.3|4.2|3.7
0-19|3.1|3.9|3.5|269|Incidence|7440270|Hispanic|Female|Acute Lymphocytic|2004|3.2|4.1|3.6
0-19|3.0|3.8|3.4|276|Incidence|7670747|Hispanic|Female|Acute Lymphocytic|2005|3.2|4.0|3.6
0-19|3.3|4.2|3.7|297|Incidence|7567809|Hispanic|Female|Acute Lymphocytic|2006|3.5|4.4|3.9
0-19|0.5|0.9|0.7|42|Incidence|6242965|Hispanic|Female|Acute Myeloid|1999|0.5|0.9|0.7
0-19|0.6|1.0|0.8|51|Incidence|6519278|Hispanic|Female|Acute Myeloid|2000|0.6|1.0|0.8
0-19|0.5|0.9|0.7|45|Incidence|6725905|Hispanic|Female|Acute Myeloid|2001|0.5|0.9|0.7
0-19|0.5|1.0|0.7|49|Incidence|6911708|Hispanic|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.6|0.8|0.7|252|Incidence|35076963|Hispanic|Female|Acute Myeloid|2002-2006|0.6|0.8|0.7
0-19|0.5|0.9|0.7|49|Incidence|7193432|Hispanic|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.6|1.0|0.8|60|Incidence|7440270|Hispanic|Female|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.5|0.9|0.7|54|Incidence|7670747|Hispanic|Female|Acute Myeloid|2005|0.5|0.9|0.7
0-19|0.6|1.0|0.7|55|Incidence|7567809|Hispanic|Female|Acute Myeloid|2006|0.5|0.9|0.7
0-19|13.1|15.0|14.0|883|Incidence|6242965|Hispanic|Female|All Cancer Sites Combined|1999|13.2|15.1|14.1
0-19|14.5|16.4|15.4|1009|Incidence|6519278|Hispanic|Female|All Cancer Sites Combined|2000|14.5|16.5|15.5
0-19|14.1|16.0|15.0|1024|Incidence|6725905|Hispanic|Female|All Cancer Sites Combined|2001|14.3|16.2|15.2
0-19|14.1|16.0|15.0|1046|Incidence|6911708|Hispanic|Female|All Cancer Sites Combined|2002|14.2|16.1|15.1
0-19|15.3|16.1|15.7|5536|Incidence|35076963|Hispanic|Female|All Cancer Sites Combined|2002-2006|15.4|16.2|15.8
0-19|14.6|16.5|15.5|1132|Incidence|7193432|Hispanic|Female|All Cancer Sites Combined|2003|14.8|16.7|15.7
0-19|15.7|17.5|16.6|1244|Incidence|7440270|Hispanic|Female|All Cancer Sites Combined|2004|15.8|17.7|16.7
0-19|14.8|16.5|15.6|1203|Incidence|7670747|Hispanic|Female|All Cancer Sites Combined|2005|14.8|16.6|15.7
0-19|14.7|16.5|15.6|1179|Incidence|7567809|Hispanic|Female|All Cancer Sites Combined|2006|14.7|16.5|15.6
0-19|0.7|1.2|0.9|53|Incidence|6242965|Hispanic|Female|Bones and Joints|1999|0.6|1.1|0.8
0-19|0.7|1.2|0.9|56|Incidence|6519278|Hispanic|Female|Bones and Joints|2000|0.6|1.1|0.9
0-19|0.5|1.0|0.7|46|Incidence|6725905|Hispanic|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.6|1.0|0.8|49|Incidence|6911708|Hispanic|Female|Bones and Joints|2002|0.5|0.9|0.7
0-19|0.8|1.0|0.9|296|Incidence|35076963|Hispanic|Female|Bones and Joints|2002-2006|0.8|0.9|0.8
0-19|0.7|1.2|0.9|61|Incidence|7193432|Hispanic|Female|Bones and Joints|2003|0.6|1.1|0.8
0-19|0.8|1.3|1.0|71|Incidence|7440270|Hispanic|Female|Bones and Joints|2004|0.7|1.2|1.0
0-19|0.7|1.1|0.9|62|Incidence|7670747|Hispanic|Female|Bones and Joints|2005|0.6|1.0|0.8
0-19|0.7|1.1|0.9|62|Incidence|7567809|Hispanic|Female|Bones and Joints|2006|0.6|1.1|0.8
0-19|2.0|2.7|2.3|150|Incidence|6242965|Hispanic|Female|Brain and Other Nervous System|1999|2.0|2.8|2.4
0-19|1.9|2.7|2.3|152|Incidence|6519278|Hispanic|Female|Brain and Other Nervous System|2000|2.0|2.7|2.3
0-19|2.0|2.7|2.3|163|Incidence|6725905|Hispanic|Female|Brain and Other Nervous System|2001|2.1|2.8|2.4
0-19|1.9|2.6|2.3|162|Incidence|6911708|Hispanic|Female|Brain and Other Nervous System|2002|2.0|2.7|2.3
0-19|2.3|2.6|2.5|883|Incidence|35076963|Hispanic|Female|Brain and Other Nervous System|2002-2006|2.4|2.7|2.5
0-19|2.1|2.8|2.4|182|Incidence|7193432|Hispanic|Female|Brain and Other Nervous System|2003|2.2|2.9|2.5
0-19|2.7|3.5|3.1|231|Incidence|7440270|Hispanic|Female|Brain and Other Nervous System|2004|2.7|3.5|3.1
0-19|2.0|2.7|2.3|182|Incidence|7670747|Hispanic|Female|Brain and Other Nervous System|2005|2.0|2.7|2.4
0-19|1.9|2.5|2.2|168|Incidence|7567809|Hispanic|Female|Brain and Other Nervous System|2006|1.9|2.6|2.2
0-19|0.5|1.0|0.8|43|Incidence|6242965|Hispanic|Female|Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|48|Incidence|6519278|Hispanic|Female|Hodgkin Lymphoma|2000|0.5|1.0|0.7
0-19|0.7|1.2|0.9|58|Incidence|6725905|Hispanic|Female|Hodgkin Lymphoma|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|49|Incidence|6911708|Hispanic|Female|Hodgkin Lymphoma|2002|0.5|0.9|0.7
0-19|0.9|1.1|1.0|307|Incidence|35076963|Hispanic|Female|Hodgkin Lymphoma|2002-2006|0.8|1.0|0.9
0-19|0.7|1.2|0.9|58|Incidence|7193432|Hispanic|Female|Hodgkin Lymphoma|2003|0.6|1.0|0.8
0-19|0.7|1.2|1.0|65|Incidence|7440270|Hispanic|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.8|1.3|1.0|71|Incidence|7670747|Hispanic|Female|Hodgkin Lymphoma|2005|0.7|1.2|0.9
0-19|0.9|1.4|1.1|75|Incidence|7567809|Hispanic|Female|Hodgkin Lymphoma|2006|0.8|1.2|1.0
0-19|0.5|0.9|0.6|44|Incidence|6242965|Hispanic|Female|Kidney and Renal Pelvis|1999|0.5|0.9|0.7
0-19|0.3|0.6|0.4|29|Incidence|6519278|Hispanic|Female|Kidney and Renal Pelvis|2000|0.3|0.6|0.4
0-19|0.4|0.8|0.6|44|Incidence|6725905|Hispanic|Female|Kidney and Renal Pelvis|2001|0.5|0.9|0.7
0-19|0.4|0.7|0.5|39|Incidence|6911708|Hispanic|Female|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.5|0.6|0.6|221|Incidence|35076963|Hispanic|Female|Kidney and Renal Pelvis|2002-2006|0.5|0.7|0.6
0-19|0.5|0.8|0.6|51|Incidence|7193432|Hispanic|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.5|0.8|0.6|51|Incidence|7440270|Hispanic|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.3|0.6|0.4|35|Incidence|7670747|Hispanic|Female|Kidney and Renal Pelvis|2005|0.3|0.6|0.5
0-19|0.5|0.8|0.6|52|Incidence|7567809|Hispanic|Female|Kidney and Renal Pelvis|2006|0.5|0.9|0.7
0-19|3.8|4.8|4.3|279|Incidence|6242965|Hispanic|Female|Leukemia|1999|4.0|5.0|4.5
0-19|4.6|5.7|5.2|348|Incidence|6519278|Hispanic|Female|Leukemia|2000|4.8|5.9|5.3
0-19|4.2|5.2|4.7|329|Incidence|6725905|Hispanic|Female|Leukemia|2001|4.4|5.4|4.9
0-19|4.5|5.5|5.0|358|Incidence|6911708|Hispanic|Female|Leukemia|2002|4.7|5.7|5.2
0-19|4.5|4.9|4.7|1715|Incidence|35076963|Hispanic|Female|Leukemia|2002-2006|4.7|5.1|4.9
0-19|4.2|5.2|4.7|351|Incidence|7193432|Hispanic|Female|Leukemia|2003|4.4|5.4|4.9
0-19|4.1|5.1|4.6|356|Incidence|7440270|Hispanic|Female|Leukemia|2004|4.3|5.3|4.8
0-19|4.1|5.0|4.5|364|Incidence|7670747|Hispanic|Female|Leukemia|2005|4.3|5.3|4.7
0-19|4.3|5.3|4.8|379|Incidence|7567809|Hispanic|Female|Leukemia|2006|4.5|5.5|5.0
0-19|0.5|1.0|0.7|44|Incidence|6242965|Hispanic|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.5|1.0|0.7|46|Incidence|6519278|Hispanic|Female|Non-Hodgkin Lymphoma|2000|0.5|0.9|0.7
0-19|0.5|0.9|0.7|43|Incidence|6725905|Hispanic|Female|Non-Hodgkin Lymphoma|2001|0.5|0.9|0.6
0-19|0.6|1.1|0.8|55|Incidence|6911708|Hispanic|Female|Non-Hodgkin Lymphoma|2002|0.6|1.0|0.8
0-19|0.7|0.8|0.7|251|Incidence|35076963|Hispanic|Female|Non-Hodgkin Lymphoma|2002-2006|0.6|0.8|0.7
0-19|0.4|0.8|0.6|42|Incidence|7193432|Hispanic|Female|Non-Hodgkin Lymphoma|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|49|Incidence|7440270|Hispanic|Female|Non-Hodgkin Lymphoma|2004|0.5|0.9|0.7
0-19|0.7|1.1|0.9|64|Incidence|7670747|Hispanic|Female|Non-Hodgkin Lymphoma|2005|0.6|1.1|0.8
0-19|0.5|1.0|0.7|52|Incidence|7567809|Hispanic|Female|Non-Hodgkin Lymphoma|2006|0.5|0.9|0.7
0-19|3.2|4.1|3.6|222|Incidence|6242965|Hispanic|Female|Other|1999|3.1|4.1|3.6
0-19|3.8|4.9|4.3|275|Incidence|6519278|Hispanic|Female|Other|2000|3.7|4.7|4.2
0-19|3.6|4.6|4.1|278|Incidence|6725905|Hispanic|Female|Other|2001|3.7|4.6|4.1
0-19|3.6|4.5|4.0|272|Incidence|6911708|Hispanic|Female|Other|2002|3.5|4.4|3.9
0-19|4.1|4.6|4.3|1498|Incidence|35076963|Hispanic|Female|Other|2002-2006|4.1|4.5|4.3
0-19|3.7|4.7|4.2|297|Incidence|7193432|Hispanic|Female|Other|2003|3.7|4.6|4.1
0-19|4.2|5.2|4.7|350|Incidence|7440270|Hispanic|Female|Other|2004|4.2|5.2|4.7
0-19|4.1|5.1|4.6|344|Incidence|7670747|Hispanic|Female|Other|2005|4.0|5.0|4.5
0-19|3.8|4.7|4.2|313|Incidence|7567809|Hispanic|Female|Other|2006|3.7|4.6|4.1
0-19|0.6|1.0|0.8|48|Incidence|6242965|Hispanic|Female|Soft Tissue|1999|0.6|1.0|0.8
0-19|0.6|1.1|0.8|55|Incidence|6519278|Hispanic|Female|Soft Tissue|2000|0.6|1.1|0.8
0-19|0.7|1.2|0.9|63|Incidence|6725905|Hispanic|Female|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.7|1.1|0.9|62|Incidence|6911708|Hispanic|Female|Soft Tissue|2002|0.7|1.1|0.9
0-19|0.9|1.1|1.0|365|Incidence|35076963|Hispanic|Female|Soft Tissue|2002-2006|0.9|1.2|1.0
0-19|1.0|1.5|1.2|90|Incidence|7193432|Hispanic|Female|Soft Tissue|2003|1.0|1.5|1.3
0-19|0.7|1.2|0.9|71|Incidence|7440270|Hispanic|Female|Soft Tissue|2004|0.7|1.2|1.0
0-19|0.8|1.3|1.1|81|Incidence|7670747|Hispanic|Female|Soft Tissue|2005|0.8|1.3|1.1
0-19|0.8|1.3|1.0|78|Incidence|7567809|Hispanic|Female|Soft Tissue|2006|0.8|1.3|1.0
0-19|3.8|4.9|4.3|297|Incidence|6646863|Hispanic|Male|Acute Lymphocytic|1999|4.0|5.0|4.5
0-19|4.0|5.0|4.4|317|Incidence|6936744|Hispanic|Male|Acute Lymphocytic|2000|4.1|5.1|4.6
0-19|3.9|4.8|4.3|315|Incidence|7128298|Hispanic|Male|Acute Lymphocytic|2001|3.9|4.9|4.4
0-19|4.2|5.2|4.7|352|Incidence|7295722|Hispanic|Male|Acute Lymphocytic|2002|4.3|5.4|4.8
0-19|4.4|4.8|4.6|1738|Incidence|36860177|Hispanic|Male|Acute Lymphocytic|2002-2006|4.5|4.9|4.7
0-19|3.5|4.4|4.0|311|Incidence|7567621|Hispanic|Male|Acute Lymphocytic|2003|3.7|4.6|4.1
0-19|4.2|5.2|4.7|381|Incidence|7812435|Hispanic|Male|Acute Lymphocytic|2004|4.4|5.4|4.9
0-19|4.2|5.1|4.6|382|Incidence|8050464|Hispanic|Male|Acute Lymphocytic|2005|4.3|5.2|4.7
0-19|4.4|5.4|4.9|396|Incidence|7937829|Hispanic|Male|Acute Lymphocytic|2006|4.5|5.5|5.0
0-19|0.7|1.2|1.0|64|Incidence|6646863|Hispanic|Male|Acute Myeloid|1999|0.7|1.2|1.0
0-19|0.5|0.9|0.7|46|Incidence|6936744|Hispanic|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.6|1.1|0.8|61|Incidence|7128298|Hispanic|Male|Acute Myeloid|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|58|Incidence|7295722|Hispanic|Male|Acute Myeloid|2002|0.6|1.0|0.8
0-19|0.8|1.0|0.9|314|Incidence|36860177|Hispanic|Male|Acute Myeloid|2002-2006|0.8|1.0|0.9
0-19|0.6|1.0|0.8|56|Incidence|7567621|Hispanic|Male|Acute Myeloid|2003|0.6|1.0|0.7
0-19|0.8|1.3|1.0|81|Incidence|7812435|Hispanic|Male|Acute Myeloid|2004|0.8|1.3|1.0
0-19|0.7|1.1|0.8|69|Incidence|8050464|Hispanic|Male|Acute Myeloid|2005|0.7|1.1|0.9
0-19|0.6|1.0|0.8|61|Incidence|7937829|Hispanic|Male|Acute Myeloid|2006|0.6|1.0|0.8
0-19|16.2|18.2|17.1|1155|Incidence|6646863|Hispanic|Male|All Cancer Sites Combined|1999|16.4|18.4|17.4
0-19|15.3|17.2|16.3|1136|Incidence|6936744|Hispanic|Male|All Cancer Sites Combined|2000|15.4|17.4|16.4
0-19|17.2|19.2|18.2|1306|Incidence|7128298|Hispanic|Male|All Cancer Sites Combined|2001|17.3|19.3|18.3
0-19|17.6|19.6|18.6|1362|Incidence|7295722|Hispanic|Male|All Cancer Sites Combined|2002|17.7|19.7|18.7
0-19|17.6|18.5|18.0|6672|Incidence|36860177|Hispanic|Male|All Cancer Sites Combined|2002-2006|17.7|18.5|18.1
0-19|15.7|17.5|16.6|1256|Incidence|7567621|Hispanic|Male|All Cancer Sites Combined|2003|15.7|17.5|16.6
0-19|17.0|18.9|17.9|1415|Incidence|7812435|Hispanic|Male|All Cancer Sites Combined|2004|17.2|19.1|18.1
0-19|16.8|18.7|17.8|1441|Incidence|8050464|Hispanic|Male|All Cancer Sites Combined|2005|17.0|18.8|17.9
0-19|17.6|19.6|18.6|1473|Incidence|7937829|Hispanic|Male|All Cancer Sites Combined|2006|17.6|19.5|18.6
0-19|0.6|1.0|0.8|48|Incidence|6646863|Hispanic|Male|Bones and Joints|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|61|Incidence|6936744|Hispanic|Male|Bones and Joints|2000|0.7|1.1|0.9
0-19|0.9|1.5|1.2|79|Incidence|7128298|Hispanic|Male|Bones and Joints|2001|0.9|1.4|1.1
0-19|0.9|1.4|1.2|79|Incidence|7295722|Hispanic|Male|Bones and Joints|2002|0.9|1.3|1.1
0-19|1.0|1.2|1.1|372|Incidence|36860177|Hispanic|Male|Bones and Joints|2002-2006|0.9|1.1|1.0
0-19|0.8|1.2|1.0|68|Incidence|7567621|Hispanic|Male|Bones and Joints|2003|0.7|1.1|0.9
0-19|0.8|1.2|1.0|71|Incidence|7812435|Hispanic|Male|Bones and Joints|2004|0.7|1.1|0.9
0-19|0.8|1.3|1.0|77|Incidence|8050464|Hispanic|Male|Bones and Joints|2005|0.8|1.2|1.0
0-19|1.0|1.5|1.2|91|Incidence|7937829|Hispanic|Male|Bones and Joints|2006|0.9|1.4|1.1
0-19|2.6|3.5|3.0|202|Incidence|6646863|Hispanic|Male|Brain and Other Nervous System|1999|2.6|3.5|3.0
0-19|2.3|3.1|2.7|187|Incidence|6936744|Hispanic|Male|Brain and Other Nervous System|2000|2.3|3.1|2.7
0-19|2.6|3.4|2.9|213|Incidence|7128298|Hispanic|Male|Brain and Other Nervous System|2001|2.6|3.4|3.0
0-19|2.5|3.3|2.9|217|Incidence|7295722|Hispanic|Male|Brain and Other Nervous System|2002|2.6|3.4|3.0
0-19|2.6|3.0|2.8|1047|Incidence|36860177|Hispanic|Male|Brain and Other Nervous System|2002-2006|2.7|3.0|2.8
0-19|2.3|3.0|2.7|205|Incidence|7567621|Hispanic|Male|Brain and Other Nervous System|2003|2.4|3.1|2.7
0-19|2.2|2.9|2.5|202|Incidence|7812435|Hispanic|Male|Brain and Other Nervous System|2004|2.2|3.0|2.6
0-19|2.5|3.2|2.8|233|Incidence|8050464|Hispanic|Male|Brain and Other Nervous System|2005|2.5|3.3|2.9
0-19|2.6|3.3|2.9|235|Incidence|7937829|Hispanic|Male|Brain and Other Nervous System|2006|2.6|3.4|3.0
0-19|0.9|1.4|1.1|72|Incidence|6646863|Hispanic|Male|Hodgkin Lymphoma|1999|0.8|1.4|1.1
0-19|0.9|1.4|1.1|74|Incidence|6936744|Hispanic|Male|Hodgkin Lymphoma|2000|0.8|1.3|1.1
0-19|1.1|1.7|1.4|93|Incidence|7128298|Hispanic|Male|Hodgkin Lymphoma|2001|1.1|1.6|1.3
0-19|0.9|1.4|1.1|78|Incidence|7295722|Hispanic|Male|Hodgkin Lymphoma|2002|0.8|1.3|1.1
0-19|1.1|1.3|1.2|420|Incidence|36860177|Hispanic|Male|Hodgkin Lymphoma|2002-2006|1.0|1.3|1.1
0-19|1.3|1.9|1.6|110|Incidence|7567621|Hispanic|Male|Hodgkin Lymphoma|2003|1.2|1.8|1.5
0-19|0.8|1.2|1.0|71|Incidence|7812435|Hispanic|Male|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.9|1.4|1.2|87|Incidence|8050464|Hispanic|Male|Hodgkin Lymphoma|2005|0.9|1.3|1.1
0-19|1.1|1.6|1.3|96|Incidence|7937829|Hispanic|Male|Hodgkin Lymphoma|2006|1.0|1.5|1.2
0-19|0.4|0.7|0.5|39|Incidence|6646863|Hispanic|Male|Kidney and Renal Pelvis|1999|0.4|0.8|0.6
0-19|0.3|0.7|0.5|35|Incidence|6936744|Hispanic|Male|Kidney and Renal Pelvis|2000|0.4|0.7|0.5
0-19|0.4|0.7|0.5|41|Incidence|7128298|Hispanic|Male|Kidney and Renal Pelvis|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|44|Incidence|7295722|Hispanic|Male|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.4|0.6|0.5|198|Incidence|36860177|Hispanic|Male|Kidney and Renal Pelvis|2002-2006|0.5|0.6|0.5
0-19|0.4|0.7|0.5|42|Incidence|7567621|Hispanic|Male|Kidney and Renal Pelvis|2003|0.4|0.8|0.6
0-19|0.3|0.6|0.4|39|Incidence|7812435|Hispanic|Male|Kidney and Renal Pelvis|2004|0.4|0.7|0.5
0-19|0.3|0.6|0.5|42|Incidence|8050464|Hispanic|Male|Kidney and Renal Pelvis|2005|0.4|0.7|0.5
0-19|0.3|0.6|0.4|37|Incidence|7937829|Hispanic|Male|Kidney and Renal Pelvis|2006|0.3|0.6|0.5
0-19|5.2|6.4|5.8|395|Incidence|6646863|Hispanic|Male|Leukemia|1999|5.4|6.6|5.9
0-19|5.0|6.1|5.5|391|Incidence|6936744|Hispanic|Male|Leukemia|2000|5.1|6.2|5.6
0-19|5.2|6.3|5.7|419|Incidence|7128298|Hispanic|Male|Leukemia|2001|5.3|6.5|5.9
0-19|5.4|6.5|6.0|446|Incidence|7295722|Hispanic|Male|Leukemia|2002|5.6|6.7|6.1
0-19|5.6|6.1|5.9|2228|Incidence|36860177|Hispanic|Male|Leukemia|2002-2006|5.8|6.3|6.0
0-19|4.6|5.6|5.1|393|Incidence|7567621|Hispanic|Male|Leukemia|2003|4.7|5.7|5.2
0-19|5.7|6.8|6.2|499|Incidence|7812435|Hispanic|Male|Leukemia|2004|5.8|7.0|6.4
0-19|5.4|6.5|5.9|491|Incidence|8050464|Hispanic|Male|Leukemia|2005|5.6|6.7|6.1
0-19|5.6|6.7|6.1|499|Incidence|7937829|Hispanic|Male|Leukemia|2006|5.7|6.9|6.3
0-19|0.9|1.5|1.2|77|Incidence|6646863|Hispanic|Male|Non-Hodgkin Lymphoma|1999|0.9|1.4|1.2
0-19|1.0|1.6|1.3|88|Incidence|6936744|Hispanic|Male|Non-Hodgkin Lymphoma|2000|1.0|1.6|1.3
0-19|1.0|1.5|1.2|86|Incidence|7128298|Hispanic|Male|Non-Hodgkin Lymphoma|2001|1.0|1.5|1.2
0-19|1.4|2.0|1.7|118|Incidence|7295722|Hispanic|Male|Non-Hodgkin Lymphoma|2002|1.3|1.9|1.6
0-19|1.3|1.5|1.4|491|Incidence|36860177|Hispanic|Male|Non-Hodgkin Lymphoma|2002-2006|1.2|1.5|1.3
0-19|0.9|1.4|1.1|81|Incidence|7567621|Hispanic|Male|Non-Hodgkin Lymphoma|2003|0.9|1.3|1.1
0-19|1.2|1.8|1.5|113|Incidence|7812435|Hispanic|Male|Non-Hodgkin Lymphoma|2004|1.2|1.7|1.4
0-19|1.1|1.6|1.3|100|Incidence|8050464|Hispanic|Male|Non-Hodgkin Lymphoma|2005|1.0|1.5|1.2
0-19|1.0|1.5|1.3|96|Incidence|7937829|Hispanic|Male|Non-Hodgkin Lymphoma|2006|1.0|1.5|1.2
0-19|3.4|4.3|3.8|262|Incidence|6646863|Hispanic|Male|Other|1999|3.5|4.4|3.9
0-19|2.9|3.7|3.3|230|Incidence|6936744|Hispanic|Male|Other|2000|2.9|3.8|3.3
0-19|3.9|4.8|4.3|310|Incidence|7128298|Hispanic|Male|Other|2001|3.9|4.9|4.3
0-19|3.7|4.7|4.2|302|Incidence|7295722|Hispanic|Male|Other|2002|3.7|4.6|4.1
0-19|4.0|4.5|4.2|1568|Incidence|36860177|Hispanic|Male|Other|2002-2006|4.0|4.5|4.3
0-19|3.5|4.4|3.9|295|Incidence|7567621|Hispanic|Male|Other|2003|3.5|4.4|3.9
0-19|3.9|4.8|4.3|340|Incidence|7812435|Hispanic|Male|Other|2004|3.9|4.8|4.4
0-19|3.8|4.7|4.3|344|Incidence|8050464|Hispanic|Male|Other|2005|3.8|4.7|4.3
0-19|3.9|4.9|4.4|346|Incidence|7937829|Hispanic|Male|Other|2006|3.9|4.8|4.4
0-19|0.7|1.1|0.9|60|Incidence|6646863|Hispanic|Male|Soft Tissue|1999|0.7|1.2|0.9
0-19|0.8|1.3|1.0|70|Incidence|6936744|Hispanic|Male|Soft Tissue|2000|0.8|1.3|1.0
0-19|0.7|1.2|0.9|65|Incidence|7128298|Hispanic|Male|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.8|1.3|1.1|78|Incidence|7295722|Hispanic|Male|Soft Tissue|2002|0.8|1.3|1.1
0-19|0.8|1.0|0.9|348|Incidence|36860177|Hispanic|Male|Soft Tissue|2002-2006|0.8|1.0|0.9
0-19|0.6|1.0|0.8|62|Incidence|7567621|Hispanic|Male|Soft Tissue|2003|0.6|1.1|0.8
0-19|0.8|1.3|1.0|80|Incidence|7812435|Hispanic|Male|Soft Tissue|2004|0.8|1.3|1.0
0-19|0.6|1.0|0.8|67|Incidence|8050464|Hispanic|Male|Soft Tissue|2005|0.6|1.1|0.8
0-19|0.7|1.2|0.9|73|Incidence|7937829|Hispanic|Male|Soft Tissue|2006|0.7|1.2|0.9
0-19|3.5|4.1|3.8|509|Incidence|12889828|Hispanic|Male and Female|Acute Lymphocytic|1999|3.6|4.3|3.9
0-19|3.9|4.6|4.2|584|Incidence|13456022|Hispanic|Male and Female|Acute Lymphocytic|2000|4.0|4.7|4.3
0-19|3.7|4.3|4.0|571|Incidence|13854203|Hispanic|Male and Female|Acute Lymphocytic|2001|3.8|4.5|4.1
0-19|3.9|4.5|4.2|620|Incidence|14207430|Hispanic|Male and Female|Acute Lymphocytic|2002|4.0|4.7|4.4
0-19|3.9|4.2|4.1|3048|Incidence|71937140|Hispanic|Male and Female|Acute Lymphocytic|2002-2006|4.1|4.4|4.2
0-19|3.5|4.1|3.8|579|Incidence|14761053|Hispanic|Male and Female|Acute Lymphocytic|2003|3.6|4.3|3.9
0-19|3.8|4.4|4.1|650|Incidence|15252705|Hispanic|Male and Female|Acute Lymphocytic|2004|3.9|4.6|4.3
0-19|3.7|4.3|4.0|658|Incidence|15721211|Hispanic|Male and Female|Acute Lymphocytic|2005|3.9|4.5|4.2
0-19|4.0|4.6|4.3|693|Incidence|15505638|Hispanic|Male and Female|Acute Lymphocytic|2006|4.1|4.8|4.5
0-19|0.7|1.0|0.8|106|Incidence|12889828|Hispanic|Male and Female|Acute Myeloid|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.7|97|Incidence|13456022|Hispanic|Male and Female|Acute Myeloid|2000|0.6|0.9|0.7
0-19|0.6|0.9|0.7|106|Incidence|13854203|Hispanic|Male and Female|Acute Myeloid|2001|0.6|0.9|0.8
0-19|0.6|0.9|0.8|107|Incidence|14207430|Hispanic|Male and Female|Acute Myeloid|2002|0.6|0.9|0.8
0-19|0.7|0.9|0.8|566|Incidence|71937140|Hispanic|Male and Female|Acute Myeloid|2002-2006|0.7|0.9|0.8
0-19|0.6|0.9|0.7|105|Incidence|14761053|Hispanic|Male and Female|Acute Myeloid|2003|0.6|0.9|0.7
0-19|0.8|1.1|0.9|141|Incidence|15252705|Hispanic|Male and Female|Acute Myeloid|2004|0.8|1.1|0.9
0-19|0.6|0.9|0.8|123|Incidence|15721211|Hispanic|Male and Female|Acute Myeloid|2005|0.7|0.9|0.8
0-19|0.6|0.9|0.8|116|Incidence|15505638|Hispanic|Male and Female|Acute Myeloid|2006|0.6|0.9|0.7
0-19|14.9|16.3|15.6|2038|Incidence|12889828|Hispanic|Male and Female|All Cancer Sites Combined|1999|15.1|16.5|15.8
0-19|15.2|16.6|15.9|2145|Incidence|13456022|Hispanic|Male and Female|All Cancer Sites Combined|2000|15.3|16.6|15.9
0-19|16.0|17.4|16.7|2330|Incidence|13854203|Hispanic|Male and Female|All Cancer Sites Combined|2001|16.1|17.5|16.8
0-19|16.2|17.6|16.9|2408|Incidence|14207430|Hispanic|Male and Female|All Cancer Sites Combined|2002|16.3|17.6|16.9
0-19|16.6|17.2|16.9|12208|Incidence|71937140|Hispanic|Male and Female|All Cancer Sites Combined|2002-2006|16.7|17.3|17.0
0-19|15.4|16.7|16.1|2388|Incidence|14761053|Hispanic|Male and Female|All Cancer Sites Combined|2003|15.5|16.8|16.2
0-19|16.6|17.9|17.3|2659|Incidence|15252705|Hispanic|Male and Female|All Cancer Sites Combined|2004|16.8|18.1|17.4
0-19|16.1|17.4|16.7|2644|Incidence|15721211|Hispanic|Male and Female|All Cancer Sites Combined|2005|16.2|17.5|16.8
0-19|16.5|17.8|17.1|2652|Incidence|15505638|Hispanic|Male and Female|All Cancer Sites Combined|2006|16.5|17.8|17.1
0-19|0.7|1.0|0.8|101|Incidence|12889828|Hispanic|Male and Female|Bones and Joints|1999|0.6|1.0|0.8
0-19|0.8|1.1|0.9|117|Incidence|13456022|Hispanic|Male and Female|Bones and Joints|2000|0.7|1.0|0.9
0-19|0.8|1.1|1.0|125|Incidence|13854203|Hispanic|Male and Female|Bones and Joints|2001|0.8|1.1|0.9
0-19|0.8|1.1|1.0|128|Incidence|14207430|Hispanic|Male and Female|Bones and Joints|2002|0.8|1.1|0.9
0-19|0.9|1.1|1.0|668|Incidence|71937140|Hispanic|Male and Female|Bones and Joints|2002-2006|0.9|1.0|0.9
0-19|0.8|1.1|0.9|129|Incidence|14761053|Hispanic|Male and Female|Bones and Joints|2003|0.7|1.0|0.9
0-19|0.8|1.2|1.0|142|Incidence|15252705|Hispanic|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.8|1.1|0.9|139|Incidence|15721211|Hispanic|Male and Female|Bones and Joints|2005|0.7|1.0|0.9
0-19|0.9|1.2|1.1|153|Incidence|15505638|Hispanic|Male and Female|Bones and Joints|2006|0.8|1.2|1.0
0-19|2.4|3.0|2.7|352|Incidence|12889828|Hispanic|Male and Female|Brain and Other Nervous System|1999|2.5|3.0|2.7
0-19|2.2|2.8|2.5|339|Incidence|13456022|Hispanic|Male and Female|Brain and Other Nervous System|2000|2.3|2.8|2.5
0-19|2.4|2.9|2.6|376|Incidence|13854203|Hispanic|Male and Female|Brain and Other Nervous System|2001|2.4|3.0|2.7
0-19|2.3|2.9|2.6|379|Incidence|14207430|Hispanic|Male and Female|Brain and Other Nervous System|2002|2.4|3.0|2.7
0-19|2.5|2.7|2.6|1930|Incidence|71937140|Hispanic|Male and Female|Brain and Other Nervous System|2002-2006|2.6|2.8|2.7
0-19|2.3|2.8|2.5|387|Incidence|14761053|Hispanic|Male and Female|Brain and Other Nervous System|2003|2.4|2.9|2.6
0-19|2.5|3.1|2.8|433|Incidence|15252705|Hispanic|Male and Female|Brain and Other Nervous System|2004|2.6|3.1|2.8
0-19|2.3|2.8|2.6|415|Incidence|15721211|Hispanic|Male and Female|Brain and Other Nervous System|2005|2.4|2.9|2.6
0-19|2.3|2.8|2.6|403|Incidence|15505638|Hispanic|Male and Female|Brain and Other Nervous System|2006|2.4|2.9|2.6
0-19|0.8|1.1|0.9|115|Incidence|12889828|Hispanic|Male and Female|Hodgkin Lymphoma|1999|0.7|1.1|0.9
0-19|0.8|1.1|1.0|122|Incidence|13456022|Hispanic|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|1.0|1.4|1.2|151|Incidence|13854203|Hispanic|Male and Female|Hodgkin Lymphoma|2001|0.9|1.3|1.1
0-19|0.8|1.2|1.0|127|Incidence|14207430|Hispanic|Male and Female|Hodgkin Lymphoma|2002|0.7|1.1|0.9
0-19|1.0|1.2|1.1|727|Incidence|71937140|Hispanic|Male and Female|Hodgkin Lymphoma|2002-2006|0.9|1.1|1.0
0-19|1.1|1.4|1.2|168|Incidence|14761053|Hispanic|Male and Female|Hodgkin Lymphoma|2003|1.0|1.3|1.1
0-19|0.8|1.2|1.0|136|Incidence|15252705|Hispanic|Male and Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.9|1.3|1.1|158|Incidence|15721211|Hispanic|Male and Female|Hodgkin Lymphoma|2005|0.9|1.2|1.0
0-19|1.0|1.4|1.2|171|Incidence|15505638|Hispanic|Male and Female|Hodgkin Lymphoma|2006|0.9|1.3|1.1
0-19|0.5|0.7|0.6|83|Incidence|12889828|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|0.5|0.8|0.6
0-19|0.3|0.6|0.4|64|Incidence|13456022|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|0.4|0.6|0.5
0-19|0.4|0.7|0.6|85|Incidence|13854203|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|0.5|0.8|0.6
0-19|0.4|0.7|0.5|83|Incidence|14207430|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.5|0.6|0.5|419|Incidence|71937140|Hispanic|Male and Female|Kidney and Renal Pelvis|2002-2006|0.5|0.6|0.6
0-19|0.5|0.7|0.6|93|Incidence|14761053|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|0.5|0.8|0.6
0-19|0.4|0.6|0.5|90|Incidence|15252705|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.4|0.6|0.4|77|Incidence|15721211|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|89|Incidence|15505638|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|0.5|0.7|0.6
0-19|4.7|5.5|5.1|674|Incidence|12889828|Hispanic|Male and Female|Leukemia|1999|4.8|5.6|5.2
0-19|5.0|5.8|5.4|739|Incidence|13456022|Hispanic|Male and Female|Leukemia|2000|5.1|5.9|5.5
0-19|4.9|5.6|5.2|748|Incidence|13854203|Hispanic|Male and Female|Leukemia|2001|5.0|5.8|5.4
0-19|5.1|5.9|5.5|804|Incidence|14207430|Hispanic|Male and Female|Leukemia|2002|5.3|6.1|5.7
0-19|5.1|5.5|5.3|3943|Incidence|71937140|Hispanic|Male and Female|Leukemia|2002-2006|5.3|5.7|5.5
0-19|4.5|5.2|4.9|744|Incidence|14761053|Hispanic|Male and Female|Leukemia|2003|4.7|5.4|5.0
0-19|5.0|5.8|5.4|855|Incidence|15252705|Hispanic|Male and Female|Leukemia|2004|5.2|6.0|5.6
0-19|4.9|5.6|5.3|855|Incidence|15721211|Hispanic|Male and Female|Leukemia|2005|5.1|5.8|5.4
0-19|5.1|5.9|5.5|878|Incidence|15505638|Hispanic|Male and Female|Leukemia|2006|5.3|6.0|5.7
0-19|0.8|1.2|1.0|121|Incidence|12889828|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|0.8|1.1|0.9
0-19|0.9|1.2|1.0|134|Incidence|13456022|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|0.8|1.2|1.0
0-19|0.8|1.1|1.0|129|Incidence|13854203|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.1|0.9
0-19|1.1|1.5|1.3|173|Incidence|14207430|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.4|1.2
0-19|1.0|1.2|1.1|742|Incidence|71937140|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002-2006|1.0|1.1|1.0
0-19|0.7|1.0|0.9|123|Incidence|14761053|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.0|0.8
0-19|0.9|1.3|1.1|162|Incidence|15252705|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.9|1.2|1.1
0-19|0.9|1.3|1.1|164|Incidence|15721211|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|0.9|1.2|1.0
0-19|0.9|1.2|1.0|148|Incidence|15505638|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.8|1.1|1.0
0-19|3.4|4.1|3.7|484|Incidence|12889828|Hispanic|Male and Female|Other|1999|3.4|4.1|3.8
0-19|3.5|4.1|3.8|505|Incidence|13456022|Hispanic|Male and Female|Other|2000|3.4|4.1|3.8
0-19|3.9|4.6|4.2|588|Incidence|13854203|Hispanic|Male and Female|Other|2001|3.9|4.6|4.2
0-19|3.8|4.4|4.1|574|Incidence|14207430|Hispanic|Male and Female|Other|2002|3.7|4.4|4.0
0-19|4.1|4.5|4.3|3066|Incidence|71937140|Hispanic|Male and Female|Other|2002-2006|4.1|4.4|4.3
0-19|3.7|4.4|4.1|592|Incidence|14761053|Hispanic|Male and Female|Other|2003|3.7|4.3|4.0
0-19|4.2|4.9|4.5|690|Incidence|15252705|Hispanic|Male and Female|Other|2004|4.2|4.9|4.5
0-19|4.1|4.8|4.4|688|Incidence|15721211|Hispanic|Male and Female|Other|2005|4.1|4.7|4.4
0-19|4.0|4.6|4.3|659|Incidence|15505638|Hispanic|Male and Female|Other|2006|3.9|4.6|4.3
0-19|0.7|1.0|0.8|108|Incidence|12889828|Hispanic|Male and Female|Soft Tissue|1999|0.7|1.0|0.8
0-19|0.8|1.1|0.9|125|Incidence|13456022|Hispanic|Male and Female|Soft Tissue|2000|0.8|1.1|0.9
0-19|0.8|1.1|0.9|128|Incidence|13854203|Hispanic|Male and Female|Soft Tissue|2001|0.8|1.1|0.9
0-19|0.8|1.1|1.0|140|Incidence|14207430|Hispanic|Male and Female|Soft Tissue|2002|0.8|1.2|1.0
0-19|0.9|1.1|1.0|713|Incidence|71937140|Hispanic|Male and Female|Soft Tissue|2002-2006|0.9|1.1|1.0
0-19|0.9|1.2|1.0|152|Incidence|14761053|Hispanic|Male and Female|Soft Tissue|2003|0.9|1.2|1.0
0-19|0.8|1.2|1.0|151|Incidence|15252705|Hispanic|Male and Female|Soft Tissue|2004|0.8|1.2|1.0
0-19|0.8|1.1|0.9|148|Incidence|15721211|Hispanic|Male and Female|Soft Tissue|2005|0.8|1.1|0.9
0-19|0.8|1.1|1.0|151|Incidence|15505638|Hispanic|Male and Female|Soft Tissue|2006|0.8|1.1|1.0
0-19|2.7|3.1|2.9|788|Incidence|27564764|White|Female|Acute Lymphocytic|1999|2.7|3.1|2.9
0-19|2.9|3.3|3.1|874|Incidence|28085099|White|Female|Acute Lymphocytic|2000|2.9|3.3|3.1
0-19|2.9|3.4|3.2|894|Incidence|28528301|White|Female|Acute Lymphocytic|2001|2.9|3.3|3.1
0-19|2.8|3.2|2.9|839|Incidence|28572305|White|Female|Acute Lymphocytic|2002|2.7|3.1|2.9
0-19|2.9|3.0|3.0|4138|Incidence|140081712|White|Female|Acute Lymphocytic|2002-2006|2.9|3.0|3.0
0-19|2.7|3.1|2.9|857|Incidence|29565517|White|Female|Acute Lymphocytic|2003|2.7|3.1|2.9
0-19|2.8|3.2|3.0|903|Incidence|30247470|White|Female|Acute Lymphocytic|2004|2.8|3.2|3.0
0-19|2.8|3.1|3.0|898|Incidence|30301817|White|Female|Acute Lymphocytic|2005|2.8|3.2|3.0
0-19|2.8|3.2|3.0|897|Incidence|29643609|White|Female|Acute Lymphocytic|2006|2.8|3.2|3.0
0-19|0.6|0.8|0.7|183|Incidence|27564764|White|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|187|Incidence|28085099|White|Female|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|195|Incidence|28528301|White|Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.6|0.8|0.7|193|Incidence|28572305|White|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.6|0.7|0.6|889|Incidence|140081712|White|Female|Acute Myeloid|2002-2006|0.6|0.7|0.6
0-19|0.5|0.7|0.6|180|Incidence|29565517|White|Female|Acute Myeloid|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|186|Incidence|30247470|White|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|197|Incidence|30301817|White|Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.6|191|Incidence|29643609|White|Female|Acute Myeloid|2006|0.6|0.7|0.6
0-19|14.9|15.9|15.4|4241|Incidence|27564764|White|Female|All Cancer Sites Combined|1999|14.9|15.9|15.4
0-19|15.7|16.6|16.2|4536|Incidence|28085099|White|Female|All Cancer Sites Combined|2000|15.7|16.6|16.2
0-19|16.4|17.4|16.9|4823|Incidence|28528301|White|Female|All Cancer Sites Combined|2001|16.4|17.4|16.9
0-19|15.9|16.8|16.4|4679|Incidence|28572305|White|Female|All Cancer Sites Combined|2002|15.9|16.9|16.4
0-19|16.4|16.8|16.6|23347|Incidence|140081712|White|Female|All Cancer Sites Combined|2002-2006|16.5|16.9|16.7
0-19|16.2|17.1|16.6|4931|Incidence|29565517|White|Female|All Cancer Sites Combined|2003|16.2|17.2|16.7
0-19|16.5|17.4|16.9|5150|Incidence|30247470|White|Female|All Cancer Sites Combined|2004|16.6|17.5|17.0
0-19|16.1|17.1|16.6|5071|Incidence|30301817|White|Female|All Cancer Sites Combined|2005|16.3|17.2|16.7
0-19|15.6|16.5|16.1|4812|Incidence|29643609|White|Female|All Cancer Sites Combined|2006|15.8|16.7|16.2
0-19|0.7|0.9|0.8|218|Incidence|27564764|White|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|231|Incidence|28085099|White|Female|Bones and Joints|2000|0.7|0.9|0.8
0-19|0.8|1.0|0.9|247|Incidence|28528301|White|Female|Bones and Joints|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|238|Incidence|28572305|White|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|0.9|0.9|1199|Incidence|140081712|White|Female|Bones and Joints|2002-2006|0.8|0.9|0.9
0-19|0.8|1.0|0.9|271|Incidence|29565517|White|Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.8|1.0|0.9|266|Incidence|30247470|White|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.7|1.0|0.8|255|Incidence|30301817|White|Female|Bones and Joints|2005|0.7|1.0|0.8
0-19|0.7|0.9|0.8|238|Incidence|29643609|White|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|2.8|3.2|3.0|814|Incidence|27564764|White|Female|Brain and Other Nervous System|1999|2.8|3.2|3.0
0-19|2.8|3.2|3.0|838|Incidence|28085099|White|Female|Brain and Other Nervous System|2000|2.8|3.2|3.0
0-19|2.8|3.2|3.0|843|Incidence|28528301|White|Female|Brain and Other Nervous System|2001|2.8|3.2|3.0
0-19|2.7|3.1|2.9|835|Incidence|28572305|White|Female|Brain and Other Nervous System|2002|2.7|3.1|2.9
0-19|2.9|3.1|3.0|4203|Incidence|140081712|White|Female|Brain and Other Nervous System|2002-2006|2.9|3.1|3.0
0-19|2.9|3.3|3.0|901|Incidence|29565517|White|Female|Brain and Other Nervous System|2003|2.9|3.3|3.0
0-19|3.0|3.4|3.2|968|Incidence|30247470|White|Female|Brain and Other Nervous System|2004|3.0|3.4|3.2
0-19|2.7|3.1|2.9|882|Incidence|30301817|White|Female|Brain and Other Nervous System|2005|2.7|3.1|2.9
0-19|2.7|3.0|2.8|844|Incidence|29643609|White|Female|Brain and Other Nervous System|2006|2.7|3.0|2.8
0-19|1.1|1.3|1.2|330|Incidence|27564764|White|Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.2|1.4|1.3|368|Incidence|28085099|White|Female|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.2|1.4|1.3|373|Incidence|28528301|White|Female|Hodgkin Lymphoma|2001|1.2|1.4|1.3
0-19|1.2|1.4|1.3|370|Incidence|28572305|White|Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.2|1.3|1.3|1785|Incidence|140081712|White|Female|Hodgkin Lymphoma|2002-2006|1.2|1.3|1.3
0-19|1.1|1.3|1.2|362|Incidence|29565517|White|Female|Hodgkin Lymphoma|2003|1.1|1.4|1.2
0-19|1.1|1.4|1.3|384|Incidence|30247470|White|Female|Hodgkin Lymphoma|2004|1.1|1.4|1.3
0-19|1.1|1.4|1.2|381|Incidence|30301817|White|Female|Hodgkin Lymphoma|2005|1.1|1.4|1.3
0-19|1.1|1.4|1.2|370|Incidence|29643609|White|Female|Hodgkin Lymphoma|2006|1.1|1.4|1.2
0-19|0.6|0.8|0.7|190|Incidence|27564764|White|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|186|Incidence|28085099|White|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|219|Incidence|28528301|White|Female|Kidney and Renal Pelvis|2001|0.7|0.9|0.8
0-19|0.5|0.7|0.6|176|Incidence|28572305|White|Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.7|0.7|0.7|977|Incidence|140081712|White|Female|Kidney and Renal Pelvis|2002-2006|0.7|0.7|0.7
0-19|0.7|0.9|0.8|227|Incidence|29565517|White|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.6|0.8|0.7|203|Incidence|30247470|White|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|213|Incidence|30301817|White|Female|Kidney and Renal Pelvis|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|209|Incidence|29643609|White|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|3.6|4.0|3.8|1050|Incidence|27564764|White|Female|Leukemia|1999|3.6|4.0|3.8
0-19|3.9|4.4|4.1|1161|Incidence|28085099|White|Female|Leukemia|2000|3.9|4.4|4.1
0-19|4.0|4.5|4.2|1196|Incidence|28528301|White|Female|Leukemia|2001|4.0|4.4|4.2
0-19|3.8|4.3|4.0|1146|Incidence|28572305|White|Female|Leukemia|2002|3.8|4.2|4.0
0-19|3.8|4.1|3.9|5535|Incidence|140081712|White|Female|Leukemia|2002-2006|3.8|4.1|4.0
0-19|3.6|4.1|3.8|1137|Incidence|29565517|White|Female|Leukemia|2003|3.6|4.1|3.8
0-19|3.7|4.2|3.9|1191|Incidence|30247470|White|Female|Leukemia|2004|3.7|4.2|3.9
0-19|3.7|4.2|4.0|1207|Incidence|30301817|White|Female|Leukemia|2005|3.8|4.2|4.0
0-19|3.8|4.2|4.0|1197|Incidence|29643609|White|Female|Leukemia|2006|3.8|4.3|4.0
0-19|0.6|0.8|0.7|196|Incidence|27564764|White|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.6|0.9|0.7|210|Incidence|28085099|White|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.7
0-19|0.7|0.9|0.8|225|Incidence|28528301|White|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|219|Incidence|28572305|White|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.8|1059|Incidence|140081712|White|Female|Non-Hodgkin Lymphoma|2002-2006|0.7|0.8|0.8
0-19|0.6|0.8|0.7|217|Incidence|29565517|White|Female|Non-Hodgkin Lymphoma|2003|0.6|0.8|0.7
0-19|0.7|0.9|0.8|232|Incidence|30247470|White|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.9|0.8|231|Incidence|30301817|White|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.6|0.8|0.7|210|Incidence|29643609|White|Female|Non-Hodgkin Lymphoma|2006|0.6|0.8|0.7
0-19|4.1|4.6|4.3|1191|Incidence|27564764|White|Female|Other|1999|4.1|4.6|4.3
0-19|4.3|4.8|4.5|1265|Incidence|28085099|White|Female|Other|2000|4.3|4.8|4.5
0-19|4.7|5.2|4.9|1414|Incidence|28528301|White|Female|Other|2001|4.7|5.2|5.0
0-19|4.7|5.2|4.9|1413|Incidence|28572305|White|Female|Other|2002|4.7|5.2|4.9
0-19|4.9|5.2|5.0|7156|Incidence|140081712|White|Female|Other|2002-2006|5.0|5.2|5.1
0-19|4.8|5.3|5.0|1498|Incidence|29565517|White|Female|Other|2003|4.8|5.3|5.1
0-19|4.9|5.4|5.2|1588|Incidence|30247470|White|Female|Other|2004|5.0|5.5|5.3
0-19|4.9|5.4|5.2|1597|Incidence|30301817|White|Female|Other|2005|5.0|5.5|5.3
0-19|4.5|5.0|4.8|1448|Incidence|29643609|White|Female|Other|2006|4.6|5.1|4.9
0-19|0.8|1.0|0.9|252|Incidence|27564764|White|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|277|Incidence|28085099|White|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|1.0|1.2|1.1|306|Incidence|28528301|White|Female|Soft Tissue|2001|1.0|1.2|1.1
0-19|0.9|1.1|1.0|282|Incidence|28572305|White|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|1.0|1.1|1.0|1433|Incidence|140081712|White|Female|Soft Tissue|2002-2006|1.0|1.1|1.0
0-19|1.0|1.2|1.1|318|Incidence|29565517|White|Female|Soft Tissue|2003|1.0|1.2|1.1
0-19|0.9|1.2|1.0|318|Incidence|30247470|White|Female|Soft Tissue|2004|0.9|1.2|1.1
0-19|0.9|1.1|1.0|305|Incidence|30301817|White|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|0.9|1.1|1.0|296|Incidence|29643609|White|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|3.5|4.0|3.7|1087|Incidence|29126353|White|Male|Acute Lymphocytic|1999|3.5|4.0|3.7
0-19|3.6|4.1|3.9|1140|Incidence|29678676|White|Male|Acute Lymphocytic|2000|3.6|4.1|3.8
0-19|3.7|4.2|3.9|1174|Incidence|30144356|White|Male|Acute Lymphocytic|2001|3.7|4.1|3.9
0-19|3.6|4.0|3.8|1134|Incidence|30169084|White|Male|Acute Lymphocytic|2002|3.5|4.0|3.8
0-19|3.7|3.9|3.8|5630|Incidence|147651244|White|Male|Acute Lymphocytic|2002-2006|3.7|3.9|3.8
0-19|3.4|3.8|3.6|1123|Incidence|31178624|White|Male|Acute Lymphocytic|2003|3.4|3.8|3.6
0-19|3.8|4.3|4.0|1286|Incidence|31874309|White|Male|Acute Lymphocytic|2004|3.8|4.3|4.0
0-19|3.5|3.9|3.7|1188|Incidence|31916662|White|Male|Acute Lymphocytic|2005|3.5|3.9|3.7
0-19|3.7|4.1|3.9|1215|Incidence|31213246|White|Male|Acute Lymphocytic|2006|3.7|4.1|3.9
0-19|0.7|0.9|0.8|228|Incidence|29126353|White|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|195|Incidence|29678676|White|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|236|Incidence|30144356|White|Male|Acute Myeloid|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|230|Incidence|30169084|White|Male|Acute Myeloid|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1095|Incidence|147651244|White|Male|Acute Myeloid|2002-2006|0.7|0.8|0.7
0-19|0.6|0.8|0.7|220|Incidence|31178624|White|Male|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.8|1.0|0.9|274|Incidence|31874309|White|Male|Acute Myeloid|2004|0.8|1.0|0.9
0-19|0.6|0.7|0.6|207|Incidence|31916662|White|Male|Acute Myeloid|2005|0.6|0.7|0.6
0-19|0.6|0.8|0.7|214|Incidence|31213246|White|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|17.3|18.3|17.8|5188|Incidence|29126353|White|Male|All Cancer Sites Combined|1999|17.3|18.3|17.8
0-19|17.6|18.6|18.1|5370|Incidence|29678676|White|Male|All Cancer Sites Combined|2000|17.6|18.6|18.1
0-19|18.3|19.3|18.8|5668|Incidence|30144356|White|Male|All Cancer Sites Combined|2001|18.3|19.3|18.8
0-19|18.6|19.6|19.1|5780|Incidence|30169084|White|Male|All Cancer Sites Combined|2002|18.7|19.7|19.2
0-19|18.4|18.9|18.7|27705|Incidence|147651244|White|Male|All Cancer Sites Combined|2002-2006|18.5|19.0|18.8
0-19|17.5|18.4|17.9|5606|Incidence|31178624|White|Male|All Cancer Sites Combined|2003|17.5|18.5|18.0
0-19|18.5|19.4|19.0|6075|Incidence|31874309|White|Male|All Cancer Sites Combined|2004|18.6|19.5|19.1
0-19|17.7|18.6|18.2|5846|Incidence|31916662|White|Male|All Cancer Sites Combined|2005|17.8|18.8|18.3
0-19|18.1|19.0|18.5|5839|Incidence|31213246|White|Male|All Cancer Sites Combined|2006|18.2|19.2|18.7
0-19|1.0|1.2|1.1|313|Incidence|29126353|White|Male|Bones and Joints|1999|1.0|1.2|1.1
0-19|0.9|1.1|1.0|290|Incidence|29678676|White|Male|Bones and Joints|2000|0.9|1.1|1.0
0-19|1.0|1.3|1.2|354|Incidence|30144356|White|Male|Bones and Joints|2001|1.1|1.3|1.2
0-19|1.0|1.2|1.1|336|Incidence|30169084|White|Male|Bones and Joints|2002|1.0|1.2|1.1
0-19|1.0|1.1|1.0|1518|Incidence|147651244|White|Male|Bones and Joints|2002-2006|1.0|1.1|1.0
0-19|0.8|1.1|1.0|300|Incidence|31178624|White|Male|Bones and Joints|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|308|Incidence|31874309|White|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|0.9|1.1|1.0|316|Incidence|31916662|White|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.2|1.1|347|Incidence|31213246|White|Male|Bones and Joints|2006|1.0|1.2|1.1
0-19|3.1|3.5|3.3|954|Incidence|29126353|White|Male|Brain and Other Nervous System|1999|3.1|3.5|3.3
0-19|3.3|3.8|3.5|1046|Incidence|29678676|White|Male|Brain and Other Nervous System|2000|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1016|Incidence|30144356|White|Male|Brain and Other Nervous System|2001|3.2|3.6|3.4
0-19|3.5|3.9|3.7|1116|Incidence|30169084|White|Male|Brain and Other Nervous System|2002|3.5|3.9|3.7
0-19|3.3|3.5|3.4|5058|Incidence|147651244|White|Male|Brain and Other Nervous System|2002-2006|3.3|3.5|3.4
0-19|3.1|3.5|3.3|1026|Incidence|31178624|White|Male|Brain and Other Nervous System|2003|3.1|3.5|3.3
0-19|3.2|3.6|3.4|1087|Incidence|31874309|White|Male|Brain and Other Nervous System|2004|3.2|3.6|3.4
0-19|3.0|3.4|3.2|1029|Incidence|31916662|White|Male|Brain and Other Nervous System|2005|3.0|3.4|3.2
0-19|3.2|3.6|3.4|1072|Incidence|31213246|White|Male|Brain and Other Nervous System|2006|3.2|3.6|3.4
0-19|1.2|1.5|1.3|392|Incidence|29126353|White|Male|Hodgkin Lymphoma|1999|1.2|1.5|1.3
0-19|1.2|1.4|1.3|388|Incidence|29678676|White|Male|Hodgkin Lymphoma|2000|1.2|1.4|1.3
0-19|1.3|1.5|1.4|420|Incidence|30144356|White|Male|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.1|1.4|1.3|386|Incidence|30169084|White|Male|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.3|1.4|1.3|2006|Incidence|147651244|White|Male|Hodgkin Lymphoma|2002-2006|1.3|1.4|1.4
0-19|1.3|1.6|1.4|445|Incidence|31178624|White|Male|Hodgkin Lymphoma|2003|1.3|1.6|1.4
0-19|1.1|1.4|1.2|396|Incidence|31874309|White|Male|Hodgkin Lymphoma|2004|1.1|1.4|1.2
0-19|1.2|1.5|1.3|435|Incidence|31916662|White|Male|Hodgkin Lymphoma|2005|1.2|1.5|1.4
0-19|1.3|1.6|1.4|449|Incidence|31213246|White|Male|Hodgkin Lymphoma|2006|1.3|1.6|1.4
0-19|0.5|0.7|0.6|182|Incidence|29126353|White|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.5|0.7|0.6|177|Incidence|29678676|White|Male|Kidney and Renal Pelvis|2000|0.5|0.7|0.6
0-19|0.5|0.7|0.6|188|Incidence|30144356|White|Male|Kidney and Renal Pelvis|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|203|Incidence|30169084|White|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.6|0.7|0.6|935|Incidence|147651244|White|Male|Kidney and Renal Pelvis|2002-2006|0.6|0.7|0.6
0-19|0.5|0.7|0.6|177|Incidence|31178624|White|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.6|0.7|0.6|205|Incidence|31874309|White|Male|Kidney and Renal Pelvis|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|198|Incidence|31916662|White|Male|Kidney and Renal Pelvis|2005|0.5|0.7|0.6
0-19|0.5|0.7|0.6|196|Incidence|31213246|White|Male|Kidney and Renal Pelvis|2006|0.5|0.7|0.6
0-19|4.7|5.2|4.9|1433|Incidence|29126353|White|Male|Leukemia|1999|4.7|5.2|4.9
0-19|4.6|5.1|4.9|1435|Incidence|29678676|White|Male|Leukemia|2000|4.6|5.1|4.8
0-19|4.9|5.4|5.1|1541|Incidence|30144356|White|Male|Leukemia|2001|4.9|5.4|5.1
0-19|4.7|5.2|5.0|1492|Incidence|30169084|White|Male|Leukemia|2002|4.7|5.2|4.9
0-19|4.9|5.1|5.0|7362|Incidence|147651244|White|Male|Leukemia|2002-2006|4.9|5.1|5.0
0-19|4.4|4.9|4.7|1457|Incidence|31178624|White|Male|Leukemia|2003|4.4|4.9|4.7
0-19|5.0|5.6|5.3|1692|Incidence|31874309|White|Male|Leukemia|2004|5.1|5.6|5.3
0-19|4.6|5.1|4.8|1542|Incidence|31916662|White|Male|Leukemia|2005|4.6|5.1|4.8
0-19|4.8|5.3|5.0|1574|Incidence|31213246|White|Male|Leukemia|2006|4.8|5.3|5.0
0-19|1.3|1.6|1.4|419|Incidence|29126353|White|Male|Non-Hodgkin Lymphoma|1999|1.3|1.6|1.4
0-19|1.4|1.7|1.6|463|Incidence|29678676|White|Male|Non-Hodgkin Lymphoma|2000|1.4|1.7|1.6
0-19|1.4|1.6|1.5|449|Incidence|30144356|White|Male|Non-Hodgkin Lymphoma|2001|1.4|1.6|1.5
0-19|1.4|1.7|1.5|464|Incidence|30169084|White|Male|Non-Hodgkin Lymphoma|2002|1.4|1.7|1.5
0-19|1.4|1.5|1.5|2195|Incidence|147651244|White|Male|Non-Hodgkin Lymphoma|2002-2006|1.4|1.6|1.5
0-19|1.3|1.6|1.4|451|Incidence|31178624|White|Male|Non-Hodgkin Lymphoma|2003|1.3|1.6|1.4
0-19|1.3|1.6|1.4|453|Incidence|31874309|White|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.3|1.6|1.5|469|Incidence|31916662|White|Male|Non-Hodgkin Lymphoma|2005|1.3|1.6|1.5
0-19|1.3|1.6|1.5|461|Incidence|31213246|White|Male|Non-Hodgkin Lymphoma|2006|1.3|1.6|1.5
0-19|4.0|4.5|4.3|1240|Incidence|29126353|White|Male|Other|1999|4.0|4.5|4.3
0-19|4.0|4.5|4.2|1252|Incidence|29678676|White|Male|Other|2000|4.0|4.5|4.2
0-19|4.4|4.9|4.6|1396|Incidence|30144356|White|Male|Other|2001|4.4|4.9|4.6
0-19|4.5|5.0|4.8|1448|Incidence|30169084|White|Male|Other|2002|4.6|5.1|4.8
0-19|4.6|4.8|4.7|7049|Incidence|147651244|White|Male|Other|2002-2006|4.7|4.9|4.8
0-19|4.3|4.7|4.5|1418|Incidence|31178624|White|Male|Other|2003|4.3|4.8|4.5
0-19|4.7|5.2|5.0|1601|Incidence|31874309|White|Male|Other|2004|4.8|5.3|5.0
0-19|4.4|4.9|4.6|1508|Incidence|31916662|White|Male|Other|2005|4.5|5.0|4.7
0-19|4.2|4.7|4.5|1422|Incidence|31213246|White|Male|Other|2006|4.3|4.8|4.6
0-19|0.8|1.0|0.9|255|Incidence|29126353|White|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|319|Incidence|29678676|White|Male|Soft Tissue|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|304|Incidence|30144356|White|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|335|Incidence|30169084|White|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|1.0|1.1|1.1|1582|Incidence|147651244|White|Male|Soft Tissue|2002-2006|1.0|1.1|1.1
0-19|0.9|1.2|1.1|332|Incidence|31178624|White|Male|Soft Tissue|2003|1.0|1.2|1.1
0-19|0.9|1.2|1.0|333|Incidence|31874309|White|Male|Soft Tissue|2004|0.9|1.2|1.0
0-19|1.0|1.2|1.1|349|Incidence|31916662|White|Male|Soft Tissue|2005|1.0|1.2|1.1
0-19|0.9|1.1|1.0|318|Incidence|31213246|White|Male|Soft Tissue|2006|0.9|1.1|1.0
0-19|3.2|3.5|3.3|1875|Incidence|56691117|White|Male and Female|Acute Lymphocytic|1999|3.2|3.5|3.3
0-19|3.4|3.7|3.5|2014|Incidence|57763775|White|Male and Female|Acute Lymphocytic|2000|3.3|3.6|3.5
0-19|3.4|3.7|3.6|2068|Incidence|58672657|White|Male and Female|Acute Lymphocytic|2001|3.4|3.7|3.5
0-19|3.2|3.5|3.4|1973|Incidence|58741389|White|Male and Female|Acute Lymphocytic|2002|3.2|3.5|3.4
0-19|3.3|3.5|3.4|9768|Incidence|287732956|White|Male and Female|Acute Lymphocytic|2002-2006|3.3|3.5|3.4
0-19|3.1|3.4|3.3|1980|Incidence|60744141|White|Male and Female|Acute Lymphocytic|2003|3.1|3.4|3.3
0-19|3.4|3.7|3.5|2189|Incidence|62121779|White|Male and Female|Acute Lymphocytic|2004|3.4|3.7|3.5
0-19|3.2|3.5|3.3|2086|Incidence|62218479|White|Male and Female|Acute Lymphocytic|2005|3.2|3.5|3.4
0-19|3.3|3.6|3.5|2112|Incidence|60856855|White|Male and Female|Acute Lymphocytic|2006|3.3|3.6|3.5
0-19|0.7|0.8|0.7|411|Incidence|56691117|White|Male and Female|Acute Myeloid|1999|0.7|0.8|0.7
0-19|0.6|0.7|0.7|382|Incidence|57763775|White|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.7|0.8|0.7|431|Incidence|58672657|White|Male and Female|Acute Myeloid|2001|0.7|0.8|0.7
0-19|0.7|0.8|0.7|423|Incidence|58741389|White|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.7|0.7|0.7|1984|Incidence|287732956|White|Male and Female|Acute Myeloid|2002-2006|0.7|0.7|0.7
0-19|0.6|0.7|0.7|400|Incidence|60744141|White|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.8|0.7|460|Incidence|62121779|White|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.6|0.7|0.6|404|Incidence|62218479|White|Male and Female|Acute Myeloid|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.7|405|Incidence|60856855|White|Male and Female|Acute Myeloid|2006|0.6|0.7|0.7
0-19|16.3|17.0|16.6|9429|Incidence|56691117|White|Male and Female|All Cancer Sites Combined|1999|16.3|17.0|16.6
0-19|16.8|17.5|17.2|9906|Incidence|57763775|White|Male and Female|All Cancer Sites Combined|2000|16.8|17.5|17.1
0-19|17.5|18.2|17.9|10491|Incidence|58672657|White|Male and Female|All Cancer Sites Combined|2001|17.5|18.2|17.9
0-19|17.4|18.1|17.8|10459|Incidence|58741389|White|Male and Female|All Cancer Sites Combined|2002|17.5|18.1|17.8
0-19|17.5|17.8|17.6|51052|Incidence|287732956|White|Male and Female|All Cancer Sites Combined|2002-2006|17.6|17.9|17.7
0-19|17.0|17.6|17.3|10537|Incidence|60744141|White|Male and Female|All Cancer Sites Combined|2003|17.0|17.7|17.3
0-19|17.6|18.3|18.0|11225|Incidence|62121779|White|Male and Female|All Cancer Sites Combined|2004|17.7|18.4|18.1
0-19|17.1|17.7|17.4|10917|Incidence|62218479|White|Male and Female|All Cancer Sites Combined|2005|17.2|17.9|17.5
0-19|17.0|17.7|17.3|10651|Incidence|60856855|White|Male and Female|All Cancer Sites Combined|2006|17.2|17.8|17.5
0-19|0.9|1.0|0.9|531|Incidence|56691117|White|Male and Female|Bones and Joints|1999|0.9|1.0|0.9
0-19|0.8|1.0|0.9|521|Incidence|57763775|White|Male and Female|Bones and Joints|2000|0.8|1.0|0.9
0-19|0.9|1.1|1.0|601|Incidence|58672657|White|Male and Female|Bones and Joints|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|574|Incidence|58741389|White|Male and Female|Bones and Joints|2002|0.9|1.1|1.0
0-19|0.9|1.0|0.9|2717|Incidence|287732956|White|Male and Female|Bones and Joints|2002-2006|0.9|1.0|0.9
0-19|0.9|1.0|0.9|571|Incidence|60744141|White|Male and Female|Bones and Joints|2003|0.9|1.0|0.9
0-19|0.8|1.0|0.9|574|Incidence|62121779|White|Male and Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.8|1.0|0.9|571|Incidence|62218479|White|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.0|1.0|585|Incidence|60856855|White|Male and Female|Bones and Joints|2006|0.9|1.0|1.0
0-19|3.0|3.3|3.1|1768|Incidence|56691117|White|Male and Female|Brain and Other Nervous System|1999|3.0|3.3|3.1
0-19|3.1|3.4|3.3|1884|Incidence|57763775|White|Male and Female|Brain and Other Nervous System|2000|3.1|3.4|3.3
0-19|3.0|3.3|3.2|1859|Incidence|58672657|White|Male and Female|Brain and Other Nervous System|2001|3.0|3.3|3.2
0-19|3.2|3.5|3.3|1951|Incidence|58741389|White|Male and Female|Brain and Other Nervous System|2002|3.2|3.5|3.3
0-19|3.2|3.3|3.2|9261|Incidence|287732956|White|Male and Female|Brain and Other Nervous System|2002-2006|3.2|3.3|3.2
0-19|3.0|3.3|3.2|1927|Incidence|60744141|White|Male and Female|Brain and Other Nervous System|2003|3.0|3.3|3.2
0-19|3.2|3.5|3.3|2055|Incidence|62121779|White|Male and Female|Brain and Other Nervous System|2004|3.2|3.5|3.3
0-19|2.9|3.2|3.1|1911|Incidence|62218479|White|Male and Female|Brain and Other Nervous System|2005|2.9|3.2|3.1
0-19|3.0|3.3|3.1|1916|Incidence|60856855|White|Male and Female|Brain and Other Nervous System|2006|3.0|3.3|3.1
0-19|1.2|1.4|1.3|722|Incidence|56691117|White|Male and Female|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.2|1.4|1.3|756|Incidence|57763775|White|Male and Female|Hodgkin Lymphoma|2000|1.2|1.4|1.3
0-19|1.3|1.4|1.3|793|Incidence|58672657|White|Male and Female|Hodgkin Lymphoma|2001|1.3|1.4|1.4
0-19|1.2|1.4|1.3|756|Incidence|58741389|White|Male and Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.3|1.3|1.3|3791|Incidence|287732956|White|Male and Female|Hodgkin Lymphoma|2002-2006|1.3|1.4|1.3
0-19|1.2|1.4|1.3|807|Incidence|60744141|White|Male and Female|Hodgkin Lymphoma|2003|1.2|1.4|1.3
0-19|1.2|1.3|1.2|780|Incidence|62121779|White|Male and Female|Hodgkin Lymphoma|2004|1.2|1.3|1.3
0-19|1.2|1.4|1.3|816|Incidence|62218479|White|Male and Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.2|1.4|1.3|819|Incidence|60856855|White|Male and Female|Hodgkin Lymphoma|2006|1.3|1.4|1.3
0-19|0.6|0.7|0.7|372|Incidence|56691117|White|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.7
0-19|0.6|0.7|0.6|363|Incidence|57763775|White|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.7|0.6
0-19|0.6|0.8|0.7|407|Incidence|58672657|White|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.6|379|Incidence|58741389|White|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.6
0-19|0.6|0.7|0.7|1912|Incidence|287732956|White|Male and Female|Kidney and Renal Pelvis|2002-2006|0.6|0.7|0.7
0-19|0.6|0.7|0.7|404|Incidence|60744141|White|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.7|408|Incidence|62121779|White|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|411|Incidence|62218479|White|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|405|Incidence|60856855|White|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.7|0.7
0-19|4.2|4.6|4.4|2483|Incidence|56691117|White|Male and Female|Leukemia|1999|4.2|4.6|4.4
0-19|4.3|4.7|4.5|2596|Incidence|57763775|White|Male and Female|Leukemia|2000|4.3|4.7|4.5
0-19|4.5|4.9|4.7|2737|Incidence|58672657|White|Male and Female|Leukemia|2001|4.5|4.8|4.7
0-19|4.3|4.7|4.5|2638|Incidence|58741389|White|Male and Female|Leukemia|2002|4.3|4.7|4.5
0-19|4.4|4.6|4.5|12897|Incidence|287732956|White|Male and Female|Leukemia|2002-2006|4.4|4.6|4.5
0-19|4.1|4.4|4.3|2594|Incidence|60744141|White|Male and Female|Leukemia|2003|4.1|4.4|4.3
0-19|4.5|4.8|4.6|2883|Incidence|62121779|White|Male and Female|Leukemia|2004|4.5|4.8|4.6
0-19|4.2|4.6|4.4|2749|Incidence|62218479|White|Male and Female|Leukemia|2005|4.3|4.6|4.4
0-19|4.4|4.7|4.5|2771|Incidence|60856855|White|Male and Female|Leukemia|2006|4.4|4.7|4.6
0-19|1.0|1.2|1.1|615|Incidence|56691117|White|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.3|1.2|673|Incidence|57763775|White|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.2|1.1|674|Incidence|58672657|White|Male and Female|Non-Hodgkin Lymphoma|2001|1.1|1.2|1.1
0-19|1.1|1.3|1.2|683|Incidence|58741389|White|Male and Female|Non-Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.1|1.2|1.1|3254|Incidence|287732956|White|Male and Female|Non-Hodgkin Lymphoma|2002-2006|1.1|1.2|1.1
0-19|1.0|1.2|1.1|668|Incidence|60744141|White|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.0|1.2|1.1|685|Incidence|62121779|White|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.2|1.1
0-19|1.0|1.2|1.1|700|Incidence|62218479|White|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.2|1.1
0-19|1.0|1.2|1.1|671|Incidence|60856855|White|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.2|1.1
0-19|4.1|4.5|4.3|2431|Incidence|56691117|White|Male and Female|Other|1999|4.1|4.5|4.3
0-19|4.2|4.5|4.4|2517|Incidence|57763775|White|Male and Female|Other|2000|4.2|4.5|4.4
0-19|4.6|4.9|4.8|2810|Incidence|58672657|White|Male and Female|Other|2001|4.6|5.0|4.8
0-19|4.7|5.0|4.8|2861|Incidence|58741389|White|Male and Female|Other|2002|4.7|5.1|4.9
0-19|4.8|5.0|4.9|14205|Incidence|287732956|White|Male and Female|Other|2002-2006|4.9|5.0|4.9
0-19|4.6|4.9|4.8|2916|Incidence|60744141|White|Male and Female|Other|2003|4.6|5.0|4.8
0-19|4.9|5.2|5.1|3189|Incidence|62121779|White|Male and Female|Other|2004|5.0|5.3|5.1
0-19|4.7|5.1|4.9|3105|Incidence|62218479|White|Male and Female|Other|2005|4.8|5.2|5.0
0-19|4.5|4.8|4.6|2870|Incidence|60856855|White|Male and Female|Other|2006|4.5|4.9|4.7
0-19|0.8|1.0|0.9|507|Incidence|56691117|White|Male and Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.1|1.0|596|Incidence|57763775|White|Male and Female|Soft Tissue|2000|1.0|1.1|1.0
0-19|1.0|1.1|1.0|610|Incidence|58672657|White|Male and Female|Soft Tissue|2001|1.0|1.1|1.0
0-19|1.0|1.1|1.0|617|Incidence|58741389|White|Male and Female|Soft Tissue|2002|1.0|1.1|1.1
0-19|1.0|1.1|1.0|3015|Incidence|287732956|White|Male and Female|Soft Tissue|2002-2006|1.0|1.1|1.0
0-19|1.0|1.1|1.1|650|Incidence|60744141|White|Male and Female|Soft Tissue|2003|1.0|1.2|1.1
0-19|1.0|1.1|1.0|651|Incidence|62121779|White|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.1|1.0|654|Incidence|62218479|White|Male and Female|Soft Tissue|2005|1.0|1.1|1.1
0-19|0.9|1.1|1.0|614|Incidence|60856855|White|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|0.2|0.3|0.3|109|Mortality|39015588|All Races|Female|Acute Lymphocytic|1999|0.2|0.3|0.3
0-19|0.3|0.4|0.3|126|Mortality|39259697|All Races|Female|Acute Lymphocytic|2000|0.3|0.4|0.3
0-19|0.3|0.4|0.3|120|Mortality|39369757|All Races|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.4|0.3|135|Mortality|39480063|All Races|Female|Acute Lymphocytic|2002|0.3|0.4|0.3
0-19|0.3|0.3|0.3|574|Mortality|198725893|All Races|Female|Acute Lymphocytic|2002-2006|0.3|0.3|0.3
0-19|0.3|0.4|0.3|122|Mortality|39601898|All Races|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.2|0.4|0.3|118|Mortality|39757586|All Races|Female|Acute Lymphocytic|2004|0.2|0.4|0.3
0-19|0.2|0.3|0.2|91|Mortality|39868057|All Races|Female|Acute Lymphocytic|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|108|Mortality|40018289|All Races|Female|Acute Lymphocytic|2006|0.2|0.3|0.3
0-19|0.2|0.3|0.3|106|Mortality|39015588|All Races|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|95|Mortality|39259697|All Races|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.3|113|Mortality|39369757|All Races|Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|100|Mortality|39480063|All Races|Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|481|Mortality|198725893|All Races|Female|Acute Myeloid|2002-2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|94|Mortality|39601898|All Races|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|96|Mortality|39757586|All Races|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|101|Mortality|39868057|All Races|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|90|Mortality|40018289|All Races|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|2.4|2.7|2.5|977|Mortality|39015588|All Races|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.6|2.5|973|Mortality|39259697|All Races|Female|All Cancer Sites Combined|2000|2.3|2.6|2.5
0-19|2.4|2.7|2.5|986|Mortality|39369757|All Races|Female|All Cancer Sites Combined|2001|2.4|2.7|2.5
0-19|2.4|2.7|2.5|989|Mortality|39480063|All Races|Female|All Cancer Sites Combined|2002|2.4|2.7|2.5
0-19|2.3|2.4|2.4|4687|Mortality|198725893|All Races|Female|All Cancer Sites Combined|2002-2006|2.3|2.4|2.4
0-19|2.2|2.5|2.4|943|Mortality|39601898|All Races|Female|All Cancer Sites Combined|2003|2.2|2.5|2.4
0-19|2.3|2.6|2.4|967|Mortality|39757586|All Races|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.5|2.3|922|Mortality|39868057|All Races|Female|All Cancer Sites Combined|2005|2.2|2.5|2.3
0-19|2.0|2.3|2.2|866|Mortality|40018289|All Races|Female|All Cancer Sites Combined|2006|2.0|2.3|2.2
0-19|0.2|0.3|0.2|92|Mortality|39015588|All Races|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.2|0.2|76|Mortality|39259697|All Races|Female|Bones and Joints|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|75|Mortality|39369757|All Races|Female|Bones and Joints|2001|0.1|0.2|0.2
0-19|0.2|0.3|0.2|83|Mortality|39480063|All Races|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.2|0.2|384|Mortality|198725893|All Races|Female|Bones and Joints|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|64|Mortality|39601898|All Races|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39757586|All Races|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|91|Mortality|39868057|All Races|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|40018289|All Races|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.6|0.7|0.7|259|Mortality|39015588|All Races|Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.5|0.7|0.6|238|Mortality|39259697|All Races|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.7|0.6|252|Mortality|39369757|All Races|Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.5|0.7|0.6|244|Mortality|39480063|All Races|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.7|0.6|1250|Mortality|198725893|All Races|Female|Brain and Other Nervous System|2002-2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|269|Mortality|39601898|All Races|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|254|Mortality|39757586|All Races|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|246|Mortality|39868057|All Races|Female|Brain and Other Nervous System|2005|0.5|0.7|0.6
0-19|0.5|0.7|0.6|237|Mortality|40018289|All Races|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.0|0.1|0.0|17|Mortality|39015588|All Races|Female|Hodgkin Lymphoma|1999|0.0|0.1|0.0
0-19|0.0|0.1|0.0|19|Mortality|39259697|All Races|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|39369757|All Races|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|39480063|All Races|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|0.0|0.0|0.0|50|Mortality|198725893|All Races|Female|Hodgkin Lymphoma|2002-2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|39601898|All Races|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|39757586|All Races|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|39868057|All Races|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|40018289|All Races|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|0.1|0.1|0.1|30|Mortality|39015588|All Races|Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|39259697|All Races|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|39|Mortality|39369757|All Races|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39480063|All Races|Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|150|Mortality|198725893|All Races|Female|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|34|Mortality|39601898|All Races|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39757586|All Races|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|39868057|All Races|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|25|Mortality|40018289|All Races|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.7|0.8|0.8|293|Mortality|39015588|All Races|Female|Leukemia|1999|0.7|0.8|0.8
0-19|0.7|0.9|0.8|302|Mortality|39259697|All Races|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|318|Mortality|39369757|All Races|Female|Leukemia|2001|0.7|0.9|0.8
0-19|0.7|0.8|0.8|296|Mortality|39480063|All Races|Female|Leukemia|2002|0.7|0.8|0.7
0-19|0.7|0.7|0.7|1375|Mortality|198725893|All Races|Female|Leukemia|2002-2006|0.7|0.7|0.7
0-19|0.6|0.8|0.7|284|Mortality|39601898|All Races|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.8|0.7|278|Mortality|39757586|All Races|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.7|0.6|258|Mortality|39868057|All Races|Female|Leukemia|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.6|259|Mortality|40018289|All Races|Female|Leukemia|2006|0.6|0.7|0.6
0-19|0.1|0.1|0.1|37|Mortality|39015588|All Races|Female|Non-Hodgkin Lymphoma|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|36|Mortality|39259697|All Races|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39369757|All Races|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|40|Mortality|39480063|All Races|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|154|Mortality|198725893|All Races|Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|38|Mortality|39601898|All Races|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39757586|All Races|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|39868057|All Races|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|19|Mortality|40018289|All Races|Female|Non-Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|0.4|0.6|0.5|189|Mortality|39015588|All Races|Female|Other|1999|0.4|0.6|0.5
0-19|0.5|0.6|0.5|207|Mortality|39259697|All Races|Female|Other|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|202|Mortality|39369757|All Races|Female|Other|2001|0.4|0.6|0.5
0-19|0.5|0.6|0.5|215|Mortality|39480063|All Races|Female|Other|2002|0.5|0.6|0.5
0-19|0.5|0.5|0.5|967|Mortality|198725893|All Races|Female|Other|2002-2006|0.5|0.5|0.5
0-19|0.4|0.5|0.5|182|Mortality|39601898|All Races|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.6|0.5|205|Mortality|39757586|All Races|Female|Other|2004|0.4|0.6|0.5
0-19|0.4|0.5|0.4|177|Mortality|39868057|All Races|Female|Other|2005|0.4|0.5|0.4
0-19|0.4|0.5|0.5|188|Mortality|40018289|All Races|Female|Other|2006|0.4|0.5|0.5
0-19|0.1|0.2|0.2|60|Mortality|39015588|All Races|Female|Soft Tissue|1999|0.1|0.2|0.2
0-19|0.1|0.2|0.2|69|Mortality|39259697|All Races|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|60|Mortality|39369757|All Races|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39480063|All Races|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.2|0.2|0.2|357|Mortality|198725893|All Races|Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|62|Mortality|39601898|All Races|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.2|0.3|0.2|81|Mortality|39757586|All Races|Female|Soft Tissue|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|87|Mortality|39868057|All Races|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.1|56|Mortality|40018289|All Races|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.4|0.5|0.4|176|Mortality|41024382|All Races|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.4|0.6|0.5|206|Mortality|41285988|All Races|Male|Acute Lymphocytic|2000|0.4|0.6|0.5
0-19|0.4|0.5|0.5|193|Mortality|41412439|All Races|Male|Acute Lymphocytic|2001|0.4|0.5|0.5
0-19|0.4|0.5|0.5|188|Mortality|41502900|All Races|Male|Acute Lymphocytic|2002|0.4|0.5|0.5
0-19|0.4|0.5|0.4|905|Mortality|208601283|All Races|Male|Acute Lymphocytic|2002-2006|0.4|0.5|0.4
0-19|0.4|0.6|0.5|206|Mortality|41585788|All Races|Male|Acute Lymphocytic|2003|0.4|0.6|0.5
0-19|0.4|0.5|0.4|177|Mortality|41721550|All Races|Male|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.4|0.5|0.4|176|Mortality|41822200|All Races|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.3|0.4|0.4|158|Mortality|41968845|All Races|Male|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.2|0.3|0.2|101|Mortality|41024382|All Races|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.3|0.4|0.3|127|Mortality|41285988|All Races|Male|Acute Myeloid|2000|0.3|0.4|0.3
0-19|0.2|0.3|0.3|114|Mortality|41412439|All Races|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|109|Mortality|41502900|All Races|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|553|Mortality|208601283|All Races|Male|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|0.2|0.3|0.3|113|Mortality|41585788|All Races|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|115|Mortality|41721550|All Races|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|111|Mortality|41822200|All Races|Male|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|105|Mortality|41968845|All Races|Male|Acute Myeloid|2006|0.2|0.3|0.3
0-19|2.9|3.3|3.1|1266|Mortality|41024382|All Races|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.3|3.1|1298|Mortality|41285988|All Races|Male|All Cancer Sites Combined|2000|3.0|3.3|3.1
0-19|2.8|3.2|3.0|1240|Mortality|41412439|All Races|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1282|Mortality|41502900|All Races|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|2.9|3.1|3.0|6258|Mortality|208601283|All Races|Male|All Cancer Sites Combined|2002-2006|2.9|3.1|3.0
0-19|2.9|3.3|3.1|1290|Mortality|41585788|All Races|Male|All Cancer Sites Combined|2003|2.9|3.3|3.1
0-19|2.8|3.2|3.0|1256|Mortality|41721550|All Races|Male|All Cancer Sites Combined|2004|2.8|3.2|3.0
0-19|2.8|3.2|3.0|1261|Mortality|41822200|All Races|Male|All Cancer Sites Combined|2005|2.9|3.2|3.0
0-19|2.6|2.9|2.8|1169|Mortality|41968845|All Races|Male|All Cancer Sites Combined|2006|2.6|2.9|2.8
0-19|0.2|0.3|0.3|117|Mortality|41024382|All Races|Male|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|105|Mortality|41285988|All Races|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|114|Mortality|41412439|All Races|Male|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|96|Mortality|41502900|All Races|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.3|556|Mortality|208601283|All Races|Male|Bones and Joints|2002-2006|0.2|0.3|0.3
0-19|0.2|0.3|0.3|122|Mortality|41585788|All Races|Male|Bones and Joints|2003|0.2|0.4|0.3
0-19|0.2|0.3|0.3|118|Mortality|41721550|All Races|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|121|Mortality|41822200|All Races|Male|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|99|Mortality|41968845|All Races|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.6|0.8|0.7|287|Mortality|41024382|All Races|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.8|0.7|307|Mortality|41285988|All Races|Male|Brain and Other Nervous System|2000|0.7|0.8|0.7
0-19|0.6|0.7|0.6|268|Mortality|41412439|All Races|Male|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.7|0.9|0.8|327|Mortality|41502900|All Races|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1521|Mortality|208601283|All Races|Male|Brain and Other Nervous System|2002-2006|0.7|0.8|0.7
0-19|0.7|0.8|0.7|308|Mortality|41585788|All Races|Male|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.8|0.7|301|Mortality|41721550|All Races|Male|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|298|Mortality|41822200|All Races|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|287|Mortality|41968845|All Races|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.0|0.1|0.1|24|Mortality|41024382|All Races|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|41285988|All Races|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|18|Mortality|41412439|All Races|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|20|Mortality|41502900|All Races|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|72|Mortality|208601283|All Races|Male|Hodgkin Lymphoma|2002-2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|41585788|All Races|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|41721550|All Races|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|41822200|All Races|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|41968845|All Races|Male|Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|32|Mortality|41024382|All Races|Male|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|28|Mortality|41285988|All Races|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|41412439|All Races|Male|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|41502900|All Races|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|139|Mortality|208601283|All Races|Male|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|41585788|All Races|Male|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|41721550|All Races|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|41822200|All Races|Male|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|29|Mortality|41968845|All Races|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.8|1.0|0.9|379|Mortality|41024382|All Races|Male|Leukemia|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|430|Mortality|41285988|All Races|Male|Leukemia|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|410|Mortality|41412439|All Races|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.0|0.9|382|Mortality|41502900|All Races|Male|Leukemia|2002|0.8|1.0|0.9
0-19|0.9|1.0|0.9|1914|Mortality|208601283|All Races|Male|Leukemia|2002-2006|0.9|1.0|0.9
0-19|0.9|1.1|1.0|404|Mortality|41585788|All Races|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.8|1.0|0.9|387|Mortality|41721550|All Races|Male|Leukemia|2004|0.8|1.0|0.9
0-19|0.8|1.0|0.9|382|Mortality|41822200|All Races|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|0.9|0.8|359|Mortality|41968845|All Races|Male|Leukemia|2006|0.8|0.9|0.9
0-19|0.1|0.2|0.2|69|Mortality|41024382|All Races|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.2|0.2|79|Mortality|41285988|All Races|Male|Non-Hodgkin Lymphoma|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|74|Mortality|41412439|All Races|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|41502900|All Races|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.2|0.2|0.2|358|Mortality|208601283|All Races|Male|Non-Hodgkin Lymphoma|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|65|Mortality|41585788|All Races|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|67|Mortality|41721550|All Races|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|41822200|All Races|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|70|Mortality|41968845|All Races|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.6|0.7|0.6|266|Mortality|41024382|All Races|Male|Other|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.6|264|Mortality|41285988|All Races|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|242|Mortality|41412439|All Races|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.7|0.7|275|Mortality|41502900|All Races|Male|Other|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.6|1289|Mortality|208601283|All Races|Male|Other|2002-2006|0.6|0.7|0.6
0-19|0.6|0.7|0.6|265|Mortality|41585788|All Races|Male|Other|2003|0.6|0.7|0.6
0-19|0.6|0.7|0.6|263|Mortality|41721550|All Races|Male|Other|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|261|Mortality|41822200|All Races|Male|Other|2005|0.6|0.7|0.6
0-19|0.5|0.6|0.5|225|Mortality|41968845|All Races|Male|Other|2006|0.5|0.6|0.5
0-19|0.2|0.3|0.2|92|Mortality|41024382|All Races|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|41285988|All Races|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|41412439|All Races|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.2|0.2|0.2|82|Mortality|41502900|All Races|Male|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|409|Mortality|208601283|All Races|Male|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.2|0.3|0.2|84|Mortality|41585788|All Races|Male|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.2|0.2|0.2|83|Mortality|41721550|All Races|Male|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.1|0.2|0.2|76|Mortality|41822200|All Races|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.2|0.2|84|Mortality|41968845|All Races|Male|Soft Tissue|2006|0.2|0.2|0.2
0-19|0.3|0.4|0.4|285|Mortality|80039970|All Races|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.4|332|Mortality|80545685|All Races|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.4
0-19|0.3|0.4|0.4|313|Mortality|80782196|All Races|Male and Female|Acute Lymphocytic|2001|0.3|0.4|0.4
0-19|0.4|0.4|0.4|323|Mortality|80982963|All Races|Male and Female|Acute Lymphocytic|2002|0.4|0.4|0.4
0-19|0.3|0.4|0.4|1479|Mortality|407327176|All Races|Male and Female|Acute Lymphocytic|2002-2006|0.3|0.4|0.4
0-19|0.4|0.5|0.4|328|Mortality|81187686|All Races|Male and Female|Acute Lymphocytic|2003|0.4|0.5|0.4
0-19|0.3|0.4|0.4|295|Mortality|81479136|All Races|Male and Female|Acute Lymphocytic|2004|0.3|0.4|0.4
0-19|0.3|0.4|0.3|267|Mortality|81690257|All Races|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.3
0-19|0.3|0.4|0.3|266|Mortality|81987134|All Races|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.2|0.3|0.3|207|Mortality|80039970|All Races|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|222|Mortality|80545685|All Races|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|227|Mortality|80782196|All Races|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|209|Mortality|80982963|All Races|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|1034|Mortality|407327176|All Races|Male and Female|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|0.2|0.3|0.3|207|Mortality|81187686|All Races|Male and Female|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|211|Mortality|81479136|All Races|Male and Female|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|212|Mortality|81690257|All Races|Male and Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|195|Mortality|81987134|All Races|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Races|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|80545685|All Races|Male and Female|All Cancer Sites Combined|2000|2.7|2.9|2.8
0-19|2.6|2.9|2.8|2226|Mortality|80782196|All Races|Male and Female|All Cancer Sites Combined|2001|2.6|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|80982963|All Races|Male and Female|All Cancer Sites Combined|2002|2.7|2.9|2.8
0-19|2.6|2.7|2.7|10945|Mortality|407327176|All Races|Male and Female|All Cancer Sites Combined|2002-2006|2.6|2.7|2.7
0-19|2.6|2.9|2.8|2233|Mortality|81187686|All Races|Male and Female|All Cancer Sites Combined|2003|2.6|2.9|2.8
0-19|2.6|2.8|2.7|2223|Mortality|81479136|All Races|Male and Female|All Cancer Sites Combined|2004|2.6|2.8|2.7
0-19|2.6|2.8|2.7|2183|Mortality|81690257|All Races|Male and Female|All Cancer Sites Combined|2005|2.6|2.8|2.7
0-19|2.4|2.6|2.5|2035|Mortality|81987134|All Races|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|0.2|0.3|0.3|209|Mortality|80039970|All Races|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|181|Mortality|80545685|All Races|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|80782196|All Races|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|179|Mortality|80982963|All Races|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.2|0.2|940|Mortality|407327176|All Races|Male and Female|Bones and Joints|2002-2006|0.2|0.2|0.2
0-19|0.2|0.3|0.2|186|Mortality|81187686|All Races|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|81479136|All Races|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|212|Mortality|81690257|All Races|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|174|Mortality|81987134|All Races|Male and Female|Bones and Joints|2006|0.2|0.2|0.2
0-19|0.6|0.7|0.7|546|Mortality|80039970|All Races|Male and Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Mortality|80545685|All Races|Male and Female|Brain and Other Nervous System|2000|0.6|0.7|0.7
0-19|0.6|0.7|0.6|520|Mortality|80782196|All Races|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.7|0.8|0.7|571|Mortality|80982963|All Races|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.7|0.7|2771|Mortality|407327176|All Races|Male and Female|Brain and Other Nervous System|2002-2006|0.7|0.7|0.7
0-19|0.7|0.8|0.7|577|Mortality|81187686|All Races|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.7|0.7|555|Mortality|81479136|All Races|Male and Female|Brain and Other Nervous System|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|544|Mortality|81690257|All Races|Male and Female|Brain and Other Nervous System|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.6|524|Mortality|81987134|All Races|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.6
0-19|0.0|0.1|0.1|41|Mortality|80039970|All Races|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|29|Mortality|80545685|All Races|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|31|Mortality|80782196|All Races|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|33|Mortality|80982963|All Races|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|122|Mortality|407327176|All Races|Male and Female|Hodgkin Lymphoma|2002-2006|0.0|0.0|0.0
0-19|0.0|0.0|0.0|21|Mortality|81187686|All Races|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|81479136|All Races|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|22|Mortality|81690257|All Races|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|81987134|All Races|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|62|Mortality|80039970|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|54|Mortality|80545685|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.1|0.1
0-19|0.1|0.1|0.1|66|Mortality|80782196|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|49|Mortality|80982963|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|289|Mortality|407327176|All Races|Male and Female|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|65|Mortality|81187686|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|59|Mortality|81479136|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|62|Mortality|81690257|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|54|Mortality|81987134|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.8|0.9|0.8|672|Mortality|80039970|All Races|Male and Female|Leukemia|1999|0.8|0.9|0.8
0-19|0.8|1.0|0.9|732|Mortality|80545685|All Races|Male and Female|Leukemia|2000|0.8|1.0|0.9
0-19|0.8|1.0|0.9|728|Mortality|80782196|All Races|Male and Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.8|0.9|0.8|678|Mortality|80982963|All Races|Male and Female|Leukemia|2002|0.8|0.9|0.8
0-19|0.8|0.8|0.8|3289|Mortality|407327176|All Races|Male and Female|Leukemia|2002-2006|0.8|0.8|0.8
0-19|0.8|0.9|0.8|688|Mortality|81187686|All Races|Male and Female|Leukemia|2003|0.8|0.9|0.8
0-19|0.8|0.9|0.8|665|Mortality|81479136|All Races|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.8|0.8|640|Mortality|81690257|All Races|Male and Female|Leukemia|2005|0.7|0.8|0.8
0-19|0.7|0.8|0.7|618|Mortality|81987134|All Races|Male and Female|Leukemia|2006|0.7|0.8|0.8
0-19|0.1|0.2|0.1|106|Mortality|80039970|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|115|Mortality|80545685|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|101|Mortality|80782196|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|118|Mortality|80982963|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.1|0.1|512|Mortality|407327176|All Races|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|0.1|0.2|0.1|103|Mortality|81187686|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.1|0.1|100|Mortality|81479136|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.1|0.2|0.1|102|Mortality|81690257|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|89|Mortality|81987134|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.5|0.6|0.6|455|Mortality|80039970|All Races|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|471|Mortality|80545685|All Races|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.6|444|Mortality|80782196|All Races|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.6|0.7|0.6|490|Mortality|80982963|All Races|Male and Female|Other|2002|0.6|0.7|0.6
0-19|0.5|0.6|0.6|2256|Mortality|407327176|All Races|Male and Female|Other|2002-2006|0.5|0.6|0.6
0-19|0.5|0.6|0.6|447|Mortality|81187686|All Races|Male and Female|Other|2003|0.5|0.6|0.6
0-19|0.5|0.6|0.6|468|Mortality|81479136|All Races|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.6|0.5|438|Mortality|81690257|All Races|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.5|0.6|0.5|413|Mortality|81987134|All Races|Male and Female|Other|2006|0.5|0.6|0.5
0-19|0.2|0.2|0.2|152|Mortality|80039970|All Races|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|144|Mortality|80545685|All Races|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.2|0.2|0.2|147|Mortality|80782196|All Races|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|153|Mortality|80982963|All Races|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|766|Mortality|407327176|All Races|Male and Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.2|0.2|0.2|146|Mortality|81187686|All Races|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|164|Mortality|81479136|All Races|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|163|Mortality|81690257|All Races|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|81987134|All Races|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Acute Lymphocytic|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Acute Myeloid|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|~|~|~
0-19|1.0|2.0|1.5|39|Mortality|2664152|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002-2006|1.0|2.0|1.5
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Bones and Joints|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Leukemia|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Other|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|556158|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|550742|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|545224|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|2664152|American Indian/Alaska Native|Female|Soft Tissue|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|538729|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|532459|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|526591|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|521149|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Acute Lymphocytic|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Acute Myeloid|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|~|~|~
0-19|1.7|4.8|2.9|16|Mortality|569883|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|1.6|4.6|2.8
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|~|~|~
0-19|1.8|3.1|2.4|65|Mortality|2747163|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002-2006|1.8|3.0|2.4
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Bones and Joints|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|0.5|1.2|0.7|20|Mortality|2747163|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002-2006|0.4|1.1|0.7
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Leukemia|2002|~|~|~
0-19|0.5|1.2|0.8|22|Mortality|2747163|American Indian/Alaska Native|Male|Leukemia|2002-2006|0.5|1.2|0.8
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Other|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|576057|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|569883|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|563027|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|2747163|American Indian/Alaska Native|Male|Soft Tissue|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|555492|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|549149|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|542742|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|536753|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|0.2|0.6|0.4|20|Mortality|5411315|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002-2006|0.2|0.6|0.4
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|5411315|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|~|~|~
0-19|1.0|2.7|1.7|19|Mortality|1132215|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|1.0|2.6|1.7
0-19|1.3|3.1|2.0|22|Mortality|1120625|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|1.2|3.0|2.0
0-19|1.4|3.4|2.2|25|Mortality|1108251|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|1.5|3.3|2.3
0-19|1.6|2.3|1.9|104|Mortality|5411315|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002-2006|1.6|2.3|1.9
0-19|1.4|3.3|2.2|24|Mortality|1094221|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|1.4|3.3|2.2
0-19|1.0|2.7|1.7|18|Mortality|1081608|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|1.0|2.6|1.7
0-19|1.0|2.7|1.7|18|Mortality|1069333|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|1.0|2.7|1.7
0-19|1.1|2.9|1.9|19|Mortality|1057902|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|1.1|2.8|1.8
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|5411315|American Indian/Alaska Native|Male and Female|Bones and Joints|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|~|~|~
0-19|0.4|0.9|0.6|32|Mortality|5411315|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002-2006|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|5411315|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|5411315|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Leukemia|2002|~|~|~
0-19|0.4|0.9|0.6|34|Mortality|5411315|American Indian/Alaska Native|Male and Female|Leukemia|2002-2006|0.4|0.9|0.6
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|5411315|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Other|2002|~|~|~
0-19|0.2|0.5|0.3|17|Mortality|5411315|American Indian/Alaska Native|Male and Female|Other|2002-2006|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1132215|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1120625|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1108251|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|5411315|American Indian/Alaska Native|Male and Female|Soft Tissue|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1094221|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1081608|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1069333|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1057902|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|~|~|~
0-19|0.2|0.4|0.3|25|Mortality|9102202|Asian/Pacific Islander|Female|Acute Lymphocytic|2002-2006|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|0.2|0.4|0.3|25|Mortality|9102202|Asian/Pacific Islander|Female|Acute Myeloid|2002-2006|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Acute Myeloid|2006|~|~|~
0-19|1.7|3.3|2.4|39|Mortality|1642417|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|1.7|3.2|2.4
0-19|1.6|3.1|2.3|39|Mortality|1694517|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|1.6|3.1|2.3
0-19|1.5|3.0|2.1|37|Mortality|1720330|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|1.5|3.0|2.2
0-19|1.5|3.0|2.2|38|Mortality|1749723|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|1.5|3.0|2.2
0-19|1.7|2.3|2.0|180|Mortality|9102202|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002-2006|1.7|2.3|2.0
0-19|1.4|2.7|2.0|35|Mortality|1783240|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|1.4|2.7|2.0
0-19|1.3|2.6|1.9|34|Mortality|1818193|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|1.3|2.6|1.9
0-19|1.2|2.5|1.7|32|Mortality|1855645|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|1.2|2.4|1.7
0-19|1.6|2.9|2.2|41|Mortality|1895401|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|1.6|2.9|2.2
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|9102202|Asian/Pacific Islander|Female|Bones and Joints|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|~|~|~
0-19|0.3|0.6|0.5|41|Mortality|9102202|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002-2006|0.3|0.6|0.5
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|9102202|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|9102202|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Leukemia|2001|~|~|~
0-19|0.6|1.6|1.0|18|Mortality|1749723|Asian/Pacific Islander|Female|Leukemia|2002|0.6|1.6|1.0
0-19|0.5|0.9|0.7|61|Mortality|9102202|Asian/Pacific Islander|Female|Leukemia|2002-2006|0.5|0.9|0.7
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Leukemia|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|9102202|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Other|2002|~|~|~
0-19|0.4|0.7|0.5|45|Mortality|9102202|Asian/Pacific Islander|Female|Other|2002-2006|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1694517|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1720330|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1749723|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|9102202|Asian/Pacific Islander|Female|Soft Tissue|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1783240|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1818193|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1855645|Asian/Pacific Islander|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1895401|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|~|~|~
0-19|0.3|0.5|0.4|35|Mortality|9507293|Asian/Pacific Islander|Male|Acute Lymphocytic|2002-2006|0.3|0.5|0.4
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|0.2|0.4|0.2|23|Mortality|9507293|Asian/Pacific Islander|Male|Acute Myeloid|2002-2006|0.2|0.4|0.2
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|2.3|4.0|3.1|53|Mortality|1714818|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|2.3|4.0|3.1
0-19|2.0|3.5|2.7|47|Mortality|1765014|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|2.0|3.5|2.7
0-19|2.1|3.7|2.8|50|Mortality|1794679|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|2.1|3.7|2.8
0-19|2.2|3.8|2.9|53|Mortality|1826258|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|2.2|3.8|2.9
0-19|2.3|3.0|2.7|252|Mortality|9507293|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002-2006|2.3|3.0|2.7
0-19|1.8|3.3|2.5|46|Mortality|1862442|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|1.8|3.3|2.5
0-19|2.2|3.8|2.9|55|Mortality|1899033|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|2.2|3.8|2.9
0-19|1.9|3.4|2.6|50|Mortality|1938715|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|1.9|3.4|2.6
0-19|1.8|3.2|2.4|48|Mortality|1980845|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|1.8|3.2|2.4
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|9507293|Asian/Pacific Islander|Male|Bones and Joints|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|~|~|~
0-19|0.5|0.9|0.7|64|Mortality|9507293|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002-2006|0.5|0.9|0.7
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|9507293|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|9507293|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.5|1.5|0.9|16|Mortality|1714818|Asian/Pacific Islander|Male|Leukemia|1999|0.5|1.5|0.9
0-19|0.8|1.9|1.3|22|Mortality|1765014|Asian/Pacific Islander|Male|Leukemia|2000|0.8|1.9|1.2
0-19|0.6|1.7|1.1|19|Mortality|1794679|Asian/Pacific Islander|Male|Leukemia|2001|0.6|1.7|1.1
0-19|0.5|1.5|0.9|17|Mortality|1826258|Asian/Pacific Islander|Male|Leukemia|2002|0.5|1.5|0.9
0-19|0.7|1.1|0.9|83|Mortality|9507293|Asian/Pacific Islander|Male|Leukemia|2002-2006|0.7|1.1|0.9
0-19|0.5|1.4|0.9|16|Mortality|1862442|Asian/Pacific Islander|Male|Leukemia|2003|0.5|1.4|0.9
0-19|0.6|1.5|0.9|18|Mortality|1899033|Asian/Pacific Islander|Male|Leukemia|2004|0.6|1.5|0.9
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Leukemia|2005|~|~|~
0-19|0.5|1.4|0.9|17|Mortality|1980845|Asian/Pacific Islander|Male|Leukemia|2006|0.5|1.4|0.9
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|9507293|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Other|2002|~|~|~
0-19|0.5|0.8|0.6|58|Mortality|9507293|Asian/Pacific Islander|Male|Other|2002-2006|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1765014|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1794679|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1826258|Asian/Pacific Islander|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|9507293|Asian/Pacific Islander|Male|Soft Tissue|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|1862442|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1899033|Asian/Pacific Islander|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1938715|Asian/Pacific Islander|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|1980845|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|0.2|0.4|0.3|60|Mortality|18609495|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002-2006|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|0.2|0.7|0.4|16|Mortality|3717226|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|0.2|0.7|0.4
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|~|~|~
0-19|0.2|0.3|0.3|48|Mortality|18609495|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|3717226|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|~|~|~
0-19|2.2|3.4|2.7|92|Mortality|3357235|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|2.2|3.4|2.7
0-19|2.0|3.1|2.5|86|Mortality|3459531|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|2.0|3.1|2.5
0-19|2.0|3.1|2.5|87|Mortality|3515009|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|2.0|3.1|2.5
0-19|2.0|3.1|2.5|91|Mortality|3575981|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|2.0|3.1|2.5
0-19|2.1|2.6|2.3|432|Mortality|18609495|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002-2006|2.1|2.6|2.3
0-19|1.8|2.8|2.2|81|Mortality|3645682|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|1.8|2.8|2.2
0-19|1.9|3.0|2.4|89|Mortality|3717226|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|1.9|2.9|2.4
0-19|1.7|2.7|2.2|82|Mortality|3794360|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|1.7|2.7|2.2
0-19|1.8|2.8|2.3|89|Mortality|3876246|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|1.8|2.8|2.3
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|~|~|~
0-19|0.1|0.2|0.1|25|Mortality|18609495|Asian/Pacific Islander|Male and Female|Bones and Joints|2002-2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|3717226|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|~|~|~
0-19|0.3|0.9|0.6|19|Mortality|3357235|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|0.3|0.9|0.6
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|0.4|0.9|0.6|21|Mortality|3515009|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|0.4|0.9|0.6
0-19|0.3|0.9|0.6|20|Mortality|3575981|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|0.3|0.9|0.6
0-19|0.5|0.7|0.6|105|Mortality|18609495|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002-2006|0.5|0.7|0.6
0-19|0.3|0.8|0.5|17|Mortality|3645682|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|0.3|0.7|0.5
0-19|0.5|1.0|0.7|26|Mortality|3717226|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|0.5|1.0|0.7
0-19|0.3|0.8|0.5|20|Mortality|3794360|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|0.3|0.8|0.5
0-19|0.4|0.9|0.6|22|Mortality|3876246|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|0.4|0.9|0.6
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|18609495|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|3717226|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|18609495|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|3717226|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.6|1.3|0.9|30|Mortality|3357235|Asian/Pacific Islander|Male and Female|Leukemia|1999|0.6|1.3|0.9
0-19|0.6|1.2|0.9|30|Mortality|3459531|Asian/Pacific Islander|Male and Female|Leukemia|2000|0.6|1.2|0.9
0-19|0.6|1.3|0.9|31|Mortality|3515009|Asian/Pacific Islander|Male and Female|Leukemia|2001|0.6|1.3|0.9
0-19|0.7|1.4|1.0|35|Mortality|3575981|Asian/Pacific Islander|Male and Female|Leukemia|2002|0.7|1.4|1.0
0-19|0.7|0.9|0.8|144|Mortality|18609495|Asian/Pacific Islander|Male and Female|Leukemia|2002-2006|0.7|0.9|0.8
0-19|0.5|1.1|0.8|29|Mortality|3645682|Asian/Pacific Islander|Male and Female|Leukemia|2003|0.5|1.1|0.8
0-19|0.5|1.1|0.8|30|Mortality|3717226|Asian/Pacific Islander|Male and Female|Leukemia|2004|0.5|1.2|0.8
0-19|0.4|1.0|0.7|25|Mortality|3794360|Asian/Pacific Islander|Male and Female|Leukemia|2005|0.4|1.0|0.7
0-19|0.4|0.9|0.6|25|Mortality|3876246|Asian/Pacific Islander|Male and Female|Leukemia|2006|0.4|1.0|0.6
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.2|0.1|22|Mortality|18609495|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|3717226|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.4|0.9|0.6|20|Mortality|3357235|Asian/Pacific Islander|Male and Female|Other|1999|0.4|0.9|0.6
0-19|0.4|1.0|0.7|23|Mortality|3459531|Asian/Pacific Islander|Male and Female|Other|2000|0.4|1.0|0.7
0-19|0.5|1.1|0.7|26|Mortality|3515009|Asian/Pacific Islander|Male and Female|Other|2001|0.5|1.1|0.7
0-19|0.3|0.9|0.5|20|Mortality|3575981|Asian/Pacific Islander|Male and Female|Other|2002|0.3|0.9|0.6
0-19|0.4|0.7|0.5|103|Mortality|18609495|Asian/Pacific Islander|Male and Female|Other|2002-2006|0.5|0.7|0.6
0-19|0.3|0.8|0.5|19|Mortality|3645682|Asian/Pacific Islander|Male and Female|Other|2003|0.3|0.8|0.5
0-19|0.3|0.8|0.5|19|Mortality|3717226|Asian/Pacific Islander|Male and Female|Other|2004|0.3|0.8|0.5
0-19|0.3|0.8|0.5|18|Mortality|3794360|Asian/Pacific Islander|Male and Female|Other|2005|0.3|0.7|0.5
0-19|0.5|1.0|0.7|27|Mortality|3876246|Asian/Pacific Islander|Male and Female|Other|2006|0.5|1.0|0.7
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|3459531|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|3515009|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|3575981|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|~|~|~
0-19|0.1|0.2|0.1|24|Mortality|18609495|Asian/Pacific Islander|Male and Female|Soft Tissue|2002-2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|3645682|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|3717226|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|3794360|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|3876246|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|6426229|Black|Female|Acute Lymphocytic|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6453139|Black|Female|Acute Lymphocytic|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6476551|Black|Female|Acute Lymphocytic|2002|~|~|~
0-19|0.1|0.2|0.1|44|Mortality|32662697|Black|Female|Acute Lymphocytic|2002-2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|6499341|Black|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|6529203|Black|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|6559181|Black|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|6598421|Black|Female|Acute Lymphocytic|2006|~|~|~
0-19|0.1|0.4|0.3|16|Mortality|6375857|Black|Female|Acute Myeloid|1999|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6426229|Black|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|6453139|Black|Female|Acute Myeloid|2001|~|~|~
0-19|0.2|0.5|0.3|19|Mortality|6476551|Black|Female|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.4|0.3|96|Mortality|32662697|Black|Female|Acute Myeloid|2002-2006|0.2|0.4|0.3
0-19|0.2|0.5|0.3|19|Mortality|6499341|Black|Female|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.5|0.4|24|Mortality|6529203|Black|Female|Acute Myeloid|2004|0.2|0.5|0.4
0-19|~|~|~|~|Mortality|6559181|Black|Female|Acute Myeloid|2005|~|~|~
0-19|0.2|0.4|0.3|19|Mortality|6598421|Black|Female|Acute Myeloid|2006|0.2|0.4|0.3
0-19|2.3|3.1|2.7|170|Mortality|6375857|Black|Female|All Cancer Sites Combined|1999|2.3|3.1|2.7
0-19|2.1|2.9|2.5|160|Mortality|6426229|Black|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|1.8|2.6|2.2|140|Mortality|6453139|Black|Female|All Cancer Sites Combined|2001|1.8|2.6|2.2
0-19|2.2|2.9|2.5|163|Mortality|6476551|Black|Female|All Cancer Sites Combined|2002|2.1|2.9|2.5
0-19|2.2|2.5|2.3|766|Mortality|32662697|Black|Female|All Cancer Sites Combined|2002-2006|2.2|2.5|2.3
0-19|1.9|2.6|2.2|143|Mortality|6499341|Black|Female|All Cancer Sites Combined|2003|1.9|2.6|2.2
0-19|2.3|3.1|2.7|176|Mortality|6529203|Black|Female|All Cancer Sites Combined|2004|2.3|3.1|2.7
0-19|1.9|2.6|2.2|145|Mortality|6559181|Black|Female|All Cancer Sites Combined|2005|1.9|2.6|2.2
0-19|1.8|2.5|2.1|139|Mortality|6598421|Black|Female|All Cancer Sites Combined|2006|1.8|2.5|2.1
0-19|~|~|~|~|Mortality|6375857|Black|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|6426229|Black|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|6453139|Black|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6476551|Black|Female|Bones and Joints|2002|~|~|~
0-19|0.1|0.2|0.2|54|Mortality|32662697|Black|Female|Bones and Joints|2002-2006|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6499341|Black|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|6529203|Black|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|6559181|Black|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|6598421|Black|Female|Bones and Joints|2006|~|~|~
0-19|0.5|1.0|0.7|46|Mortality|6375857|Black|Female|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.4|0.8|0.6|37|Mortality|6426229|Black|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.7|0.5|33|Mortality|6453139|Black|Female|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.6|42|Mortality|6476551|Black|Female|Brain and Other Nervous System|2002|0.5|0.9|0.6
0-19|0.6|0.7|0.6|206|Mortality|32662697|Black|Female|Brain and Other Nervous System|2002-2006|0.5|0.7|0.6
0-19|0.4|0.8|0.6|39|Mortality|6499341|Black|Female|Brain and Other Nervous System|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Mortality|6529203|Black|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Mortality|6559181|Black|Female|Brain and Other Nervous System|2005|0.4|0.8|0.5
0-19|0.5|0.9|0.7|45|Mortality|6598421|Black|Female|Brain and Other Nervous System|2006|0.5|0.9|0.7
0-19|~|~|~|~|Mortality|6375857|Black|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6426229|Black|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6453139|Black|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6476551|Black|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|32662697|Black|Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|6499341|Black|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6529203|Black|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6559181|Black|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6598421|Black|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6426229|Black|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6453139|Black|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6476551|Black|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.0|0.1|0.1|21|Mortality|32662697|Black|Female|Kidney and Renal Pelvis|2002-2006|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|6499341|Black|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|6529203|Black|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|6559181|Black|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|6598421|Black|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.4|0.8|0.6|39|Mortality|6375857|Black|Female|Leukemia|1999|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6426229|Black|Female|Leukemia|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6453139|Black|Female|Leukemia|2001|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6476551|Black|Female|Leukemia|2002|0.4|0.8|0.6
0-19|0.5|0.7|0.6|195|Mortality|32662697|Black|Female|Leukemia|2002-2006|0.5|0.7|0.6
0-19|0.4|0.8|0.6|38|Mortality|6499341|Black|Female|Leukemia|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|43|Mortality|6529203|Black|Female|Leukemia|2004|0.5|0.9|0.7
0-19|0.4|0.8|0.6|40|Mortality|6559181|Black|Female|Leukemia|2005|0.4|0.8|0.6
0-19|0.4|0.7|0.5|35|Mortality|6598421|Black|Female|Leukemia|2006|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6375857|Black|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6426229|Black|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6453139|Black|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6476551|Black|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.1|0.1|34|Mortality|32662697|Black|Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6499341|Black|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6529203|Black|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6559181|Black|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6598421|Black|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.4|0.7|0.5|33|Mortality|6375857|Black|Female|Other|1999|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6426229|Black|Female|Other|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|32|Mortality|6453139|Black|Female|Other|2001|0.3|0.7|0.5
0-19|0.5|1.0|0.7|47|Mortality|6476551|Black|Female|Other|2002|0.5|1.0|0.7
0-19|0.5|0.7|0.6|188|Mortality|32662697|Black|Female|Other|2002-2006|0.5|0.7|0.6
0-19|0.3|0.7|0.5|32|Mortality|6499341|Black|Female|Other|2003|0.3|0.7|0.5
0-19|0.5|0.9|0.6|41|Mortality|6529203|Black|Female|Other|2004|0.5|0.9|0.6
0-19|0.4|0.8|0.6|40|Mortality|6559181|Black|Female|Other|2005|0.4|0.8|0.6
0-19|0.3|0.6|0.4|28|Mortality|6598421|Black|Female|Other|2006|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|6375857|Black|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6426229|Black|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6453139|Black|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|6476551|Black|Female|Soft Tissue|2002|~|~|~
0-19|0.1|0.2|0.2|61|Mortality|32662697|Black|Female|Soft Tissue|2002-2006|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6499341|Black|Female|Soft Tissue|2003|~|~|~
0-19|0.2|0.5|0.3|20|Mortality|6529203|Black|Female|Soft Tissue|2004|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6559181|Black|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|6598421|Black|Female|Soft Tissue|2006|~|~|~
0-19|0.3|0.6|0.4|26|Mortality|6562662|Black|Male|Acute Lymphocytic|1999|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6623278|Black|Male|Acute Lymphocytic|2000|0.2|0.5|0.3
0-19|0.3|0.6|0.4|29|Mortality|6663149|Black|Male|Acute Lymphocytic|2001|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6689105|Black|Male|Acute Lymphocytic|2002|0.2|0.5|0.3
0-19|0.2|0.3|0.3|92|Mortality|33705536|Black|Male|Acute Lymphocytic|2002-2006|0.2|0.3|0.3
0-19|0.1|0.4|0.2|16|Mortality|6707522|Black|Male|Acute Lymphocytic|2003|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6736193|Black|Male|Acute Lymphocytic|2004|~|~|~
0-19|0.2|0.5|0.3|22|Mortality|6766834|Black|Male|Acute Lymphocytic|2005|0.2|0.5|0.3
0-19|0.2|0.4|0.3|19|Mortality|6805882|Black|Male|Acute Lymphocytic|2006|0.2|0.4|0.3
0-19|0.2|0.5|0.3|20|Mortality|6562662|Black|Male|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.3|0.6|0.4|25|Mortality|6623278|Black|Male|Acute Myeloid|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|20|Mortality|6663149|Black|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6689105|Black|Male|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|103|Mortality|33705536|Black|Male|Acute Myeloid|2002-2006|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6707522|Black|Male|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.5|0.4|24|Mortality|6736193|Black|Male|Acute Myeloid|2004|0.2|0.5|0.4
0-19|0.2|0.5|0.3|22|Mortality|6766834|Black|Male|Acute Myeloid|2005|0.2|0.5|0.3
0-19|0.1|0.4|0.2|17|Mortality|6805882|Black|Male|Acute Myeloid|2006|0.1|0.4|0.2
0-19|2.8|3.7|3.3|212|Mortality|6562662|Black|Male|All Cancer Sites Combined|1999|2.8|3.7|3.2
0-19|2.7|3.6|3.2|207|Mortality|6623278|Black|Male|All Cancer Sites Combined|2000|2.7|3.6|3.1
0-19|2.7|3.5|3.1|203|Mortality|6663149|Black|Male|All Cancer Sites Combined|2001|2.6|3.5|3.0
0-19|2.7|3.6|3.2|210|Mortality|6689105|Black|Male|All Cancer Sites Combined|2002|2.7|3.6|3.1
0-19|2.7|3.1|2.9|981|Mortality|33705536|Black|Male|All Cancer Sites Combined|2002-2006|2.7|3.1|2.9
0-19|2.4|3.2|2.8|188|Mortality|6707522|Black|Male|All Cancer Sites Combined|2003|2.4|3.2|2.8
0-19|2.5|3.3|2.9|192|Mortality|6736193|Black|Male|All Cancer Sites Combined|2004|2.5|3.3|2.9
0-19|2.6|3.5|3.0|204|Mortality|6766834|Black|Male|All Cancer Sites Combined|2005|2.6|3.5|3.0
0-19|2.4|3.2|2.7|187|Mortality|6805882|Black|Male|All Cancer Sites Combined|2006|2.4|3.2|2.7
0-19|0.1|0.4|0.3|16|Mortality|6562662|Black|Male|Bones and Joints|1999|0.1|0.4|0.2
0-19|0.2|0.5|0.3|21|Mortality|6623278|Black|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6663149|Black|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6689105|Black|Male|Bones and Joints|2002|~|~|~
0-19|0.2|0.3|0.2|81|Mortality|33705536|Black|Male|Bones and Joints|2002-2006|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|6707522|Black|Male|Bones and Joints|2003|~|~|~
0-19|0.2|0.5|0.3|22|Mortality|6736193|Black|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6766834|Black|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6805882|Black|Male|Bones and Joints|2006|~|~|~
0-19|0.5|0.9|0.7|47|Mortality|6562662|Black|Male|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.6|1.0|0.8|51|Mortality|6623278|Black|Male|Brain and Other Nervous System|2000|0.6|1.0|0.8
0-19|0.4|0.7|0.5|34|Mortality|6663149|Black|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.7|1.1|0.9|58|Mortality|6689105|Black|Male|Brain and Other Nervous System|2002|0.7|1.1|0.9
0-19|0.6|0.8|0.7|225|Mortality|33705536|Black|Male|Brain and Other Nervous System|2002-2006|0.6|0.8|0.7
0-19|0.5|0.9|0.7|45|Mortality|6707522|Black|Male|Brain and Other Nervous System|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6736193|Black|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Mortality|6766834|Black|Male|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.4|0.8|0.5|37|Mortality|6805882|Black|Male|Brain and Other Nervous System|2006|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6562662|Black|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6623278|Black|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6663149|Black|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6689105|Black|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|33705536|Black|Male|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|6707522|Black|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6736193|Black|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6766834|Black|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6805882|Black|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6562662|Black|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6623278|Black|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6663149|Black|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6689105|Black|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.1|0.1|0.1|34|Mortality|33705536|Black|Male|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6707522|Black|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|6736193|Black|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|6766834|Black|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|6805882|Black|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.8|1.3|1.0|65|Mortality|6562662|Black|Male|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|62|Mortality|6623278|Black|Male|Leukemia|2000|0.7|1.2|0.9
0-19|0.8|1.3|1.0|67|Mortality|6663149|Black|Male|Leukemia|2001|0.8|1.3|1.0
0-19|0.6|1.0|0.8|52|Mortality|6689105|Black|Male|Leukemia|2002|0.6|1.0|0.8
0-19|0.7|0.9|0.8|268|Mortality|33705536|Black|Male|Leukemia|2002-2006|0.7|0.9|0.8
0-19|0.5|0.9|0.7|47|Mortality|6707522|Black|Male|Leukemia|2003|0.5|0.9|0.7
0-19|0.6|1.1|0.8|54|Mortality|6736193|Black|Male|Leukemia|2004|0.6|1.0|0.8
0-19|0.7|1.1|0.9|60|Mortality|6766834|Black|Male|Leukemia|2005|0.7|1.1|0.9
0-19|0.6|1.1|0.8|55|Mortality|6805882|Black|Male|Leukemia|2006|0.6|1.1|0.8
0-19|~|~|~|~|Mortality|6562662|Black|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6623278|Black|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6663149|Black|Male|Non-Hodgkin Lymphoma|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6689105|Black|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.2|0.2|63|Mortality|33705536|Black|Male|Non-Hodgkin Lymphoma|2002-2006|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6707522|Black|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6736193|Black|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6766834|Black|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|6805882|Black|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.5|0.9|0.7|46|Mortality|6562662|Black|Male|Other|1999|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Mortality|6623278|Black|Male|Other|2000|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6663149|Black|Male|Other|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.7|47|Mortality|6689105|Black|Male|Other|2002|0.5|0.9|0.7
0-19|0.6|0.8|0.7|227|Mortality|33705536|Black|Male|Other|2002-2006|0.6|0.8|0.7
0-19|0.6|1.0|0.8|52|Mortality|6707522|Black|Male|Other|2003|0.6|1.0|0.8
0-19|0.5|0.9|0.7|44|Mortality|6736193|Black|Male|Other|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.6|43|Mortality|6766834|Black|Male|Other|2005|0.5|0.9|0.6
0-19|0.4|0.8|0.6|41|Mortality|6805882|Black|Male|Other|2006|0.4|0.8|0.6
0-19|0.2|0.4|0.3|17|Mortality|6562662|Black|Male|Soft Tissue|1999|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6623278|Black|Male|Soft Tissue|2000|~|~|~
0-19|0.2|0.4|0.3|18|Mortality|6663149|Black|Male|Soft Tissue|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|6689105|Black|Male|Soft Tissue|2002|0.2|0.4|0.3
0-19|0.2|0.3|0.2|77|Mortality|33705536|Black|Male|Soft Tissue|2002-2006|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|6707522|Black|Male|Soft Tissue|2003|~|~|~
0-19|0.1|0.4|0.3|17|Mortality|6736193|Black|Male|Soft Tissue|2004|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6766834|Black|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|6805882|Black|Male|Soft Tissue|2006|~|~|~
0-19|0.2|0.4|0.3|37|Mortality|12938519|Black|Male and Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13049507|Black|Male and Female|Acute Lymphocytic|2000|0.2|0.4|0.3
0-19|0.3|0.5|0.3|45|Mortality|13116288|Black|Male and Female|Acute Lymphocytic|2001|0.3|0.5|0.3
0-19|0.2|0.3|0.2|31|Mortality|13165656|Black|Male and Female|Acute Lymphocytic|2002|0.2|0.3|0.2
0-19|0.2|0.2|0.2|136|Mortality|66368233|Black|Male and Female|Acute Lymphocytic|2002-2006|0.2|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13206863|Black|Male and Female|Acute Lymphocytic|2003|0.1|0.3|0.2
0-19|0.1|0.2|0.2|20|Mortality|13265396|Black|Male and Female|Acute Lymphocytic|2004|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13326015|Black|Male and Female|Acute Lymphocytic|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13404303|Black|Male and Female|Acute Lymphocytic|2006|0.1|0.3|0.2
0-19|0.2|0.4|0.3|36|Mortality|12938519|Black|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13049507|Black|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|33|Mortality|13116288|Black|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|37|Mortality|13165656|Black|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.3|0.3|0.3|199|Mortality|66368233|Black|Male and Female|Acute Myeloid|2002-2006|0.3|0.3|0.3
0-19|0.2|0.4|0.3|41|Mortality|13206863|Black|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.3|0.5|0.4|48|Mortality|13265396|Black|Male and Female|Acute Myeloid|2004|0.3|0.5|0.4
0-19|0.2|0.4|0.3|37|Mortality|13326015|Black|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13404303|Black|Male and Female|Acute Myeloid|2006|0.2|0.4|0.3
0-19|2.7|3.3|3.0|382|Mortality|12938519|Black|Male and Female|All Cancer Sites Combined|1999|2.7|3.3|3.0
0-19|2.6|3.1|2.8|367|Mortality|13049507|Black|Male and Female|All Cancer Sites Combined|2000|2.5|3.1|2.8
0-19|2.4|2.9|2.6|343|Mortality|13116288|Black|Male and Female|All Cancer Sites Combined|2001|2.3|2.9|2.6
0-19|2.6|3.2|2.8|373|Mortality|13165656|Black|Male and Female|All Cancer Sites Combined|2002|2.6|3.1|2.8
0-19|2.5|2.8|2.6|1747|Mortality|66368233|Black|Male and Female|All Cancer Sites Combined|2002-2006|2.5|2.8|2.6
0-19|2.2|2.8|2.5|331|Mortality|13206863|Black|Male and Female|All Cancer Sites Combined|2003|2.2|2.8|2.5
0-19|2.5|3.1|2.8|368|Mortality|13265396|Black|Male and Female|All Cancer Sites Combined|2004|2.5|3.1|2.8
0-19|2.4|2.9|2.6|349|Mortality|13326015|Black|Male and Female|All Cancer Sites Combined|2005|2.4|2.9|2.6
0-19|2.2|2.7|2.4|326|Mortality|13404303|Black|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.4
0-19|0.2|0.3|0.2|29|Mortality|12938519|Black|Male and Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|32|Mortality|13049507|Black|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13116288|Black|Male and Female|Bones and Joints|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13165656|Black|Male and Female|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.2|0.2|135|Mortality|66368233|Black|Male and Female|Bones and Joints|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|21|Mortality|13206863|Black|Male and Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.2|0.4|0.3|35|Mortality|13265396|Black|Male and Female|Bones and Joints|2004|0.2|0.4|0.3
0-19|0.1|0.3|0.2|29|Mortality|13326015|Black|Male and Female|Bones and Joints|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|13404303|Black|Male and Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|0.6|0.9|0.7|93|Mortality|12938519|Black|Male and Female|Brain and Other Nervous System|1999|0.6|0.9|0.7
0-19|0.5|0.8|0.7|88|Mortality|13049507|Black|Male and Female|Brain and Other Nervous System|2000|0.5|0.8|0.7
0-19|0.4|0.6|0.5|67|Mortality|13116288|Black|Male and Female|Brain and Other Nervous System|2001|0.4|0.6|0.5
0-19|0.6|0.9|0.8|100|Mortality|13165656|Black|Male and Female|Brain and Other Nervous System|2002|0.6|0.9|0.8
0-19|0.6|0.7|0.7|431|Mortality|66368233|Black|Male and Female|Brain and Other Nervous System|2002-2006|0.6|0.7|0.6
0-19|0.5|0.8|0.6|84|Mortality|13206863|Black|Male and Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.8|0.6|85|Mortality|13265396|Black|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.6
0-19|0.5|0.8|0.6|80|Mortality|13326015|Black|Male and Female|Brain and Other Nervous System|2005|0.5|0.7|0.6
0-19|0.5|0.8|0.6|82|Mortality|13404303|Black|Male and Female|Brain and Other Nervous System|2006|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13049507|Black|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|13116288|Black|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|13165656|Black|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|66368233|Black|Male and Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|13206863|Black|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|13265396|Black|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|13326015|Black|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|13404303|Black|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|0.1|0.2|0.1|16|Mortality|13049507|Black|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.2|21|Mortality|13116288|Black|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|13165656|Black|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.1|0.1|0.1|55|Mortality|66368233|Black|Male and Female|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|13206863|Black|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|13265396|Black|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|13326015|Black|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|13404303|Black|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.7|1.0|0.8|104|Mortality|12938519|Black|Male and Female|Leukemia|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.8|100|Mortality|13049507|Black|Male and Female|Leukemia|2000|0.6|0.9|0.8
0-19|0.7|1.0|0.8|105|Mortality|13116288|Black|Male and Female|Leukemia|2001|0.7|1.0|0.8
0-19|0.6|0.9|0.7|91|Mortality|13165656|Black|Male and Female|Leukemia|2002|0.6|0.8|0.7
0-19|0.6|0.8|0.7|463|Mortality|66368233|Black|Male and Female|Leukemia|2002-2006|0.6|0.8|0.7
0-19|0.5|0.8|0.6|85|Mortality|13206863|Black|Male and Female|Leukemia|2003|0.5|0.8|0.6
0-19|0.6|0.9|0.7|97|Mortality|13265396|Black|Male and Female|Leukemia|2004|0.6|0.9|0.7
0-19|0.6|0.9|0.7|100|Mortality|13326015|Black|Male and Female|Leukemia|2005|0.6|0.9|0.8
0-19|0.5|0.8|0.7|90|Mortality|13404303|Black|Male and Female|Leukemia|2006|0.5|0.8|0.7
0-19|0.1|0.3|0.2|26|Mortality|12938519|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.3|0.2
0-19|0.1|0.2|0.1|16|Mortality|13049507|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.3|0.2|21|Mortality|13116288|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.3|0.2|23|Mortality|13165656|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.1|97|Mortality|66368233|Black|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|21|Mortality|13206863|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.1|17|Mortality|13265396|Black|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|17|Mortality|13326015|Black|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.2|0.1|19|Mortality|13404303|Black|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|0.5|0.8|0.6|79|Mortality|12938519|Black|Male and Female|Other|1999|0.5|0.8|0.6
0-19|0.5|0.8|0.7|88|Mortality|13049507|Black|Male and Female|Other|2000|0.5|0.8|0.7
0-19|0.4|0.7|0.6|73|Mortality|13116288|Black|Male and Female|Other|2001|0.4|0.7|0.6
0-19|0.6|0.9|0.7|94|Mortality|13165656|Black|Male and Female|Other|2002|0.6|0.9|0.7
0-19|0.6|0.7|0.6|415|Mortality|66368233|Black|Male and Female|Other|2002-2006|0.6|0.7|0.6
0-19|0.5|0.8|0.6|84|Mortality|13206863|Black|Male and Female|Other|2003|0.5|0.8|0.6
0-19|0.5|0.8|0.6|85|Mortality|13265396|Black|Male and Female|Other|2004|0.5|0.8|0.6
0-19|0.5|0.8|0.6|83|Mortality|13326015|Black|Male and Female|Other|2005|0.5|0.8|0.6
0-19|0.4|0.7|0.5|69|Mortality|13404303|Black|Male and Female|Other|2006|0.4|0.7|0.5
0-19|0.2|0.4|0.3|32|Mortality|12938519|Black|Male and Female|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.3|0.2|21|Mortality|13049507|Black|Male and Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13116288|Black|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13165656|Black|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.2|0.2|0.2|138|Mortality|66368233|Black|Male and Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.1|0.3|0.2|24|Mortality|13206863|Black|Male and Female|Soft Tissue|2003|0.1|0.3|0.2
0-19|0.2|0.4|0.3|37|Mortality|13265396|Black|Male and Female|Soft Tissue|2004|0.2|0.4|0.3
0-19|0.1|0.3|0.2|23|Mortality|13326015|Black|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|25|Mortality|13404303|Black|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.4|0.7|0.5|32|Mortality|6382096|Hispanic|Female|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.4|0.7|0.5|34|Mortality|6661704|Hispanic|Female|Acute Lymphocytic|2000|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6856774|Hispanic|Female|Acute Lymphocytic|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.6|44|Mortality|7057875|Hispanic|Female|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.4|0.6|0.5|176|Mortality|37503021|Hispanic|Female|Acute Lymphocytic|2002-2006|0.4|0.5|0.5
0-19|0.3|0.7|0.5|35|Mortality|7265830|Hispanic|Female|Acute Lymphocytic|2003|0.3|0.7|0.5
0-19|0.4|0.8|0.6|41|Mortality|7487405|Hispanic|Female|Acute Lymphocytic|2004|0.4|0.7|0.5
0-19|0.3|0.6|0.4|28|Mortality|7720046|Hispanic|Female|Acute Lymphocytic|2005|0.2|0.5|0.4
0-19|0.2|0.5|0.4|28|Mortality|7971865|Hispanic|Female|Acute Lymphocytic|2006|0.2|0.5|0.4
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6661704|Hispanic|Female|Acute Myeloid|2000|0.1|0.4|0.2
0-19|0.2|0.4|0.3|20|Mortality|6856774|Hispanic|Female|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.4|0.3|19|Mortality|7057875|Hispanic|Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.3|0.3|97|Mortality|37503021|Hispanic|Female|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|21|Mortality|7265830|Hispanic|Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|7487405|Hispanic|Female|Acute Myeloid|2004|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|7720046|Hispanic|Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.1|0.4|0.2|19|Mortality|7971865|Hispanic|Female|Acute Myeloid|2006|0.1|0.4|0.2
0-19|2.2|3.1|2.6|166|Mortality|6382096|Hispanic|Female|All Cancer Sites Combined|1999|2.2|3.0|2.6
0-19|2.2|2.9|2.5|165|Mortality|6661704|Hispanic|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|2.3|3.2|2.7|185|Mortality|6856774|Hispanic|Female|All Cancer Sites Combined|2001|2.3|3.1|2.7
0-19|2.3|3.1|2.7|187|Mortality|7057875|Hispanic|Female|All Cancer Sites Combined|2002|2.3|3.1|2.6
0-19|2.3|2.6|2.5|916|Mortality|37503021|Hispanic|Female|All Cancer Sites Combined|2002-2006|2.3|2.6|2.4
0-19|2.1|2.8|2.4|174|Mortality|7265830|Hispanic|Female|All Cancer Sites Combined|2003|2.1|2.8|2.4
0-19|2.2|2.9|2.5|189|Mortality|7487405|Hispanic|Female|All Cancer Sites Combined|2004|2.2|2.9|2.5
0-19|2.1|2.8|2.5|186|Mortality|7720046|Hispanic|Female|All Cancer Sites Combined|2005|2.1|2.8|2.4
0-19|2.0|2.7|2.3|180|Mortality|7971865|Hispanic|Female|All Cancer Sites Combined|2006|1.9|2.6|2.3
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|18|Mortality|6661704|Hispanic|Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|17|Mortality|6856774|Hispanic|Female|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7057875|Hispanic|Female|Bones and Joints|2002|0.1|0.4|0.2
0-19|0.2|0.3|0.2|75|Mortality|37503021|Hispanic|Female|Bones and Joints|2002-2006|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|7265830|Hispanic|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|7487405|Hispanic|Female|Bones and Joints|2004|~|~|~
0-19|0.1|0.4|0.2|17|Mortality|7720046|Hispanic|Female|Bones and Joints|2005|0.1|0.4|0.2
0-19|0.1|0.3|0.2|16|Mortality|7971865|Hispanic|Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|0.5|0.9|0.6|42|Mortality|6382096|Hispanic|Female|Brain and Other Nervous System|1999|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6661704|Hispanic|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6856774|Hispanic|Female|Brain and Other Nervous System|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|38|Mortality|7057875|Hispanic|Female|Brain and Other Nervous System|2002|0.4|0.7|0.5
0-19|0.5|0.7|0.6|235|Mortality|37503021|Hispanic|Female|Brain and Other Nervous System|2002-2006|0.5|0.7|0.6
0-19|0.5|0.8|0.6|46|Mortality|7265830|Hispanic|Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.9|0.7|54|Mortality|7487405|Hispanic|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.7|56|Mortality|7720046|Hispanic|Female|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.4|0.7|0.5|41|Mortality|7971865|Hispanic|Female|Brain and Other Nervous System|2006|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6661704|Hispanic|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6856774|Hispanic|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7057875|Hispanic|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|37503021|Hispanic|Female|Hodgkin Lymphoma|2002-2006|~|~|~
0-19|~|~|~|~|Mortality|7265830|Hispanic|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7487405|Hispanic|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|7720046|Hispanic|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|7971865|Hispanic|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6661704|Hispanic|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6856774|Hispanic|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7057875|Hispanic|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.0|0.1|0.0|18|Mortality|37503021|Hispanic|Female|Kidney and Renal Pelvis|2002-2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|7265830|Hispanic|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|7487405|Hispanic|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|7720046|Hispanic|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|7971865|Hispanic|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.8|1.4|1.1|67|Mortality|6382096|Hispanic|Female|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|63|Mortality|6661704|Hispanic|Female|Leukemia|2000|0.7|1.2|0.9
0-19|0.9|1.5|1.2|81|Mortality|6856774|Hispanic|Female|Leukemia|2001|0.9|1.5|1.2
0-19|0.8|1.3|1.0|73|Mortality|7057875|Hispanic|Female|Leukemia|2002|0.8|1.3|1.0
0-19|0.8|1.0|0.9|336|Mortality|37503021|Hispanic|Female|Leukemia|2002-2006|0.8|1.0|0.9
0-19|0.7|1.2|0.9|67|Mortality|7265830|Hispanic|Female|Leukemia|2003|0.7|1.2|0.9
0-19|0.7|1.2|1.0|71|Mortality|7487405|Hispanic|Female|Leukemia|2004|0.7|1.2|0.9
0-19|0.6|1.1|0.8|62|Mortality|7720046|Hispanic|Female|Leukemia|2005|0.6|1.0|0.8
0-19|0.6|1.0|0.8|63|Mortality|7971865|Hispanic|Female|Leukemia|2006|0.6|1.0|0.8
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6661704|Hispanic|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6856774|Hispanic|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7057875|Hispanic|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.1|0.1|29|Mortality|37503021|Hispanic|Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|7265830|Hispanic|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7487405|Hispanic|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|7720046|Hispanic|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|7971865|Hispanic|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|6382096|Hispanic|Female|Other|1999|0.2|0.5|0.4
0-19|0.2|0.6|0.4|25|Mortality|6661704|Hispanic|Female|Other|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6856774|Hispanic|Female|Other|2001|0.2|0.5|0.3
0-19|0.3|0.7|0.5|35|Mortality|7057875|Hispanic|Female|Other|2002|0.3|0.7|0.5
0-19|0.3|0.5|0.4|144|Mortality|37503021|Hispanic|Female|Other|2002-2006|0.3|0.5|0.4
0-19|0.2|0.5|0.3|22|Mortality|7265830|Hispanic|Female|Other|2003|0.2|0.5|0.3
0-19|0.3|0.6|0.4|30|Mortality|7487405|Hispanic|Female|Other|2004|0.3|0.6|0.4
0-19|0.2|0.5|0.3|26|Mortality|7720046|Hispanic|Female|Other|2005|0.2|0.5|0.3
0-19|0.3|0.6|0.4|31|Mortality|7971865|Hispanic|Female|Other|2006|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6661704|Hispanic|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6856774|Hispanic|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|7057875|Hispanic|Female|Soft Tissue|2002|~|~|~
0-19|0.2|0.3|0.2|73|Mortality|37503021|Hispanic|Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|~|~|~|~|Mortality|7265830|Hispanic|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|7487405|Hispanic|Female|Soft Tissue|2004|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7720046|Hispanic|Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.4|0.2|18|Mortality|7971865|Hispanic|Female|Soft Tissue|2006|0.1|0.4|0.2
0-19|0.4|0.7|0.5|34|Mortality|6802550|Hispanic|Male|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.6|1.0|0.8|55|Mortality|7095428|Hispanic|Male|Acute Lymphocytic|2000|0.6|1.0|0.8
0-19|0.6|1.1|0.8|59|Mortality|7271497|Hispanic|Male|Acute Lymphocytic|2001|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|7452933|Hispanic|Male|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.6|0.8|0.7|270|Mortality|39427065|Hispanic|Male|Acute Lymphocytic|2002-2006|0.6|0.8|0.7
0-19|0.7|1.1|0.9|65|Mortality|7645229|Hispanic|Male|Acute Lymphocytic|2003|0.7|1.1|0.9
0-19|0.6|1.0|0.8|58|Mortality|7862389|Hispanic|Male|Acute Lymphocytic|2004|0.6|1.0|0.7
0-19|0.5|0.9|0.7|56|Mortality|8102266|Hispanic|Male|Acute Lymphocytic|2005|0.5|0.9|0.7
0-19|0.4|0.7|0.5|44|Mortality|8364248|Hispanic|Male|Acute Lymphocytic|2006|0.4|0.7|0.5
0-19|0.2|0.5|0.4|24|Mortality|6802550|Hispanic|Male|Acute Myeloid|1999|0.2|0.5|0.4
0-19|0.2|0.5|0.3|23|Mortality|7095428|Hispanic|Male|Acute Myeloid|2000|0.2|0.5|0.3
0-19|0.2|0.5|0.3|23|Mortality|7271497|Hispanic|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.5|0.4|26|Mortality|7452933|Hispanic|Male|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.3|0.3|110|Mortality|39427065|Hispanic|Male|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|20|Mortality|7645229|Hispanic|Male|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.5|0.3|26|Mortality|7862389|Hispanic|Male|Acute Myeloid|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|20|Mortality|8102266|Hispanic|Male|Acute Myeloid|2005|0.2|0.4|0.2
0-19|0.1|0.3|0.2|18|Mortality|8364248|Hispanic|Male|Acute Myeloid|2006|0.1|0.3|0.2
0-19|2.5|3.3|2.8|192|Mortality|6802550|Hispanic|Male|All Cancer Sites Combined|1999|2.4|3.3|2.8
0-19|3.1|4.0|3.5|247|Mortality|7095428|Hispanic|Male|All Cancer Sites Combined|2000|3.1|3.9|3.5
0-19|2.9|3.7|3.3|233|Mortality|7271497|Hispanic|Male|All Cancer Sites Combined|2001|2.8|3.6|3.2
0-19|2.8|3.7|3.2|234|Mortality|7452933|Hispanic|Male|All Cancer Sites Combined|2002|2.8|3.6|3.1
0-19|3.0|3.4|3.2|1232|Mortality|39427065|Hispanic|Male|All Cancer Sites Combined|2002-2006|3.0|3.3|3.1
0-19|3.3|4.2|3.7|278|Mortality|7645229|Hispanic|Male|All Cancer Sites Combined|2003|3.2|4.1|3.6
0-19|2.9|3.7|3.3|248|Mortality|7862389|Hispanic|Male|All Cancer Sites Combined|2004|2.8|3.6|3.2
0-19|2.7|3.5|3.1|246|Mortality|8102266|Hispanic|Male|All Cancer Sites Combined|2005|2.7|3.4|3.0
0-19|2.4|3.1|2.7|226|Mortality|8364248|Hispanic|Male|All Cancer Sites Combined|2006|2.4|3.1|2.7
0-19|0.2|0.5|0.3|21|Mortality|6802550|Hispanic|Male|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|22|Mortality|7095428|Hispanic|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|7271497|Hispanic|Male|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7452933|Hispanic|Male|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.3|0.3|101|Mortality|39427065|Hispanic|Male|Bones and Joints|2002-2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|19|Mortality|7645229|Hispanic|Male|Bones and Joints|2003|0.1|0.4|0.2
0-19|0.2|0.5|0.4|25|Mortality|7862389|Hispanic|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|21|Mortality|8102266|Hispanic|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.4|0.3|20|Mortality|8364248|Hispanic|Male|Bones and Joints|2006|0.1|0.4|0.2
0-19|0.4|0.8|0.6|39|Mortality|6802550|Hispanic|Male|Brain and Other Nervous System|1999|0.4|0.8|0.6
0-19|0.7|1.1|0.9|61|Mortality|7095428|Hispanic|Male|Brain and Other Nervous System|2000|0.7|1.1|0.9
0-19|0.4|0.8|0.5|40|Mortality|7271497|Hispanic|Male|Brain and Other Nervous System|2001|0.4|0.7|0.6
0-19|0.5|0.9|0.7|52|Mortality|7452933|Hispanic|Male|Brain and Other Nervous System|2002|0.5|0.9|0.7
0-19|0.6|0.7|0.6|253|Mortality|39427065|Hispanic|Male|Brain and Other Nervous System|2002-2006|0.6|0.7|0.6
0-19|0.6|1.0|0.7|57|Mortality|7645229|Hispanic|Male|Brain and Other Nervous System|2003|0.6|1.0|0.7
0-19|0.5|0.8|0.6|48|Mortality|7862389|Hispanic|Male|Brain and Other Nervous System|2004|0.5|0.8|0.6
0-19|0.4|0.8|0.6|45|Mortality|8102266|Hispanic|Male|Brain and Other Nervous System|2005|0.4|0.7|0.6
0-19|0.4|0.8|0.6|51|Mortality|8364248|Hispanic|Male|Brain and Other Nervous System|2006|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7095428|Hispanic|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7271497|Hispanic|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7452933|Hispanic|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|0.0|0.1|0.0|18|Mortality|39427065|Hispanic|Male|Hodgkin Lymphoma|2002-2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|7645229|Hispanic|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7862389|Hispanic|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|8102266|Hispanic|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8364248|Hispanic|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|7095428|Hispanic|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|7271497|Hispanic|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7452933|Hispanic|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.0|0.1|0.0|19|Mortality|39427065|Hispanic|Male|Kidney and Renal Pelvis|2002-2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|7645229|Hispanic|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|7862389|Hispanic|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|8102266|Hispanic|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|8364248|Hispanic|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.9|1.4|1.1|74|Mortality|6802550|Hispanic|Male|Leukemia|1999|0.9|1.4|1.1
0-19|1.1|1.6|1.3|92|Mortality|7095428|Hispanic|Male|Leukemia|2000|1.0|1.6|1.3
0-19|1.2|1.8|1.5|106|Mortality|7271497|Hispanic|Male|Leukemia|2001|1.2|1.8|1.5
0-19|1.0|1.6|1.3|91|Mortality|7452933|Hispanic|Male|Leukemia|2002|1.0|1.5|1.2
0-19|1.2|1.4|1.3|488|Mortality|39427065|Hispanic|Male|Leukemia|2002-2006|1.1|1.4|1.2
0-19|1.1|1.7|1.4|105|Mortality|7645229|Hispanic|Male|Leukemia|2003|1.1|1.7|1.4
0-19|1.2|1.8|1.5|112|Mortality|7862389|Hispanic|Male|Leukemia|2004|1.2|1.7|1.4
0-19|1.1|1.6|1.3|103|Mortality|8102266|Hispanic|Male|Leukemia|2005|1.0|1.5|1.3
0-19|0.7|1.2|0.9|77|Mortality|8364248|Hispanic|Male|Leukemia|2006|0.7|1.2|0.9
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7095428|Hispanic|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7271497|Hispanic|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7452933|Hispanic|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.2|0.2|57|Mortality|39427065|Hispanic|Male|Non-Hodgkin Lymphoma|2002-2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|7645229|Hispanic|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7862389|Hispanic|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|8102266|Hispanic|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|8364248|Hispanic|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.3|0.6|0.4|29|Mortality|6802550|Hispanic|Male|Other|1999|0.3|0.6|0.4
0-19|0.5|0.9|0.7|49|Mortality|7095428|Hispanic|Male|Other|2000|0.5|0.9|0.7
0-19|0.3|0.6|0.4|31|Mortality|7271497|Hispanic|Male|Other|2001|0.3|0.6|0.4
0-19|0.4|0.8|0.6|46|Mortality|7452933|Hispanic|Male|Other|2002|0.5|0.8|0.6
0-19|0.5|0.6|0.6|222|Mortality|39427065|Hispanic|Male|Other|2002-2006|0.5|0.6|0.6
0-19|0.5|0.9|0.7|54|Mortality|7645229|Hispanic|Male|Other|2003|0.5|0.9|0.7
0-19|0.2|0.5|0.4|28|Mortality|7862389|Hispanic|Male|Other|2004|0.2|0.5|0.4
0-19|0.4|0.8|0.6|48|Mortality|8102266|Hispanic|Male|Other|2005|0.4|0.8|0.6
0-19|0.4|0.7|0.5|46|Mortality|8364248|Hispanic|Male|Other|2006|0.4|0.7|0.5
0-19|0.1|0.4|0.2|16|Mortality|6802550|Hispanic|Male|Soft Tissue|1999|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7095428|Hispanic|Male|Soft Tissue|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7271497|Hispanic|Male|Soft Tissue|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7452933|Hispanic|Male|Soft Tissue|2002|~|~|~
0-19|0.2|0.2|0.2|74|Mortality|39427065|Hispanic|Male|Soft Tissue|2002-2006|0.1|0.2|0.2
0-19|0.2|0.4|0.3|21|Mortality|7645229|Hispanic|Male|Soft Tissue|2003|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|7862389|Hispanic|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|8102266|Hispanic|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|8364248|Hispanic|Male|Soft Tissue|2006|~|~|~
0-19|0.4|0.7|0.5|66|Mortality|13184646|Hispanic|Male and Female|Acute Lymphocytic|1999|0.4|0.6|0.5
0-19|0.5|0.8|0.7|89|Mortality|13757132|Hispanic|Male and Female|Acute Lymphocytic|2000|0.5|0.8|0.6
0-19|0.6|0.9|0.7|99|Mortality|14128271|Hispanic|Male and Female|Acute Lymphocytic|2001|0.6|0.9|0.7
0-19|0.5|0.8|0.7|91|Mortality|14510808|Hispanic|Male and Female|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.5|0.7|0.6|446|Mortality|76930086|Hispanic|Male and Female|Acute Lymphocytic|2002-2006|0.5|0.6|0.6
0-19|0.5|0.8|0.7|100|Mortality|14911059|Hispanic|Male and Female|Acute Lymphocytic|2003|0.5|0.8|0.7
0-19|0.5|0.8|0.7|99|Mortality|15349794|Hispanic|Male and Female|Acute Lymphocytic|2004|0.5|0.8|0.6
0-19|0.4|0.7|0.6|84|Mortality|15822312|Hispanic|Male and Female|Acute Lymphocytic|2005|0.4|0.7|0.5
0-19|0.4|0.6|0.5|72|Mortality|16336113|Hispanic|Male and Female|Acute Lymphocytic|2006|0.3|0.6|0.4
0-19|0.2|0.4|0.3|43|Mortality|13184646|Hispanic|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|39|Mortality|13757132|Hispanic|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|14128271|Hispanic|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|45|Mortality|14510808|Hispanic|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.3|0.3|207|Mortality|76930086|Hispanic|Male and Female|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|41|Mortality|14911059|Hispanic|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|15349794|Hispanic|Male and Female|Acute Myeloid|2004|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|15822312|Hispanic|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|37|Mortality|16336113|Hispanic|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|2.5|3.0|2.7|358|Mortality|13184646|Hispanic|Male and Female|All Cancer Sites Combined|1999|2.4|3.0|2.7
0-19|2.8|3.4|3.0|412|Mortality|13757132|Hispanic|Male and Female|All Cancer Sites Combined|2000|2.7|3.3|3.0
0-19|2.7|3.3|3.0|418|Mortality|14128271|Hispanic|Male and Female|All Cancer Sites Combined|2001|2.7|3.3|3.0
0-19|2.7|3.3|3.0|421|Mortality|14510808|Hispanic|Male and Female|All Cancer Sites Combined|2002|2.6|3.2|2.9
0-19|2.7|3.0|2.9|2148|Mortality|76930086|Hispanic|Male and Female|All Cancer Sites Combined|2002-2006|2.7|2.9|2.8
0-19|2.8|3.4|3.1|452|Mortality|14911059|Hispanic|Male and Female|All Cancer Sites Combined|2003|2.8|3.3|3.0
0-19|2.7|3.2|2.9|437|Mortality|15349794|Hispanic|Male and Female|All Cancer Sites Combined|2004|2.6|3.1|2.8
0-19|2.5|3.1|2.8|432|Mortality|15822312|Hispanic|Male and Female|All Cancer Sites Combined|2005|2.5|3.0|2.7
0-19|2.3|2.8|2.5|406|Mortality|16336113|Hispanic|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.5
0-19|0.2|0.4|0.3|40|Mortality|13184646|Hispanic|Male and Female|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13757132|Hispanic|Male and Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|35|Mortality|14128271|Hispanic|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|32|Mortality|14510808|Hispanic|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|176|Mortality|76930086|Hispanic|Male and Female|Bones and Joints|2002-2006|0.2|0.3|0.2
0-19|0.2|0.4|0.3|34|Mortality|14911059|Hispanic|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.4|0.3|36|Mortality|15349794|Hispanic|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.4|0.3|38|Mortality|15822312|Hispanic|Male and Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|36|Mortality|16336113|Hispanic|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.5|0.7|0.6|81|Mortality|13184646|Hispanic|Male and Female|Brain and Other Nervous System|1999|0.5|0.8|0.6
0-19|0.6|0.9|0.7|100|Mortality|13757132|Hispanic|Male and Female|Brain and Other Nervous System|2000|0.6|0.9|0.7
0-19|0.4|0.7|0.6|79|Mortality|14128271|Hispanic|Male and Female|Brain and Other Nervous System|2001|0.4|0.7|0.6
0-19|0.5|0.8|0.6|90|Mortality|14510808|Hispanic|Male and Female|Brain and Other Nervous System|2002|0.5|0.8|0.6
0-19|0.6|0.7|0.6|488|Mortality|76930086|Hispanic|Male and Female|Brain and Other Nervous System|2002-2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|103|Mortality|14911059|Hispanic|Male and Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.5|0.8|0.7|102|Mortality|15349794|Hispanic|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.7
0-19|0.5|0.8|0.6|101|Mortality|15822312|Hispanic|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.4|0.7|0.6|92|Mortality|16336113|Hispanic|Male and Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13757132|Hispanic|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|14128271|Hispanic|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|14510808|Hispanic|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|0.0|0.1|0.0|24|Mortality|76930086|Hispanic|Male and Female|Hodgkin Lymphoma|2002-2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|14911059|Hispanic|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|15349794|Hispanic|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|15822312|Hispanic|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|16336113|Hispanic|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|13757132|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|14128271|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|14510808|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.0|0.1|0.0|37|Mortality|76930086|Hispanic|Male and Female|Kidney and Renal Pelvis|2002-2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|14911059|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|15349794|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|15822312|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|16336113|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.9|1.3|1.1|141|Mortality|13184646|Hispanic|Male and Female|Leukemia|1999|0.9|1.3|1.1
0-19|1.0|1.3|1.2|155|Mortality|13757132|Hispanic|Male and Female|Leukemia|2000|1.0|1.3|1.1
0-19|1.2|1.6|1.3|187|Mortality|14128271|Hispanic|Male and Female|Leukemia|2001|1.1|1.5|1.3
0-19|1.0|1.4|1.2|164|Mortality|14510808|Hispanic|Male and Female|Leukemia|2002|1.0|1.3|1.1
0-19|1.0|1.2|1.1|824|Mortality|76930086|Hispanic|Male and Female|Leukemia|2002-2006|1.0|1.1|1.1
0-19|1.0|1.4|1.2|172|Mortality|14911059|Hispanic|Male and Female|Leukemia|2003|1.0|1.3|1.2
0-19|1.1|1.4|1.2|183|Mortality|15349794|Hispanic|Male and Female|Leukemia|2004|1.0|1.4|1.2
0-19|0.9|1.3|1.1|165|Mortality|15822312|Hispanic|Male and Female|Leukemia|2005|0.9|1.2|1.0
0-19|0.7|1.0|0.9|140|Mortality|16336113|Hispanic|Male and Female|Leukemia|2006|0.7|1.0|0.9
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13757132|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.2|0.1|17|Mortality|14128271|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|14510808|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.1|0.1|86|Mortality|76930086|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|0.1|0.2|0.1|20|Mortality|14911059|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.1|20|Mortality|15349794|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|15822312|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.2|0.1|19|Mortality|16336113|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|0.3|0.5|0.4|52|Mortality|13184646|Hispanic|Male and Female|Other|1999|0.3|0.5|0.4
0-19|0.4|0.7|0.5|74|Mortality|13757132|Hispanic|Male and Female|Other|2000|0.4|0.7|0.5
0-19|0.3|0.5|0.4|52|Mortality|14128271|Hispanic|Male and Female|Other|2001|0.3|0.5|0.4
0-19|0.4|0.7|0.6|81|Mortality|14510808|Hispanic|Male and Female|Other|2002|0.4|0.7|0.6
0-19|0.4|0.5|0.5|366|Mortality|76930086|Hispanic|Male and Female|Other|2002-2006|0.4|0.5|0.5
0-19|0.4|0.6|0.5|76|Mortality|14911059|Hispanic|Male and Female|Other|2003|0.4|0.6|0.5
0-19|0.3|0.5|0.4|58|Mortality|15349794|Hispanic|Male and Female|Other|2004|0.3|0.5|0.4
0-19|0.4|0.6|0.5|74|Mortality|15822312|Hispanic|Male and Female|Other|2005|0.4|0.6|0.5
0-19|0.4|0.6|0.5|77|Mortality|16336113|Hispanic|Male and Female|Other|2006|0.4|0.6|0.5
0-19|0.1|0.3|0.2|24|Mortality|13184646|Hispanic|Male and Female|Soft Tissue|1999|0.1|0.3|0.2
0-19|0.1|0.3|0.2|26|Mortality|13757132|Hispanic|Male and Female|Soft Tissue|2000|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|14128271|Hispanic|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|14510808|Hispanic|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.2|0.2|0.2|147|Mortality|76930086|Hispanic|Male and Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.2|0.3|0.2|35|Mortality|14911059|Hispanic|Male and Female|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.1|0.2|0.2|25|Mortality|15349794|Hispanic|Male and Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|15822312|Hispanic|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.1|0.3|0.2|30|Mortality|16336113|Hispanic|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.2|0.4|0.3|92|Mortality|30457609|White|Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.3|0.4|0.4|108|Mortality|30582793|White|Female|Acute Lymphocytic|2000|0.3|0.4|0.4
0-19|0.3|0.4|0.3|99|Mortality|30645546|White|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.5|0.4|115|Mortality|30708565|White|Female|Acute Lymphocytic|2002|0.3|0.4|0.4
0-19|0.3|0.4|0.3|499|Mortality|154296842|White|Female|Acute Lymphocytic|2002-2006|0.3|0.4|0.3
0-19|0.3|0.4|0.3|101|Mortality|30780588|White|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.3|0.4|0.3|103|Mortality|30877731|White|Female|Acute Lymphocytic|2004|0.3|0.4|0.3
0-19|0.2|0.3|0.3|84|Mortality|30926640|White|Female|Acute Lymphocytic|2005|0.2|0.3|0.3
0-19|0.3|0.4|0.3|96|Mortality|31003318|White|Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.2|0.3|0.3|83|Mortality|30457609|White|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|76|Mortality|30582793|White|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.4|0.3|94|Mortality|30645546|White|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|76|Mortality|30708565|White|Female|Acute Myeloid|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|357|Mortality|154296842|White|Female|Acute Myeloid|2002-2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|67|Mortality|30780588|White|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|69|Mortality|30877731|White|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|78|Mortality|30926640|White|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|67|Mortality|31003318|White|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|2.3|2.7|2.5|760|Mortality|30457609|White|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.7|2.5|767|Mortality|30582793|White|Female|All Cancer Sites Combined|2000|2.3|2.7|2.5
0-19|2.4|2.8|2.6|803|Mortality|30645546|White|Female|All Cancer Sites Combined|2001|2.4|2.8|2.6
0-19|2.4|2.7|2.5|776|Mortality|30708565|White|Female|All Cancer Sites Combined|2002|2.4|2.7|2.5
0-19|2.3|2.5|2.4|3702|Mortality|154296842|White|Female|All Cancer Sites Combined|2002-2006|2.3|2.5|2.4
0-19|2.3|2.6|2.5|756|Mortality|30780588|White|Female|All Cancer Sites Combined|2003|2.3|2.6|2.5
0-19|2.3|2.6|2.4|753|Mortality|30877731|White|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.6|2.4|741|Mortality|30926640|White|Female|All Cancer Sites Combined|2005|2.2|2.6|2.4
0-19|2.0|2.3|2.2|676|Mortality|31003318|White|Female|All Cancer Sites Combined|2006|2.0|2.4|2.2
0-19|0.2|0.3|0.2|74|Mortality|30457609|White|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|30582793|White|Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|64|Mortality|30645546|White|Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|72|Mortality|30708565|White|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.2|0.2|315|Mortality|154296842|White|Female|Bones and Joints|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|53|Mortality|30780588|White|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|55|Mortality|30877731|White|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|77|Mortality|30926640|White|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.2|58|Mortality|31003318|White|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.6|0.8|0.7|201|Mortality|30457609|White|Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.5|0.7|0.6|189|Mortality|30582793|White|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.8|0.7|209|Mortality|30645546|White|Female|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.5|0.7|0.6|191|Mortality|30708565|White|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.7|0.6|991|Mortality|154296842|White|Female|Brain and Other Nervous System|2002-2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|220|Mortality|30780588|White|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|199|Mortality|30877731|White|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.6|0.8|0.7|204|Mortality|30926640|White|Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.5|0.7|0.6|177|Mortality|31003318|White|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|~|~|~|~|Mortality|30457609|White|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|0.0|0.1|0.1|16|Mortality|30582793|White|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|30645546|White|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|30708565|White|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|0.0|0.0|0.0|39|Mortality|154296842|White|Female|Hodgkin Lymphoma|2002-2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|30780588|White|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|30877731|White|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|30926640|White|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|31003318|White|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|0.0|0.1|0.1|20|Mortality|30457609|White|Female|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|18|Mortality|30582793|White|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30645546|White|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30708565|White|Female|Kidney and Renal Pelvis|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|126|Mortality|154296842|White|Female|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30780588|White|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30877731|White|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|30926640|White|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|31003318|White|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.7|0.9|0.8|238|Mortality|30457609|White|Female|Leukemia|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|253|Mortality|30582793|White|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.8|1.0|0.9|265|Mortality|30645546|White|Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|236|Mortality|30708565|White|Female|Leukemia|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1107|Mortality|154296842|White|Female|Leukemia|2002-2006|0.7|0.8|0.7
0-19|0.6|0.8|0.7|227|Mortality|30780588|White|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.8|0.7|222|Mortality|30877731|White|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|206|Mortality|30926640|White|Female|Leukemia|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|216|Mortality|31003318|White|Female|Leukemia|2006|0.6|0.8|0.7
0-19|0.0|0.1|0.1|22|Mortality|30457609|White|Female|Non-Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30582793|White|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|30645546|White|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30708565|White|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|113|Mortality|154296842|White|Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|26|Mortality|30780588|White|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|30877731|White|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|30926640|White|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|31003318|White|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.4|0.6|0.5|149|Mortality|30457609|White|Female|Other|1999|0.4|0.6|0.5
0-19|0.4|0.6|0.5|151|Mortality|30582793|White|Female|Other|2000|0.4|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|30645546|White|Female|Other|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|30708565|White|Female|Other|2002|0.4|0.6|0.5
0-19|0.4|0.5|0.5|726|Mortality|154296842|White|Female|Other|2002-2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|141|Mortality|30780588|White|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.6|0.5|157|Mortality|30877731|White|Female|Other|2004|0.4|0.6|0.5
0-19|0.3|0.5|0.4|128|Mortality|30926640|White|Female|Other|2005|0.3|0.5|0.4
0-19|0.4|0.5|0.5|142|Mortality|31003318|White|Female|Other|2006|0.4|0.5|0.5
0-19|0.1|0.2|0.1|43|Mortality|30457609|White|Female|Soft Tissue|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|30582793|White|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|50|Mortality|30645546|White|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|59|Mortality|30708565|White|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.2|0.2|0.2|285|Mortality|154296842|White|Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|51|Mortality|30780588|White|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|58|Mortality|30877731|White|Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|73|Mortality|30926640|White|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.1|0.2|0.1|44|Mortality|31003318|White|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.4|0.5|0.4|144|Mortality|32187349|White|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.5|0.6|0.5|176|Mortality|32321639|White|Male|Acute Lymphocytic|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|32384728|White|Male|Acute Lymphocytic|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|32424510|White|Male|Acute Lymphocytic|2002|0.4|0.6|0.5
0-19|0.4|0.5|0.5|764|Mortality|162641291|White|Male|Acute Lymphocytic|2002-2006|0.4|0.5|0.5
0-19|0.5|0.6|0.6|180|Mortality|32460332|White|Male|Acute Lymphocytic|2003|0.5|0.6|0.6
0-19|0.4|0.5|0.5|151|Mortality|32537175|White|Male|Acute Lymphocytic|2004|0.4|0.5|0.5
0-19|0.4|0.5|0.4|146|Mortality|32573909|White|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.3|0.5|0.4|129|Mortality|32645365|White|Male|Acute Lymphocytic|2006|0.3|0.5|0.4
0-19|0.2|0.3|0.2|75|Mortality|32187349|White|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|95|Mortality|32321639|White|Male|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.3|0.3|89|Mortality|32384728|White|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32424510|White|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|420|Mortality|162641291|White|Male|Acute Myeloid|2002-2006|0.2|0.3|0.3
0-19|0.2|0.3|0.3|84|Mortality|32460332|White|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32537175|White|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|80|Mortality|32573909|White|Male|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|84|Mortality|32645365|White|Male|Acute Myeloid|2006|0.2|0.3|0.3
0-19|2.9|3.3|3.1|994|Mortality|32187349|White|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1032|Mortality|32321639|White|Male|All Cancer Sites Combined|2000|3.0|3.4|3.2
0-19|2.8|3.2|3.0|971|Mortality|32384728|White|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1006|Mortality|32424510|White|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|3.0|3.1|3.0|4960|Mortality|162641291|White|Male|All Cancer Sites Combined|2002-2006|3.0|3.1|3.0
0-19|3.0|3.4|3.2|1041|Mortality|32460332|White|Male|All Cancer Sites Combined|2003|3.0|3.4|3.2
0-19|2.9|3.3|3.1|995|Mortality|32537175|White|Male|All Cancer Sites Combined|2004|2.9|3.3|3.1
0-19|2.9|3.2|3.0|993|Mortality|32573909|White|Male|All Cancer Sites Combined|2005|2.9|3.2|3.0
0-19|2.6|3.0|2.8|925|Mortality|32645365|White|Male|All Cancer Sites Combined|2006|2.7|3.0|2.8
0-19|0.2|0.4|0.3|94|Mortality|32187349|White|Male|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.3|0.3|82|Mortality|32321639|White|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.4|0.3|95|Mortality|32384728|White|Male|Bones and Joints|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|79|Mortality|32424510|White|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.3|452|Mortality|162641291|White|Male|Bones and Joints|2002-2006|0.3|0.3|0.3
0-19|0.3|0.4|0.3|103|Mortality|32460332|White|Male|Bones and Joints|2003|0.3|0.4|0.3
0-19|0.2|0.3|0.3|92|Mortality|32537175|White|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.4|0.3|98|Mortality|32573909|White|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|80|Mortality|32645365|White|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.6|0.8|0.7|230|Mortality|32187349|White|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|248|Mortality|32321639|White|Male|Brain and Other Nervous System|2000|0.7|0.9|0.8
0-19|0.6|0.8|0.7|219|Mortality|32384728|White|Male|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.7|0.9|0.8|249|Mortality|32424510|White|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1212|Mortality|162641291|White|Male|Brain and Other Nervous System|2002-2006|0.7|0.8|0.7
0-19|0.7|0.9|0.8|250|Mortality|32460332|White|Male|Brain and Other Nervous System|2003|0.7|0.9|0.8
0-19|0.7|0.8|0.7|241|Mortality|32537175|White|Male|Brain and Other Nervous System|2004|0.7|0.8|0.7
0-19|0.6|0.8|0.7|234|Mortality|32573909|White|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.8|0.7|238|Mortality|32645365|White|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.0|0.1|0.1|21|Mortality|32187349|White|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32321639|White|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|32384728|White|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.1|17|Mortality|32424510|White|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.1
0-19|0.0|0.1|0.0|65|Mortality|162641291|White|Male|Hodgkin Lymphoma|2002-2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|32460332|White|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|32537175|White|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|32573909|White|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|32645365|White|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|0.0|0.1|0.1|24|Mortality|32187349|White|Male|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|17|Mortality|32321639|White|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32384728|White|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|0.0|0.1|0.1|17|Mortality|32424510|White|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|102|Mortality|162641291|White|Male|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|32460332|White|Male|Kidney and Renal Pelvis|2003|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|32537175|White|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32573909|White|Male|Kidney and Renal Pelvis|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32645365|White|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.8|1.0|0.9|296|Mortality|32187349|White|Male|Leukemia|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|343|Mortality|32321639|White|Male|Leukemia|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|321|Mortality|32384728|White|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.1|1.0|310|Mortality|32424510|White|Male|Leukemia|2002|0.9|1.1|1.0
0-19|0.9|1.0|0.9|1541|Mortality|162641291|White|Male|Leukemia|2002-2006|0.9|1.0|0.9
0-19|0.9|1.1|1.0|335|Mortality|32460332|White|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|310|Mortality|32537175|White|Male|Leukemia|2004|0.8|1.1|1.0
0-19|0.8|1.0|0.9|302|Mortality|32573909|White|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|1.0|0.9|284|Mortality|32645365|White|Male|Leukemia|2006|0.8|1.0|0.9
0-19|0.1|0.2|0.2|53|Mortality|32187349|White|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.3|0.2|66|Mortality|32321639|White|Male|Non-Hodgkin Lymphoma|2000|0.2|0.3|0.2
0-19|0.1|0.2|0.2|56|Mortality|32384728|White|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32424510|White|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.2|0.2|0.2|278|Mortality|162641291|White|Male|Non-Hodgkin Lymphoma|2002-2006|0.2|0.2|0.2
0-19|0.1|0.2|0.1|48|Mortality|32460332|White|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|32537175|White|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32573909|White|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|54|Mortality|32645365|White|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.5|0.7|0.6|203|Mortality|32187349|White|Male|Other|1999|0.5|0.7|0.6
0-19|0.6|0.7|0.6|208|Mortality|32321639|White|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|187|Mortality|32384728|White|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|214|Mortality|32424510|White|Male|Other|2002|0.6|0.8|0.7
0-19|0.6|0.6|0.6|995|Mortality|162641291|White|Male|Other|2002-2006|0.6|0.7|0.6
0-19|0.5|0.7|0.6|200|Mortality|32460332|White|Male|Other|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|205|Mortality|32537175|White|Male|Other|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|208|Mortality|32573909|White|Male|Other|2005|0.6|0.7|0.6
0-19|0.4|0.6|0.5|168|Mortality|32645365|White|Male|Other|2006|0.4|0.6|0.5
0-19|0.2|0.3|0.2|73|Mortality|32187349|White|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32321639|White|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|65|Mortality|32384728|White|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.1|0.2|0.2|59|Mortality|32424510|White|Male|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.2|0.2|0.2|315|Mortality|162641291|White|Male|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.2|0.3|0.2|70|Mortality|32460332|White|Male|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32537175|White|Male|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|57|Mortality|32573909|White|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.3|0.2|67|Mortality|32645365|White|Male|Soft Tissue|2006|0.2|0.3|0.2
0-19|0.3|0.4|0.4|236|Mortality|62644958|White|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.5|284|Mortality|62904432|White|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.5
0-19|0.4|0.5|0.4|253|Mortality|63030274|White|Male and Female|Acute Lymphocytic|2001|0.4|0.5|0.4
0-19|0.4|0.5|0.4|273|Mortality|63133075|White|Male and Female|Acute Lymphocytic|2002|0.4|0.5|0.4
0-19|0.4|0.4|0.4|1263|Mortality|316938133|White|Male and Female|Acute Lymphocytic|2002-2006|0.4|0.4|0.4
0-19|0.4|0.5|0.4|281|Mortality|63240920|White|Male and Female|Acute Lymphocytic|2003|0.4|0.5|0.4
0-19|0.4|0.5|0.4|254|Mortality|63414906|White|Male and Female|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.3|0.4|0.4|230|Mortality|63500549|White|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.4
0-19|0.3|0.4|0.4|225|Mortality|63648683|White|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.2|0.3|0.3|158|Mortality|62644958|White|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|171|Mortality|62904432|White|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.3|0.3|0.3|183|Mortality|63030274|White|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|162|Mortality|63133075|White|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|777|Mortality|316938133|White|Male and Female|Acute Myeloid|2002-2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|151|Mortality|63240920|White|Male and Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|155|Mortality|63414906|White|Male and Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|158|Mortality|63500549|White|Male and Female|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|151|Mortality|63648683|White|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|2.7|2.9|2.8|1754|Mortality|62644958|White|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|3.0|2.9|1799|Mortality|62904432|White|Male and Female|All Cancer Sites Combined|2000|2.7|3.0|2.9
0-19|2.7|2.9|2.8|1774|Mortality|63030274|White|Male and Female|All Cancer Sites Combined|2001|2.7|2.9|2.8
0-19|2.7|3.0|2.8|1782|Mortality|63133075|White|Male and Female|All Cancer Sites Combined|2002|2.7|3.0|2.8
0-19|2.7|2.8|2.7|8662|Mortality|316938133|White|Male and Female|All Cancer Sites Combined|2002-2006|2.7|2.8|2.7
0-19|2.7|3.0|2.8|1797|Mortality|63240920|White|Male and Female|All Cancer Sites Combined|2003|2.7|3.0|2.8
0-19|2.6|2.9|2.8|1748|Mortality|63414906|White|Male and Female|All Cancer Sites Combined|2004|2.6|2.9|2.8
0-19|2.6|2.9|2.7|1734|Mortality|63500549|White|Male and Female|All Cancer Sites Combined|2005|2.6|2.9|2.7
0-19|2.4|2.6|2.5|1601|Mortality|63648683|White|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|0.2|0.3|0.3|168|Mortality|62644958|White|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|144|Mortality|62904432|White|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.3|159|Mortality|63030274|White|Male and Female|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63133075|White|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|767|Mortality|316938133|White|Male and Female|Bones and Joints|2002-2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|156|Mortality|63240920|White|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|147|Mortality|63414906|White|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|175|Mortality|63500549|White|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|138|Mortality|63648683|White|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.6|0.8|0.7|431|Mortality|62644958|White|Male and Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|437|Mortality|62904432|White|Male and Female|Brain and Other Nervous System|2000|0.6|0.8|0.7
0-19|0.6|0.7|0.7|428|Mortality|63030274|White|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.7
0-19|0.6|0.8|0.7|440|Mortality|63133075|White|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.7|0.7|2203|Mortality|316938133|White|Male and Female|Brain and Other Nervous System|2002-2006|0.7|0.7|0.7
0-19|0.7|0.8|0.7|470|Mortality|63240920|White|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.8|0.7|440|Mortality|63414906|White|Male and Female|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|438|Mortality|63500549|White|Male and Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|415|Mortality|63648683|White|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.7
0-19|0.0|0.1|0.1|34|Mortality|62644958|White|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|22|Mortality|62904432|White|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63030274|White|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63133075|White|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|104|Mortality|316938133|White|Male and Female|Hodgkin Lymphoma|2002-2006|0.0|0.0|0.0
0-19|0.0|0.0|0.0|20|Mortality|63240920|White|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|20|Mortality|63414906|White|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63500549|White|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63648683|White|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|44|Mortality|62644958|White|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|35|Mortality|62904432|White|Male and Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63030274|White|Male and Female|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63133075|White|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|228|Mortality|316938133|White|Male and Female|Kidney and Renal Pelvis|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|53|Mortality|63240920|White|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|48|Mortality|63414906|White|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|45|Mortality|63500549|White|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63648683|White|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.8|0.9|0.9|534|Mortality|62644958|White|Male and Female|Leukemia|1999|0.8|0.9|0.9
0-19|0.9|1.0|0.9|596|Mortality|62904432|White|Male and Female|Leukemia|2000|0.9|1.0|0.9
0-19|0.9|1.0|0.9|586|Mortality|63030274|White|Male and Female|Leukemia|2001|0.9|1.0|0.9
0-19|0.8|0.9|0.9|546|Mortality|63133075|White|Male and Female|Leukemia|2002|0.8|0.9|0.9
0-19|0.8|0.9|0.8|2648|Mortality|316938133|White|Male and Female|Leukemia|2002-2006|0.8|0.9|0.8
0-19|0.8|1.0|0.9|562|Mortality|63240920|White|Male and Female|Leukemia|2003|0.8|1.0|0.9
0-19|0.8|0.9|0.8|532|Mortality|63414906|White|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.9|0.8|508|Mortality|63500549|White|Male and Female|Leukemia|2005|0.7|0.9|0.8
0-19|0.7|0.9|0.8|500|Mortality|63648683|White|Male and Female|Leukemia|2006|0.7|0.9|0.8
0-19|0.1|0.2|0.1|75|Mortality|62644958|White|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|90|Mortality|62904432|White|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|78|Mortality|63030274|White|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|88|Mortality|63133075|White|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.1|0.1|391|Mortality|316938133|White|Male and Female|Non-Hodgkin Lymphoma|2002-2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|74|Mortality|63240920|White|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.2|0.1|79|Mortality|63414906|White|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|83|Mortality|63500549|White|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|67|Mortality|63648683|White|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.5|0.6|0.6|352|Mortality|62644958|White|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|359|Mortality|62904432|White|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.5|341|Mortality|63030274|White|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.5|0.7|0.6|372|Mortality|63133075|White|Male and Female|Other|2002|0.5|0.7|0.6
0-19|0.5|0.6|0.5|1721|Mortality|316938133|White|Male and Female|Other|2002-2006|0.5|0.6|0.5
0-19|0.5|0.6|0.5|341|Mortality|63240920|White|Male and Female|Other|2003|0.5|0.6|0.5
0-19|0.5|0.6|0.6|362|Mortality|63414906|White|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.6|0.5|336|Mortality|63500549|White|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.4|0.5|0.5|310|Mortality|63648683|White|Male and Female|Other|2006|0.4|0.5|0.5
0-19|0.2|0.2|0.2|116|Mortality|62644958|White|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|116|Mortality|62904432|White|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.2|0.2|0.2|115|Mortality|63030274|White|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|118|Mortality|63133075|White|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|600|Mortality|316938133|White|Male and Female|Soft Tissue|2002-2006|0.2|0.2|0.2
0-19|0.2|0.2|0.2|121|Mortality|63240920|White|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|120|Mortality|63414906|White|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|130|Mortality|63500549|White|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.1|0.2|0.2|111|Mortality|63648683|White|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
